Coping with stress: The Impact of the Hypothalamus Pituitary Adrenal (HPA) System and Neurotrophic Circuits in the Learned Helplessness Model of Depression by Chourbaji, Sabine
From the Group of Behavioural Biology, Institute of Psychiatry 
Central Institute of Mental Health (Director Prof. Dr. Dr. Fritz A. Henn) 
University of Heidelberg 
(PD Dr. Peter Gass) 
 
 
 
 
 
 
 
Coping with stress: 
The Impact of the Hypothalamus Pituitary Adrenal (HPA) System and 
Neurotrophic Circuits in the Learned Helplessness Model of 
Depression 
 
 
 
 
 
 
 
 
 
 
 
 
Doctoral Thesis 
 
Ruprecht-Karls-University of Heidelberg 
presented by Sabine Chourbaji 
from Heidelberg 
2005
www.pdfmailer.de   PDFMAILER.DE 
 
Kostenfrei und werbegesponsert PDF drucken und direkt per E-Mail 
versenden >Test it free www.pdfmailer.de 
  2 
Index: 
ABSTRACT ............................................................................................................................. 5 
1 INTRODUCTION .............................................................................................. 6 
1.1 DEPRESSION......................................................................................................... 6 
1.1.1 THEORETICAL CONCEPTS OF PATHOPHYSIOLOGY AND TREATMENT OF DEPRESSION 7 
1.1.2 THE MONOAMINE HYPOTHESIS.............................................................................. 8 
1.1.3 THE NEUROTROPHIN HYPOTHESIS ......................................................................... 9 
1.1.4 THE STRESS HYPOTHESIS .................................................................................... 11 
1.1.5 NEUROGENESIS ................................................................................................... 14 
1.1.6 THE MACROPHAGE THEORY OF DEPRESSION........................................................ 14 
1.2 ANIMAL MODELS OF DEPRESSION ..................................................................... 15 
1.2.1 LESION MODELS.................................................................................................. 16 
1.2.2 CHRONIC MILD STRESS ....................................................................................... 17 
1.2.3 LEARNED HELPLESSNESS..................................................................................... 17 
1.2.4 GENETIC APPROACHES ........................................................................................ 18 
1.2.4.1 BDNF Heterozygous Mice (BDNF+/-)................................................................. 18 
1.2.4.2 CREB Ser142A Mutant Mice.................................................................................. 19 
1.2.4.3 Glucocorticoid Receptor Mutant Mice and Current Implications......................... 19 
1.2.4.4 Interleukin-6 Receptor Mutant Mice (IL-6-/-) ..................................................... 22 
1.2.4.5 Endothelial Nitric Oxide Deficient Mice (NOS III)............................................. 22 
1.3 CURRENT TREATMENT CONCEPTS OF DEPRESSION........................................... 23 
1.4 CONCEPTUAL CONSIDERATIONS........................................................................ 24 
1.5 AIM OF THIS THESIS........................................................................................... 26 
2 MATERIAL AND METHODS........................................................................ 28 
2.1 ANIMALS ............................................................................................................ 28 
2.1.1 HOUSING CONDITIONS......................................................................................... 28 
2.2 GENETIC APPROACHES...................................................................................... 29 
2.2.1 BDNF HETEROZYGOUS ANIMALS (BDNF+/-) ....................................................... 29 
2.2.2 CREB SER142A MUTANT ANIMALS......................................................................... 30 
2.2.3 GLUCOCORTICOID HETEROZYGOUS ANIMALS (GR+/-)........................................... 30 
2.2.4 GLUCOCORTICOID OVEREXPRESSING ANIMALS (YGRS)....................................... 30 
2.2.5 INTERLEUKIN-6 KNOCK-OUT ANIMALS (IL-6-/-).................................................... 30 
2.2.6 ENDOTHELIAL NITRIC OXIDE SYNTHASE KNOCK-OUT ANIMALS (NOS III-/-)......... 31 
2.3 BEHAVIOURAL ANALYSIS................................................................................... 31 
2.3.1 BASAL BEHAVIOUR ............................................................................................. 31 
2.3.1.1 Motoric Abilities ................................................................................................ 31 
2.3.1.2 Openfield ........................................................................................................... 31 
2.3.1.3 Novel Cage......................................................................................................... 32 
2.3.1.4 Barrier Test ........................................................................................................ 33 
2.3.1.5 Dark-Light Box (DLB)....................................................................................... 33 
2.3.1.6 O-Maze .............................................................................................................. 34 
2.3.1.7 Marble-Burying (Defensive Burying) ................................................................. 34 
www.pdfmailer.de   PDFMAILER.DE 
 
Kostenfrei und werbegesponsert PDF drucken und direkt per E-Mail 
versenden >Test it free www.pdfmailer.de 
  3 
2.3.2 LEARNING........................................................................................................... 34 
2.3.2.1 Fear Conditioning............................................................................................... 34 
2.3.2.2 T-Maze............................................................................................................... 35 
2.3.3 DEPRESSION-LINKED BEHAVIOUR ........................................................................ 36 
2.3.3.1 Porsolt Forced Swim Test ................................................................................... 36 
2.3.3.2 Sucrose Consumption ......................................................................................... 37 
2.3.4 NOVEL OBJECT TEST ........................................................................................... 37 
2.3.4.1 Learned Helplessness ......................................................................................... 38 
2.4 STRESS ENDOCRINOLOGY.................................................................................. 39 
2.4.1 CORTICOSTERONE DETERMINATION..................................................................... 39 
2.4.2 DEXAMETHASONE TEST (DEX-TEST) AND DEX/CRH-TEST .................................. 40 
2.4.3 ACTH DETERMINATION...................................................................................... 41 
2.5 NEUROTROPHINS AND MONOAMINES................................................................. 41 
2.5.1 BRAIN–DERIVED NEUROTROPHIC FACTOR AND NERVE GROWTH FACTOR ............ 42 
2.5.2 TIME COURSE EXPERIMENT ................................................................................. 42 
2.5.3 MONOAMINES AND CHOLINE ACETYLTRANSFERASE ............................................ 42 
2.6 INTERLEUKIN-6 (IL-6) ....................................................................................... 43 
2.7 PHARMACOLOGICAL EXPERIMENTS .................................................................. 43 
2.7.1 PHARMACOLOGICAL VALIDATION........................................................................ 43 
2.8 STATISTICAL EVALUATION ................................................................................ 44 
3 RESULTS ......................................................................................................... 45 
3.1 ESTABLISHMENT OF THE LEARNED HELPLESSNESS PARADIGM......................... 45 
3.1.1 PROTOCOLS......................................................................................................... 45 
3.1.2 FINAL PROTOCOL FOR THE LEARNED HELPLESSNESS:........................................... 47 
3.1.3 VALIDATION ....................................................................................................... 48 
3.1.4 NEUROTROPHIN TIMECOURSE.............................................................................. 48 
3.1.5 ASSOCIATED PARAMETERS .................................................................................. 49 
3.1.6 CHRONIC STRESS AND HOUSING CONDITIONS ...................................................... 49 
3.1.6.1 Group Housing Affects Exploratory Behaviour but not Locomotion ................... 49 
3.1.6.2 Group Housing and Enrichment Evoke Reduced Anxiety-like Behaviour ........... 50 
3.1.6.3 Housing Conditions Affect the Coping Behaviour in the Learned Helplessness 
Paradigm ......................................................................................................... 52 
3.1.6.4 Hotplate: Housing Conditions do not Affect Pain Sensitivity .............................. 53 
3.2 GENETIC APPROACH.......................................................................................... 53 
3.2.1 BDNF+/- ANIMALS DO NOT REPRESENT AN ANIMAL MODEL OF DEPRESSION......... 53 
3.2.1.1 Basal Behaviour ................................................................................................. 54 
3.2.1.2 Depressive-Linked Behaviour............................................................................. 55 
3.2.1.3 Stress Endocrinology.......................................................................................... 56 
3.2.1.4 Neurotrophins and Monoamines ......................................................................... 57 
3.2.2 CREBS142A ANIMALS DO NOT REPRESENT AN ANIMAL MODEL OF DEPRESSION ..... 58 
3.2.2.1 Basal Behaviour ................................................................................................. 59 
3.2.2.2 Depressive-Linked Behaviour............................................................................. 59 
3.2.2.3 Stress Endocrinology.......................................................................................... 60 
3.2.3 GR+/- ANIMALS DISPLAY A DEPRESSIVE-LIKE PHENOTYPE WITH CHARACTERISTIC 
STRESSPHYSIOLOGY IN THE DEX/CRH TEST AND REDUCTION OF NEUROTROPHINS
........................................................................................................................... 61 
www.pdfmailer.de   PDFMAILER.DE 
 
Kostenfrei und werbegesponsert PDF drucken und direkt per E-Mail 
versenden >Test it free www.pdfmailer.de 
  4 
3.2.3.1 Basal Behaviour ................................................................................................. 62 
3.2.3.2 Depressive-Linked Behaviour............................................................................. 63 
3.2.3.3 Stress Endocrinology.......................................................................................... 63 
3.2.3.4 Neurotrophins..................................................................................................... 65 
3.2.4 YGR MUTANT ANIMALS DEMONSTRATE AN ANTI-DEPRESSIVE PHENOTYPE ........ 66 
3.2.4.1 Basal Behaviour ................................................................................................. 66 
3.2.4.2 Depressive-Linked Behaviour............................................................................. 66 
3.2.4.3 Stress Endocrinology.......................................................................................... 67 
3.2.4.4 Neurotrophins..................................................................................................... 68 
3.2.5 IL-6 DEFICIENT ANIMALS DEMONSTRATE A STRESS RESISTANCE ......................... 69 
3.2.5.1 Basal Behaviour ................................................................................................. 70 
3.2.5.2 Depressive-Linked Behaviour............................................................................. 70 
3.2.6 NOS III (-/-) MUTANT ANIMALS .......................................................................... 71 
3.2.6.1 Basal Behaviour ................................................................................................. 71 
3.2.6.2 Depressive-Linked Behaviour............................................................................. 71 
4 DISCUSSION ................................................................................................... 73 
4.1 GENERAL DISCUSSION ....................................................................................... 73 
4.2 THE LEARNED HELPLESSNESS AS A MODEL OF DEPRESSION............................. 74 
4.3 ROLE OF NEUROTROPHIC CIRCUITS.................................................................. 77 
4.3.1 BRAIN-DERIVED NEUROTROPHIC FACTOR............................................................ 77 
4.3.2 CREB................................................................................................................. 79 
4.4 ROLE OF THE HPA SYSTEM............................................................................... 81 
4.4.1 GLUCOCORTICOID RECEPTOR .............................................................................. 81 
4.5 ROLE OF INTERLEUKIN-6................................................................................... 84 
4.6 ROLE OF NOS III............................................................................................... 85 
4.7 GENERAL CONCLUSIONS ................................................................................... 86 
4.8 PERSPECTIVES ................................................................................................... 88 
5 OWN PUBLICATIONS ................................................................................... 89 
6 LITERATURE ................................................................................................. 90 
7 APPENDIX … ...… … … … … … … … … … … … … … … … … … … … … … … .… … 111 
 
8 CURRICULUM VITAE … … … ...… … … … … … … … … … … … … … … … … … 134 
 
9 ACKNOWLEDGEMENTS ...… … … … … … … … … … … … … … … … … … … ...135 
 
 
 
 
www.pdfmailer.de   PDFMAILER.DE 
 
Kostenfrei und werbegesponsert PDF drucken und direkt per E-Mail 
versenden >Test it free www.pdfmailer.de 
  5 
Abstract 
Animal models currently represent a viable route for gaining further insights into the mechanisms 
involved in the pathogenesis of particular diseases. Depression, in this respect, constitutes a major 
challenge since the characterization of disease-specific traits is complicated due to the multifactorial 
nature of the disorder. The understanding of diverse factors, e.g. neurotrophic circuits and the role of 
the HPA axis, which have to be considered in the pathophysiology of the disease represent a major 
target of behavioural animal models of depression. Working on a model such as Learned Helplessness, 
consequently requires careful consideration of modulating aspects to ensure representative results. 
This work aims at elucidating the role of recently postulated target genes of depression as well as the 
impact of potential distorting factors, such as housing conditions of the experimental animals. To 
guarantee a specific readout, which permits concrete statements regarding the role of particular target 
genes like BDNF, CREB, and GR, we compared both, the effects of different social and as 
environmental factors with regard to general and Helplessness-specific effects on behaviour. 
Furthermore, we confirmed the model by a pharmacological validation, simultaneously monitoring 
effects of the obligatory handling procedure.  In studies of depression and emotionality it is important 
to establish standardized protocols, involving the animal’s environment, to be able to precisely assess 
potential sources of stress and exclude artefacts. The design and modification of animal models like 
the Learned Helplessness subsequently bears the advantage of not only detecting potential genetic 
aspects by investigating mice carrying mutations of particular target genes, e.g. the glucocorticoid 
receptor, in which significant differences with regard to helpless behaviour and further depressive-like 
parameters became evident, but also to exploit fundamental causes of depressive-like phenotypes such 
as stress effects.  
The detailed evaluation of the Learned Helplessness in mice as a model of depression suggests it as a 
valuable instrument to investigate mouse models for depression, like GR heterozygous animals, in 
which the behavioural phenotype was associated with depressive-like characteristics such as a 
decrease of BDNF protein and relevant physiological parameters which mimick stress, i.e. a 
depression-typical Dex/CRH Test and elevated corticosterone levels after restraint stress. 
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1 Introduction 
 
Affective disorders represent a serious, nevertheless still often underestimated disease with a course 
that has always been difficult to define clearly and precisely as documented by the remarkable breadth 
the research on this topic during the last decades. Distinct characteristics of this illness as well as co-
morbidities are still relatively ill defined and the interrelations are not yet fully understood. This most 
certainly results from the heterogeneity and multi-factorial pathogenesis of this disease. Presumably it 
will be impossible to formulate a single mechanism describing the exact causes and symptoms of 
depression, however, target-orientated hypothesis-conducted research on structural, molecular, and 
behavioural level ought to lead to some classification about single elements involved in the 
pathophysiology and treatment of this disease. Since genetic vulnerability as well as environmental 
factors, such as stress, are postulated to play a predominant role, it appears essential to combine the 
possibilities of genetic manipulation and determination with the standardized examination of 
environmentally induced effects. The development of an interdisciplinary interest in this field seems to 
be one of the most relevant steps to elucidate pathogenesis-related mechanisms of depression. Since 
genetic as well as environmental factors are likely to influence each other, this fact has to be 
considered in the experimental design. Consequently, an aim of this doctoral thesis comprises the 
merging of insights from a stress-induced model of depression, the Learned Helplessness paradigm, 
with findings of genetically engineered mouse models, which have been postulated to reflect 
depressive-like changes according to particular hypotheses of depression, i.e. the Neurotrophin- and/or 
Stress Hypothesis of Depression. After the detailed description of the materials and methods employed 
in this thesis, the published as well as unpublished results of the experiments are presented and 
subsequently utilized to point to future ideas and suggestions concerning research in this area . 
 
1.1 Depression 
Depression is a devastating illness, affecting approximately 12-17 % of the population at some point in 
life (121). Worldwide the occurrence of depression is such that this disorder represents a major health 
problem. Despite this overwhelming impact there is still a lack of knowledge concerning the 
underlying aetiology and pathophysiology. Certainly antidepressants are commonly prescribed for 
depression as well as other types of affective disorders, even though the molecular and cellular 
mechanisms, by which these agents exert their therapeutic effects, are not yet fully explainable. The 
appearance of mood disorders likely arises from the complex interaction of multiple vulnerability 
genes and environmental factors. Pre-clinical and clinical studies have focused on the interactions 
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between stress and depression and their effects on particular brain regions (63, 146). Loss of 
subjective control over stressors as well as their unpredictability seem to be very important factors for 
the development of behavioural depression (237). The phenotypic expression of this disorder includes 
not only episodic and often profound mood disturbances, but also a distinct constellation of cognitive, 
psychomotor, autonomic, and endocrine abnormalities. Most hypotheses regarding depressive 
disorders are based on the dysregulation of the HPA-axis and the malfunction of the hippocampus and 
implicate corticotropin-releasing factor, glucocorticoids, brain-derived neurotrophic factor, and the 
transcription factor CREB (54, 223). The hippocampus on one hand is an important candidate area as 
an anatomic localization of emotional behaviours; on the other hand it is an essential region with 
regard to concentration- and memory processes, which are also regularly affected in severe depressive 
episodes. Recently, other brain regions, that are thought to be involved in depression, have also been 
investigated. The nucleus accumbens, amygdala, and certain hypothalamic nuclei are critical in 
regulating motivation, eating, sleeping, energy level, circadian rhythm, and response to rewarding and 
aversive stimuli, which are all abnormal in depressed patients. 
For better understanding of the neurobiology of depression, it is also essential to identify the genes 
according to distinct hypotheses, e.g. the Stress- or Neurotrophin Hypothesis, which modulate the 
predisposition of individuals to be vulnerable or resistant to the syndrome (61, 223). 
 
 
1.1.1 Theoretical Concepts of Pathophysiology and Treatment of Depression 
Depression represents a multifactorial disease, which is not defined by one distinct clear course or 
pathogenesis. So far it remains unclear which features or combination of factors are responsible for the 
origin of a depressive state, which makes it extremely difficult to model this disease. By means of 
behavioural, pharmacological, as well as genetic tools it is nevertheless feasible to mimic some 
characteristics of depression and to investigate the occurrence of symptomatic correlates. This offers 
options to look for the interrelations between genetic and environmental aspects in this disease, aiming 
at illuminating the problem of cause and consequence, i.e. by vulnerability-, or gene expression studies 
(Fig. 1). On the other hand it is nowadays possible to target points of action of antidepressants on a 
molecular level and look for potential behavioural effects, whereby one has to consider the still 
unknown cause for a resistance to antidepressive treatment occurring in up to 30 % of depressed 
patients as well as the fairly long period to initiation of efficacy. 
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Figure 1: The Interaction of Monoamines, Neurotrophins, Stress, and Neurogenesis in Depression. 
Different mechanisms regarding the pathogenesis of depression are postulated. It is, however, thinkable that the 
disturbed balance of these postulated mechanisms might occur in diverse variations, always dependent on timing 
and combination of physiological, environmental, and genetic factors. The primary regulation is hypothesized to 
follow general rules and interact up to a distinct point, which can be used for the design of experiments, though 
theoretic and practical conditions may diverge from the assumption. 
 
 
1.1.2 The Monoamine Hypothesis 
The monoaminergic hypothesis predicts that depression is associated with an impairment of 
neurotransmission by serotonin, norepinephrine, and most likely also dopamine (22, 30, 189). This 
insufficiency can result from several mechanisms: i) decreased synthesis or increased degradation of 
neurotransmitters, ii) altered expression or function of the respective neurotransmitter receptors, iii) 
impairment of the signal transduction systems activated by post-synaptic receptors. Almost all 
antidepressant drugs act primarily via the first mechanism, which is supposed to improve 
monoaminergic transmission by increasing the presence of neurotransmitters inside the synaptic cleft. 
This can be caused by an inhibition of neurotransmitter re-uptake (e.g. by tricyclic or selective 
serotonin or norepinephrine re-uptake inhibitors, TCAs, SSRIs, NARIs) or by reducing the 
degradation (monoamine oxidase inhibitors, MAOIs). Progress has also been made with regard to the 
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selectivity of antidepressants and their number and intensity of side effects. Some of these compounds 
have additional effects on pre- or postsynaptic receptors.  
Yet it remains unclear how the various antidepressants with their different modes of action finally 
induce emotional and behavioural improvement and recovery. The common feature of all classes of 
antidepressants is, that their onset of action can take up to three weeks. Therefore, a key biological 
mechanism must account for the fact that chronic administration has delayed mood-elevating effects in 
patients, while enhancement of serotonergic or noradrenergic neurotransmission is already enhanced 
within minutes after the drug reaches the brain. Recent concepts for pathogenesis and therapy focus on 
slowly developing plasticity changes induced by chronic alterations in monoaminergic 
neurotransmission. In this respect, two biological systems have attracted attention: i) the stress-
responsive hypothalamic-pituitary-adrenal (HPA) system, which is disinhibited in many patients with 
major depressive episodes (86, 106, 154, 165) and ii) the neurotrophin "brain-derived neurotrophic 
factor” (BDNF), which has been implicated in hippocampal maladaptation processes related to 
depressive episodes (59, 78). Interestingly, regulatory mechanisms of stress hormones and the 
mechanisms that control hippocampal BDNF expression are linked to each other. This has led to the 
so-called "Neurotrophin Hypothesis” of depression.  
 
1.1.3 The Neurotrophin Hypothesis 
The "Neurotrophin Hypothesis" of depression predicts that depressive disorders in humans coincide 
with a decreased activity and/or expression of brain-derived neurotrophic factor (BDNF) in the brain 
(3, 61). Recent basic and clinical studies have provided evidence for this hypothesis of depression and 
antidepressive treatment, postulating that plasticity-related changes, such as hippocampal atrophy in 
depressed patients, are related to a decreased expression or function of brain-derived neurotrophic 
factor (BDNF) and/or its high-affinity receptor TrkB (3, 61, 155, 224, 247) (Fig. 2). This theory is 
supported by the fact that BDNF is found in high concentrations in the hippocampus and cerebral 
cortex, brain areas known to play a role in depression (85, 130, 140). Furthermore, BDNF expression 
in these areas is decreased by stress exposure, which is currently the only behavioural measure to 
induce depression-like states in rodents (201, 202, 220). Moreover, chronic, but not acute treatment 
with antidepressants as well as electroconvulsive therapy induce increased levels of BDNF mRNA and 
protein, mainly in the hippocampus (64, 186, 253). Local cerebral administration of BDNF itself is 
reported to exert antidepressant-like effects in animal models of depression (197, 199). The hypothesis 
has been put forward that mice with compromised BDNF-TrkB signalling pathways could provide a 
genetic murine model of depression, which would be reflected by neurochemical and 
neuroendocrinological alterations in specific brain regions as well as by characteristic changes of 
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emotional behaviours (137, 187). Therefore it is interesting to investigate, whether i.e. mice with a 
reduced BDNF or TrkB expression due to a heterozygous gene disruption represent potential mouse 
models for depression-like neurochemical changes or behavioural symptoms. Thus, a chronic 
reduction of BDNF protein content in adult mice could induce neurochemical or behavioural 
alterations modelling depressive symptoms in humans. It seems furthermore promising to examine, 
whether mice with a heterozygous BDNF knock-out exhibit differences in monoamine levels in 
various forebrain areas, because the “Monoamine Hypothesis of Depression” predicts that depression 
is related to an impairment of neurotransmission by serotonin (5-HT), norepinephrine (NE), and most 
likely also dopamine (DA) (22, 25, 189). Disinhibition of the hypothalamic-pituitary-adrenal- (HPA) 
system is regarded as a hallmark neuroendocrinological correlate for major depressive episodes in 
human patients (10, 154) The analysis of the HPA-system of BDNF-heterozygous mice under baseline 
conditions and following stress exposure could shed light on the interrelationship between these 
systems. Furthermore, identification of alterations in a test battery for emotional behaviours, analysing 
locomotion and exploration as well as anxiety- and depression-related behaviours in these mice, is 
obligatory. For better understanding of the neurobiology of depression it is also essential to identify 
the genes, which make individuals vulnerable or resistant to the syndrome. With the help of the Cre-
LoxP technique, transgenic mice that lack specific genes in the brain or even in defined brain regions 
can be designed and studied according to current hypotheses. Appropriate behavioural analyses serve 
to investigate, if the mutagenesis of these genes leads to behavioural changes within the animal models 
of depression (222). These advances will fundamentally improve the treatment and prevention of 
depressive disorders. 
www.pdfmailer.de   PDFMAILER.DE 
 
Kostenfrei und werbegesponsert PDF drucken und direkt per E-Mail 
versenden >Test it free www.pdfmailer.de 
Introduction 
___________________________________________________________________________ 
  11 
 
Figure 2: The Neurotrophin Hypothesis of Depression. It is stated that a downregulation of brain derived 
neurotrophic factor (BDNF), its tyrosine kinase receptor TrkB as well as the transcription factor CREB is 
associated with a depressive state, which results in a lack of synaptic neurotransmitters. In the course of 
depression external stress may block the expression of BDNF mRNA via activation of glucocorticoid receptors, 
which exert their effects by binding to negative glucocorticoid receptor binding elements (nGRE). The reduction 
of neurotrophins can be reverted by antidepressants that enhance the circuit followed by an increase of 
monoamines in the synaptic cleft.  
 
 
1.1.4 The Stress Hypothesis 
Dysregulations and dysfunctions of corticosteroid receptors have been implicated in the pathogenesis 
of stress-related psychiatric disorders such as depression and posttraumatic stress disorder (7, 17, 23, 
50, 105, 250). It is still uncertain whether these corticosteroid receptor disturbances are cause or 
consequence of affective disorders. Clinical studies have convincingly shown a hyperactivity of the 
hypothalamic-pituitary-adrenal (HPA) system with elevated plasma cortisol levels in many patients 
with major depression (103, 106, 254). In these patients, diminished corticosteroid receptor expression 
or functioning have been postulated as a causative factor for a deficient feedback of cortisol and may 
explain their increased HPA activity and stress sensitivity (Fig. 3). 
Neurotrophin Hypothesis of Depression  
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An alternative hypothesis claims that the cause of the HPA dysregulation is due to a primary 
upregulation of hypothalamic corticotropin releasing hormone (CRH), which secondarily leads to 
corticosteroid receptor downregulation in the limbic system and the hypothalamus which perpetuates 
the disease state (7, 105). According to the latter concept, the changes of the HPA system may result 
from a primary disturbance of monoaminergic systems and their widespread connections to higher 
brain centres including cortex, limbic system, and hypothalamus (30). 
Molecular studies have so far identified two corticosteroid receptor subtypes: type 1 or 
mineralocorticoid receptor (MR) and type 2 or glucocorticoid receptor (GR) (9, 104). Both receptors 
function as ligand-binding transcription factors that belong to the nuclear hormone receptor 
superfamily (13, 217). They modulate a wide range of neural functions including stress responsiveness 
and cognition (50, 105, 181). According to current concepts, particularly GR mediated functions are 
disturbed in patients with severe depressive episodes. However, since studies of the GR in the human 
brain are not feasible in vivo, such evidence mainly derives from pharmacological challenge tests with 
GR agonists, like the dexamethasone suppression Test, which indirectly measures GR function in the 
pituitary and maybe in part also in the central nervous system (96). Therefore, the analysis of direct 
effects of GR dysfunction and its potential role for “emotional behaviour” are currently restricted to 
animal models. For this purpose, targeted mutagenesis in mice seems to be particularly promising, 
since it allows the genetical manipulation of both GR expression and specific GR functions (81). 
Several mouse strains with impaired GR expression or function have been generated: i) mice with a 
GR point mutation (GRdim), which prevents GR dimerization and binding to its cognate element GRE 
(176); ii) a strain with a brain-specific GR knock-out (GRNesCre) (216); and iii) a GR-antisense model 
with reduced expression in brain and some peripheral tissues (171). While GRdim mice do not reveal 
any alterations in emotional behaviour, both brain-specific GR knock-out mice as well as GR-
antisense mice surprisingly exhibit reduced depression-like behaviours. However, with respect to 
human (psycho-) pathology, the genetic defects generated in these mouse strains are very unlikely to 
occur in man. To test the “GR-Hypothesis of depression” we decided to work with mice that over- or 
underexpress GR, which may – according to the concepts outlined above - mimic the situation of 
patients with affective disorders more closely. Such mice have been generated by a knock-out strategy 
(GR+/- mice; (217)) and by a transgenic approach using a yeast artificial chromosome (YGR mice; 
(179)). So far, these strains have not been characterized behaviourally. According to the theory, one 
would expect mice, which underexpress GR to have a predisposition for developing depression-like 
behaviours after stress. Furthermore, they should show a depression-like response in the Dex/CRH 
Test. In this test, the synthetic glucocorticoid dexamethasone is administrated to challenge the 
negative feedback function of the HPA system (11). On the other hand, the Glucocorticoid Hypothesis 
of Depression would predict that mice overexpressing GR are more resistant to develop depression-
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like features than wildtype mice. To test these hypotheses, we subjected GR+/- and YGR mice to a 
large test battery for emotional behaviours, including tests for depression-like signs such as despair 
and Helplessness. Furthermore, we analysed the HPA system under baseline conditions, after stress, 
and following a Dex/CRH challenge.  
 
 
 
 
 
 
Figure 3: The Stress Hypothesis of Depression. This hypothesis declares that stress via an activation of 
glucocorticoid receptors by glucocorticoids leads to a decrease of neurotrophins (red arrows), as predicted by the 
Neurotrophin Hypothesis of Depression. Moreover an activation of those receptors challenges the hypothalamus 
pituitary adrenal axis (HPA) with increased levels of corticotrophin releasing hormone (CRH), 
adrenocorticotrophic hormone (ACTH) and corticosterone (red arrows), which are regulated by a negative 
feedback system. In view of the fact that these hormones are dysregulated in depressive patients but normalized 
by antidepressive treatment (green arrows) the HPA axis is suggested to play a crucial role for the 
pathophysiology of depression which may be linked to the dysregulation in the neurotrophin circuit.  
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1.1.5 Neurogenesis 
The proliferation of so-called progenitor cells and their differentiation (neurogenesis), which is 
controversially discussed to be a major factor in the pathogenesis of depression (101) takes place in 
the hippocampus, a part of the limbic system, and in the olfactoric bulbus . Since neurogenesis 
represents an important biological correlate for plasticity in the nervous system (88), a new hypothesis 
arose, which assumed that genesis of neurons is involved in the pathogenesis of affective disorders 
(23, 111). This is indicated by the fact, that depression-evoking aspects, such as stress and an elevation 
of glucocorticoids, cause a reduction of neurogenesis in the hippocampi of mammals and a decrease of 
serotonin levels, which may be transmitted by an activation of glucocorticoid receptors (GR). 
Conversely, the rate of neurogenesis in the rat is increased by antidepressive therapy, which causes an 
elevation of the serotonin concentration in the synaptic cleft (30). An alternative method to increase 
neurogenesis is the behavioural stimulation of animals by means of physical activity (running wheels) 
or housing in an enriched environment. Mouse models for depressive diseases open the possibility to 
mimic the molecular mechanisms of neurogenesis by means of targeted mutation of genes to 
investigate their respective relevance for affective disorders. First, several genes suspected to be 
involved in pathogenetic mechanisms and responsible for changes in neurogenesis: BDNF (brain-
derived neurotrophic factor), TrkB, its tyrosine kinase receptor and the type I and II glucocorticoid 
receptors GR (glucocorticoid receptor) and MR (mineralocorticoid receptor) as well as the recently 
described endothelial NOS III (nitric oxide synthase). 
 
1.1.6 The Macrophage Theory of Depression 
An interaction between immune system and mood disorders has been hypothesized for more than 70 
years, however, it is still unclear whether immune system changes are just a reflection of the stress-
induced pathological state or if they are primarily responsible for the modifications in central 
neurotransmission that induce behavioural alterations (128). A variety of immunological aspects have 
been established as valuable markers of depression (128). Moreover, the links between HPA axis and 
immune system are numerous and have led to the so-called macrophage theory of depression (203). In 
particular, cytokines are considered as potential triggers of major depression (5, 28, 124). The 
relationship between mood disorders and immune system are evidenced on three levels (5): i) 
Administration of cytokines or activation of the immune system induces depression and physiological 
alterations similar to those observed in depression (39, 47). The role of cytokines in psychopathologies 
has been discovered by clinicians, who treated cancer patients with cytokines to enhance their immune 
system. After several weeks of treatment these patients exhibited a variety of psychiatric disorders, 
including depression (28). Consistently, cytokine antagonists have been shown to prevent the 
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development of Learned Helplessness in rats. ii) Major depression is accompanied by an immune 
response with an increased activation of several components of the immune system. It is hypothesized 
that increased monocytic production of interleukins in severe depression may constitute key 
phenomena underlying the various aspects of the immune and "acute" phase response, while 
contributing to hypothalamic-pituitary-adrenal (HPA) axis hyperactivity, disorders in the serotonin 
metabolism, and to the vegetative symptoms (i.e. the sickness behaviour) of severe depression (138). 
iii) Successful antidepressant treatment normalizes the immune system activation in humans (190, 
200), and attenuates the behavioural and neuroendocrine effects of immune activation in rodents 
(251). However, it is not known whether the effect of antidepressants on immune function contributes 
to the efficacy of the treatment or is just an epiphenomenon.   
 
1.2 Animal Models of Depression 
At present animal models represent the unique possibility to gain insights into the pathophysiology of 
depression because the examination of stress effects and accordingly the inspection of brain tissue may 
not be done in patients. Several animal models of depression have been described (for review see 
(238)), but only a small fraction is capable to fulfil predictive, face, and construct validity, according 
to their quality of mimicking the situation of depressive patients. Some of the traditional models and 
tests methods were rejected as invalid; the models and/or respective tests with the highest overall 
validity are the intracranial self-stimulation, chronic stress, Learned Helplessness in rats, and primate 
separation models (238). An ideal model for human mental disorders is thought to be applicable if it 
resembles the condition it models in its aetiology, biochemistry, symptomatology, and treatment (148), 
however it has to be noted that validating criteria themselves may be subject of intense research and 
speculation. Therefore face validity describes the phenomenological similarities between the model 
and the condition modelled, predictive validity describes the success of predictions made from the 
model, and construct validity reflects its theoretical rationale. The following paragraphs introduce five 
approaches by which depression could be modelled and illustrates examples for each possibility to 
induce a depressive state. Signs of depression described in the human “Diagnostic Statistical Manual 
IV” that can so far be modelled by current animal analyses are listed in the catalogue below: 
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1.2.1 Lesion Models 
As an example for lesion models, the bilateral destruction of the olfactory bulbs creates a chronically 
altered brain state with complex changes of behavioural, neurochemical, neuroendocrinological, and 
neuroimmunological parameters, many of which are comparable to those seen in patients with major 
depression (46, 112, 135, 227). Since such a lesion does not naturally occur in humans, the face 
validity of this model is not very strong, nevertheless it can be used to induce a depressive-like state 
that can be reversed by chronic antidepressive treatment and can therefore serve to deal with basic 
questions regarding the pathophysiological background, bearing the advantage of being a high-
throughput model of depression. Thus, the olfactory bulbectomy (OBX) in rodents has been proposed 
to represent a model for chronic psychomotoric agitated depression, which also has a high predictive 
validity (45, 46, 95). The major behavioural change in this model is a hyperactive response in a 
brightly illuminated Openfield arena (256), which is reversed almost exclusively by chronic, but not 
acute, antidepressant treatment (117, 129). Furthermore, in rats bulbectomy leads to different signs of 
anhedonia, combined with deficits in spatial learning, avoidance learning, conditioned taste aversion, 
and food-motivated behaviours (95, 117). While the olfactory bulbectomy (OBX) model has been 
intensely investigated in rats, fewer studies were conducted with mice. Indeed it has been cautioned to 
overextrapolate the data obtained in rats to mice (46). Apart from the characteristic hyperlocomotion, 
in mice OBX induces deficits in active and passive avoidance learning (93, 108, 164, 213, 256) and in 
spatial memory (19, 20, 256).  
 
 
DSM IV/ICD 10 
 
Core Symptoms 
· Depressive mood („sadness“) 
· Loss of interest in pleasurable activities („anhedonia“) 
· Fatigue and loss of energy 
 
Associated Psychopathological Signs and Symptoms 
· Hopelessness, feelings of guilt  
· Restricted ability to think and concentrate 
· Recidive thoughts of death and suicide 
· Extreme sensitivity 
· Psychomotoric agitation or retardation 
 
Vegetative Signs and Symptoms 
· Insomnia or Hypersomnia 
· Altered appetite und body weight 
· Loss of libido 
 
 
DSM for Mice (mDSM I) 
 
      Core Symptoms 
· "anhedonia"   ( ¯ consumption of sugar solution) 
· "giving up"   (Learned Helplessness)  
· "despair"   (Porsolt Forced Swim Test)   
 
      Associated Behavioural Features 
· Anxiety & Neophobia  (O-Maze, Dark-light-box) 
· Psychomotoric Behaviour (Activity chambers, Openfield Test) 
 
      Vegetative and Biological Features 
· Sleeping, eating and sexual behaviour 
· Hypothalamus Pituitary Adrenal system (HPA) 
 
 
 
                                       Gass et al..,Physiol. &  Behav., 2001 
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1.2.2 Chronic Mild Stress 
The model of “chronic mild stress”, a model of depression with good face, predictive, and construct 
validity, states that stress, which cannot be controlled, may lead to a depressive state (240). Besides its 
time-consuming experimental protocols, however, the problem persists that the model cannot 
constantly be reproduced adequately, not even by the same experimentators, which reduces its 
reliability, and restricts its possible applications in studies that require high throughput. The chronic 
stress model involves mild stressors that are applied for several weeks, e.g. wet chow, changes in their 
social constellation, short periods of food deprivation or altered illumination during activity-and 
resting periods, respectively (48). Anhedonia, which is the major readout of this concept, is assessed 
by means of measuring the preference for a 2 % sugar solution versus water in stressed and control 
animals. In addition to the anhedonic state, decreases in locomotion, body weight, libido, as well as 
disturbances in the sleep structure are reported, which are comparable to symptoms in human 
depression (241). Those changes can be reverted by chronic antidepressive treatment, which makes 
this model an excellent tool for an adequately naturalistic induction of a depressive state, which is 
however restricted by the fact that it is endangered by artefacts and therefore not always reliable. 
In this thesis, one category of chronic mild stress and its effects on the development of a depressive-
like phenotype in the Learned Helplessness paradigm was investigated by analysing the influence of 
different, commonly applied housing conditions that could represent potential stressors regarding this 
paradigm. 
 
1.2.3 Learned Helplessness 
In 1976 the concept of the Learned Helplessness was created by Seligman and Meier, who 
hypothesized that exposure to unpredictable and uncontrollable stress may lead to a depressive state 
(191). This hypothesis has initiated an epoch of florid discussions regarding the aetiology of 
depression, since it is true for animals as well as humans, that only a part of the individuals exposed to 
stress develop depressive features or Learned Helplessness. Hence a hypothesis was postulated 
assuming that humans with a stable style of attribution regarding negative experiences are vulnerable 
for depression (1). In the original version of the model, rats are exposed to uncontrollable footshocks 
and are tested the following day concerning their ability to terminate the shocks by pressing a lever. 
Animals without preceding stress exposure learn promptly how to avoid the aversive stimuli, while 
stressed animals show a passive coping style demonstrating less motivation to stop the aversive 
stimulus (66). Like the chronic mild stress, the model of Learned Helplessness produces signs 
characteristic for a depressive disease, such as cognitive deficits, loss of appetite, libido, and 
locomotion, as well as alterations in sleep structure (2). Those changes are reversed by chronic 
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antidepressive treatment with substances from different classes as well as by electroconvulsive therapy 
(ECT), while other psychopharmaceuticals like antipsychotics or benzodiazepines, are not effective 
(196). It is assumed that corticosterone plays a major role in this model. This is supported by the fact 
that helpless animals present typical endocrinological changes, e.g. decreased suppression of 
corticosterone after application of dexamethasone (91). Moreover it is concluded, that secretion from 
the adrenal cortex is necessary for the incorporation of a learned response after stress and that a 
dysregulation of the hypothalamic-pituitary-adrenal axis seems to be involved in helpless behaviour 
(65, 100). Furthermore several neurobiological alterations were identified, for example a stable 
increase of β-adrenergic and serotonergic receptors and the serotonin reuptake transporter (SERT) in 
the hippocampus (142). These changes may be converted by antidepressants (100). While there are 
numerous studies on the subject of Learned Helplessness and its mechanisms in rats, in mice this 
procedure remains rather unexploited. 
 
1.2.4 Genetic Approaches 
The genetic approach permits to study the role of target genes, which are postulated to play a role in 
the pathogenesis or treatment of depression, in vivo. The deletion and overexpression of such genes of 
interest is especially attractive with regard to the search for the pathophysiological genetic fundaments 
of the vulnerability to depression and how this can be manipulated by environmental factors. Hereby 
transgenic mice represent the major tool since currently the mouse is the main specimen in which 
transgenic techniques are practicable. In the following section mutations of relevance concerning 
pathophysiological background of depression will be described. 
 
1.2.4.1 BDNF Heterozygous Mice (BDNF+/-)  
Recent studies propose the CREB-BDNF-TrkB pathway to be relevant regarding pathogenesis and 
therapy of depression (3, 223). While stress compromises the activity of this signalling cascade (158), 
antidepressants activate it (31, 57, 123, 158, 159). Likewise, BDNF-infusion into the hippocampus 
exerts antidepressive effects (197 , 199). A conventional BDNF knock-out leads to severe 
developmental defects that are incompatible with survival to adulthood (40). Behavioural experiments 
are therefore restricted to heterozygous mice (BDNF+/-) or mice with a conditional knock-out.  
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1.2.4.2 CREB Ser142A Mutant Mice 
Expression and activation of CREB (cAMP response element-binding protein) have been implicated in 
the molecular mechanisms of pathogenesis and therapy of affective disorders (155, 212). Thus, human 
postmortem studies demonstrate decreased CREB levels in temporal lobes of untreated depressive 
patients (29, 57, 187). In animal models chronic antidepressive treatment increases hippocampal 
expression/activation of CREB (159, 215). Furthermore, virus-mediated hippocampal CREB 
overexpression produces antidepressant effects in Forced Swim Test and Learned Helplessness (31). 
CREB is activated by cellular signalling pathways acting via cAMP- or Ca2+-activated kinases or 
tyrosine kinases. This activation is achieved by phosphorylation of CREB at two different serine 
residues (Ser133 (152) and Ser142 (144)), resulting in CRE-mediated transcription of genes, i.e. brain-
derived neurotrophic factor (BDNF). Transgenic studies showed that CREB activation by Ser142 
phosphorylation reflects a mechanism regarding synchronization of day-night cycle and circadian 
rhythm (83). Indeed, CREB is involved in light-induced entrainment of the circadian clock in the 
suprachiasmatic nucleus (SCN) and is proposed to draw a molecular interface between neuronal and 
endocrine cues resetting this clock (55, 232). This is especially relevant concerning the role of CREB, 
since disrupted biological rhythms represent a hallmark of depression (155, 212). Thus, depressive 
patients show disturbances of their sleep/wake cycle and/or circadian rhythms, e.g. body temperature, 
cortisol secretion etc. Vice versa, sleep deprivation, phase advance of circadian rhythm and light-
therapy represent therapeutics alleviating depressive symptoms (115, 244). In seasonal affective 
disorder (SAD) (168), the efficacy of light-treatment and the seasonality of symptoms suggest a 
circadian pacemaker. This implies that CREB Ser142 phosphorylation could be involved in the 
development of depressive symptoms.  
 
1.2.4.3 Glucocorticoid Receptor Mutant Mice and Current Implications 
Glucocorticoid receptors (GR, or type II corticosteroid receptors) and mineralocorticoid receptors 
(MR, or type I corticosteroid receptors) are ligand-dependent transcription factors. They belong to a 
superfamily of nuclear hormone receptors. The GR is expressed ubiquitously in the brain. In the HPA 
system, GR plays a key role in the feedback regulation of glucocorticoid hormones. Its absence is 
expected to lead to hypercortisolism, mimicking the HPA system disturbances observed in humans 
with severe depression. Several mouse lines with an altered expression of the GR have been generated: 
i) two different conventional knock-outs, ii) mice overexpressing an antisense of the GR mRNA, iii) 
nervous system-specific knock-outs, iv) mice in which the GR dimerization has been disrupted, v) 
mice overexpressing GR, and vi) mice with conditional overexpression of the GR. HPA system 
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dysregulation and behavioural symptoms in mice with targeted mutations of GR and MR have been 
reviewed earlier (81, 153, 223).  
 
GR-antisense: Chronic stress leads to a desensitisation of the GR, impairing the negative feedback 
loop of the HPA axis, which, by a vicious circle results in hypercortisolemia in humans. Reduction of 
GR expression in mutant mice by overexpressing an antisense GR gene leads to similar dysfunctions 
(170). GR antisense mice show a reduced CRF expression in the hypothalamus but no changes in 
ACTH and corticosterone levels at various time points of the circadian rhythm (11, 53, 113). The 
expected up-regulation of the HPA system in GR antisense mice only becomes apparent under 
stressful conditions (170, 171) and is reversed by antidepressant treatment (10, 151). Moreover, GR 
antisense mice fail to respond adequately to the dexamethasone suppression Test, which is in 
agreement with observations in depressed patients (11). On the behavioural level, GR antisense mice 
present several cognitive deficits (151, 185). Surprisingly, they demonstrate less anxiety-like 
behaviour in the Elevated Plus-Maze (151, 182, 211) and following intense psychological stress (i.e. 
rat exposure) (132). Moreover, they display locomotor hyperactivity when placed into a novel 
environment (14) and they exhibit enhanced responses to novelty and increased conditioned approach 
responses, again in contrast to the predictions of the theory (207). Furthermore, these mice are less 
immobile than wildtype control mice in the Forced Swim Test (151), which also suggests a decreased 
depression-like behaviour. Taken together, GR antisense mice display only few of the neuroendocrine 
and behavioural features observed in depression. However, since many of the deficits observed in 
these mice are reversed by antidepressant treatment, this line may be a valuable tool for the discovery 
of new antidepressants (151). 
 
GRNesCre : Since conventional GR knock-out mice do not survive to adulthood, nervous system 
specific knock-out mice have been generated using the Cre/loxP recombination system under the 
control of the rat nestin promoter (216). The so-called GRNesCre mice are viable and lack the GR in 
neurons and glial cells. As one would expect, their HPA system is drastically over-activated (216) but 
is still responsive to acute immobilization stress, resulting in increased levels of both circulating 
ACTH and corticosterone. These mice thus display neuroendocrinological alterations that closely 
resemble those of patients with a major depression. At the behavioural level, however, GRNesCre mice 
enter the aversive compartments of both the Dark-Light Box and the elevated O-Maze more often, 
thereby displaying less anxiety-related behaviour (216). Additionally, they do not develop despair-like 
behaviour in the Forced Swim Test, contrarily to what would be expected in a depression model (216). 
This paradoxical finding can be explained by the fact that the neurons of GRNesCre mice do not express 
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the GR. Consequently the hypercortisolism cannot affect these neurons and cause subsequent changes 
in behaviour. Thus, despite their hypercortisolism, these mice most likely represent a genetic model of 
resistance to depression. To test this hypothesis, they have to be subjected to stress-induced 
behavioural depression paradigms.  
 
GRdim : GR regulates transcription by two major mechanisms: i) as dimer, binding to positive and 
negative GREs in the promoter of target genes; ii) as monomer, modulating the activity of other 
transcription factors via protein-protein interactions (176). The two modes of action can be dissected 
by introducing a point mutation (A458T) into one of the dimerization domains of the GR (97). Using a 
knock-in strategy to replace the endogenous GR gene, this mutation was generated in mice (176). 
These so-called GRdim mice express GR molecules that cannot dimerize, but still act as monomers. 
Consequently, GRdim mice cannot activate GRE driven genes, but are still able to modulate other 
transcription factors, e.g. AP-1 and NF-κB (176, 218). In contrast to mice carrying disrupted alleles of 
GR, GRdim mice are viable and can be used to study physiology and behaviour in adulthood (176). 
While CRF levels in the hypothalamus are normal in these mutants, ACTH and corticosterone plasma 
levels are markedly elevated compared to control mice, indicating that the mechanism of protein-
protein interactions are important for the negative feedback at the level of the hypothalamus (176). 
Behaviourally GRdim mice do not differ from controls regarding locomotion and exploration, but 
display spatial memory deficits in the Morris Watermaze (162). Neither anxiety-related behaviours nor 
immobility in the Forced Swim Test are affected in this line (162). This result indicates that this 
approach, even if it can be used to dissect the modes of action of GR, does not represent a suitable 
model of depression. 
 
GR+/-: The GR is essential for survival: its disruption leads to death immediately after birth due to 
severe atelectasis of the lungs (216). A conventional knock-out of the receptor, obtained by insertion 
of a neomycin cassette into exon 2 of the GR gene, also results in an impaired lung development and 
causes death in more than 90 % of the newborns because of respiratory failure (37). The founders of 
GR heterozygous mice (GR+/-) were developed by using homologous recombination in embryonic 
stem cells. Homozygous knock-out mice show enhanced transcription of both CRH in the 
hypothalamus and proopiomelanocortin (POMC) in the anterior lobe of the pituitary, as well as 
elevated corticosterone plasma levels. Even though the HPA axis dysregulation in these mutants is 
similar to the alterations seen in depressed patients, it is difficult to speculate about their potential role 
as a model of depression, since the surviving individuals have not yet been tested behaviourally. 
 
www.pdfmailer.de   PDFMAILER.DE 
 
Kostenfrei und werbegesponsert PDF drucken und direkt per E-Mail 
versenden >Test it free www.pdfmailer.de 
Introduction 
___________________________________________________________________________ 
  22 
YGR: Overexpressing a gene is another strategy to study its role in pathophysiological mechanisms. 
GR overexpression in mice has been achieved by insertion of two additional copies of the GR gene 
using a yeast artificial chromosome (YGR) (178). These mice overexpress GR mRNA by 20 to 25 %, 
and GR protein by 50 %, and display a strong suppression of the HPA system (178). Overexpression 
of GR can also be obtained conditionally by putting the gene under the control of the forebrain 
specific promoter calcium calmodulin dependent kinase II (CaMKII) (236). In this line, the HPA 
system is not affected and the animals show normal locomotor activity, while displaying more anxiety 
in the Dark-Light Box Test.  
 
1.2.4.4 Interleukin-6 Receptor Mutant Mice (IL-6-/-) 
According to the macrophage theory, IL-6 knock-out mice (125) represent an interesting animal model 
of depression. They display an increased locomotion in the Openfield (26) and spend less time in the 
open arms of the Elevated Plus-Maze (8, 26). IL-6-knock-out female mice show a blunted 
corticosterone response to restraint stress. For males however, the stress-induced corticosterone 
response is comparable to wildtype mice. This result suggests that the dimorphic HPA axis response to 
stress may involve IL-6 activation (16). 
 
1.2.4.5 Endothelial Nitric Oxide Deficient Mice (NOS III) 
The generation of new neurons in the adult brain has been increasingly within the last years 
(118). On the functional level adult neurogenesis (119) has been postulated to be involved in 
the pathogenesis of depressive disorders and/or mediation action of antidepressants (188). So 
far, little is known about the mechanisms that regulate neurogenesis. Stress, age, physical 
exercise, as well as a variety of messenger molecules, transcription-, and growth factors have 
been implicated (62). The gaseous messenger molecule nitric oxide (NO) is synthesized from 
L-arginine by a family of three NO synthases (NOS), nominated NOS I, II, and the 
endothelial NOS III. NO exerts multiple actions in the central nervous system and is involved 
in behavioural processes such as learning and memory (204), which makes it an interesting 
factor to be investigated regarding neurogenesis. The neuroprotective role of NO was 
demonstrated by the finding that an inhibition of NOS I increased cell death in the dentate 
gyrus after adrenalectomy (167). In the human as well as in the rodent dentate gyrus, the main 
site of adult neurogenesis, NOS I and NOS III have been detected and NOS III is expressed in 
endothelial cells and probably in CA 1 pyramidal cells (161, 166). Since NOS III therefore 
www.pdfmailer.de   PDFMAILER.DE 
 
Kostenfrei und werbegesponsert PDF drucken und direkt per E-Mail 
versenden >Test it free www.pdfmailer.de 
Introduction 
___________________________________________________________________________ 
  23 
might have the spatial potential to regulate adult neurogenesis, it seemed interesting to 
analyse the behaviour in these mice as well (180). 
 
1.3 Current Treatment Concepts of Depression 
Antidepressants were discovered by serendipity half a century ago, when it was observed in 1954 that 
some tuberculosis therapies exerted a beneficial effect for the well-being of the treated patients (18, 
193). According to these results, iproniazid, a member of the monoamine oxidase inhibitor (MAO-I 
family), became the first antidepressant (134, 252). At the same time, imipramine was found to exert 
positive effects in depression, exposing a completely new approach: the monoamine theory of 
depression (25, 42, 189). However, the effectiveness of antidepressants cannot be explained 
sufficiently by neurotransmission theories. Molecular-pharmacological studies demonstrate that, 
besides the effects in synaptic neurotransmission, antidepressive treatment influences signal 
transduction cascades and gene transcription mechanisms, thereby regulating the expression of 
particular target genes (157). Those genes control molecules, which are responsible for synaptic 
plasticity, i.e. chronic, but not acute treatment with antidepressants influences the cAMP messenger 
system and elevates the expression of neurotrophic factors, e.g. BDNF, which is known to play an 
important role in neuronal plasticity, survival and function. Decreased BDNF expression as a 
consequence of stress may play a role in stress-induced neuronal damage, which is accompanied by 
neuronal atrophy or apoptosis in hippocampal CA3 neurons (146). Besides an increase of BDNF, an 
elevation of its tyrosine kinase receptor TrkB can be observed within the hippocampus. Moreover, 
several classes of antidepressants (selective norepinephrine and serotonin reuptake inhibitors, non-
selective tricyclic monoamine re-uptake inhibitors and MAO inhibitors) as well as electroconvulsive 
therapy up-regulate the expression of CREB mRNA in the hippocampus (159). This suggests the 
transcription factor CREB, that is down-regulated in the cortex of depressed patients (57) to serve as a 
common target for antidepressant treatment with very different primary sites of action. It is induced 
after approximately 10 days of treatment, which is in line with the onset of effectiveness of 
antidepressive therapy (159). Support for the hypothesis that enhanced cAMP signalling may be 
induced by antidepressants, derives from studies of the phosphodiesterase inhibitor rolipram, which 
has been reported to have antidepressive effects in clinical trials (224). Furthermore, antidepressive 
treatment can enhance neurogenesis in the hippocampus (214). Stress represents an important risk 
factor with regard to psychiatric disorders but often exerts opposite effects. Antidepressants, which 
affect on glucocorticoid receptor functioning, affect not only the peripheral stress hormone system 
which is normalized by antidepressive pharmacotherapy; therefore current strategies for developing 
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antidepressants with high efficacy and good compatibility depend on an improved knowledge about 
the molecular, cellular, and behavioural effects of stress (210, 214). 
The chronic application of antidepressants causes a decrease in ACTH and corticosterone under basal 
and stress conditions. When analysed in a time course, an alteration of GR and MR functioning first 
became detectable after one week of treatment (169). According to the suppressive activity of the MR 
on the stress hormone system, which was characterized by MR antagonists and antisense studies, the 
elevation of MR appears to be the first step towards the inhibition of CRH in the hypothalamus. 
Subsequently an enhanced capacity of GR transcription can be observed during antidepressive therapy 
(105).  
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Figure 4: Point of action in antidepressive therapy. Antidepressants exert their mood-elevating effects by 
different mechanisms, i.e. inhibition of serotonin and norepinephrine re-uptake (SSRI/NRI), inhibition of 
degradation by blocking MAO A activity or increasing the neurotransmitters in the synaptic cleft. Chronic 
treatment with antidepressants causes an elevation of CREB, thereby regulating all factors of the neurotrophic 
pathway (i.e. BDNF and TrkB), as well as a CREB-enhanced synaptic function and release of monoamines. 
 
1.4 Conceptual Considerations 
Since there is an enormous demand on behavioural phenotyping of transgenic mice carrying mutations 
of target genes relevant for research of human diseases, it is important to improve tools for proper 
behavioural analysis. The adequate design of animal models, also considering limitations and 
distinctiveness of other types of approaches, represents a cornerstone for the clarification of postulated 
aspects in depression. A first goal was therefore the optimisation and adaptation of the “Learned 
Helplessness” paradigm to mice (in which genetic manipulations may be studied) and to embed it in a 
www.pdfmailer.de   PDFMAILER.DE 
 
Kostenfrei und werbegesponsert PDF drucken und direkt per E-Mail 
versenden >Test it free www.pdfmailer.de 
Introduction 
___________________________________________________________________________ 
  25 
standardized behavioural test battery for associated parameters at the behavioural and neurochemical 
level. Despite the need of animal models such as the Learned Helplessness, which represent valid tools 
for research, this model, demonstrating excellent validity, was rarely utilized during the last decades. 
Optimal connections between the different disciplines consequently open promising possibilities for a 
complex and detailed investigation of the pathophysiological and therapeutic pathways.  
 A major goal of generating animals by targeted mutagenesis is to elucidate the role of the genes that 
might be changed in (patho)physiological processes. Mutant mice are powerful tools to study specific 
functions of molecules such as neurotransmitters or their receptors. Apart from these fundamental 
objectives, mutant animals can also constitute disease models. With respect to depression, many lines 
of mice have been generated according to the molecular hypotheses underlying affective disorders to 
explore the biological mechanisms thought to be involved in the pathogenesis and therapy of 
depression. Using this approach successfully, two possible outcomes may be surveyed theoretically:  
inactivation of a gene, whose product is usually blocked by antidepressants, should lead to models of 
resistance to depression; vice versa inactivation of a gene, whose product is induced or activated by 
antidepressants, e.g. BDNF, should result in overt "endogenous depression" or in a model of 
susceptibility to depression. Among the lines generated, only very few may represent models of 
endogenous depression. A few lines most likely constitute susceptibility models of depression, i.e. 
they do not present depression-like symptoms under baseline conditions but are more "depressed” 
following environmental stress, like in the Learned Helplessness model or chronic (mild) stress (e.g. 
CREB over-expressing mice). Like any model, also the transgenic approach has limitations. Classical 
transgenic and knock-out mice carry their mutations from the very first stages of development. Thus, 
the phenotype observed in adulthood could be due to developmental defects or adaptations of the 
organism (92). Hidden side effects of a mutation may also entail differences in the animals' social 
behaviour, affecting the whole progeny. If mutagenesis affects maternal care behaviour, a phenotype 
observed in the offspring may rather reflect this environmental factor than the mutation (73). Another 
level of complexity is added by the fact that many behavioural findings are only present in a specific 
genetic background (e.g. C57BL/6) but missing when this background is lost (245, 246). In light of 
these deficiencies, mutant mice often serve to "confirm” hypotheses derived from pharmacological 
studies or clinical observations, but may also falsify such concepts.  
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1.5 Aim of this Thesis 
To elucidate the role and interrelation of genetic and environmental factors, the investigations of all 
mice with targeted stress-related and neurotrophic candidate genes in this thesis are investigated 
hypotheses-conducted in essential paradigms for depression-like behaviour. Coupling behavioural 
with neurochemical markers of depressive behaviour serve to enhance confidence regarding the results 
obtained (79), which is applied for the investigation of the aspects involved in the Learned 
Helplessness (see Figure below).  
 
Figure 5: Regulation of Learned Helplessness: Potential Factors and Systems. The regulation of Learned 
Helplessness is driven by stressful experiences causing this phenotype, which can be reverted by antidepressive 
therapy. Stress, as well as antidepressants, moreover exerts controversial effects regarding neurotrophic circuits, 
glucocorticoid receptors, and Interleukin-6.  
 
It is known that Learned Helplessness and depression, respectively, are influenced by different 
systems, which are stated in the common hypotheses of depression. To gain further insight into the 
relations and prove the relevance of particular factors in these systems, the subsequent questions were 
addressed: 
 
· Is the Learned Helplessness paradigm of depression a stable, reproducible model 
regarding a depressive-like phenotype in mice, and may this be proven 
pharmacologically? How does this model affect BDNF and NGF protein levels when 
examined in a time course experiment? 
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· How and to what extent does “chronic stress”, caused by a particular housing condition 
affect the results in the Learned Helplessness model? 
 
· Does a heterozygous mutation of the BDNF gene lead to a depressive-like phenotype and 
is this phenotype accompanied by disease-specific alterations at the monoaminergic and 
stress-physiological level? 
 
· Does a point-mutation of CREB, which prevents phosphorylation at this particular site, 
cause a depressive-like phenotype (besides the observed phase shifts as potential 
indicators), which is associated with changes in stress-hormone release? 
 
· To what extent does a heterozygous mutation of the glucocorticoid receptor affect 
depressive-like behaviour in the Learned Helplessness paradigm, stress endocrinology, 
and neurotrophin levels and mimic depression-like features in the DEX/CRH Test? 
 
· In how far can the expected changes be replicated by the over-expression of the 
glucocorticoid receptor? 
 
· Is a knock-out of IL-6 capable of inducing depression-typical behavioural and stress-
endocrinological parameters in the Learned Helplessness paradigm, and does the 
Learned Helplessness paradigm itself cause changes in IL-6? 
 
· How does a knock-out of endothelial nitric oxide synthase (NOS III), which is suggested 
to be involved in the reduction in neuronal progenitor cell proliferation in the dentate 
gyrus, affect the behaviour in the Learned Helplessness? 
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2 Material and Methods 
2.1 Animals 
The experimental animals were generally housed individual in standard macrolon cages (type II) with 
bedding material and were acclimatized for 2 weeks to a reversed 12-hour dark-light cycle (light: 
18:00 - 6:00) at 22±1°C. Animals received a standard pellet diet and water ad libitum. The numbers of 
mutant animals tested in each experiment were dependent on the availability of mice of approximately 
the same age. All animal experiments were approved by the animal welfare office of the 
Regierungspräsidium Karlsruhe, Germany.  
 
2.1.1 Housing Conditions 
All behavioural tests were conducted in 4-months old male C57BL6/N mice. The animals were 
purchased from Charles River (Sulzfeld, Germany) at an age of 8 weeks and were then housed under 
specific conditions in type II cages for single and type III cages for group rearing, for 7 weeks. Four 
cohorts of mice were investigated: 1.) single housed, impoverished conditions (n=16), 2.) single 
housed, enriched conditions (n=16), 3.) group housed, impoverished conditions (n=16), 4.) group 
housed, enriched conditions (n=16). Enrichment consisted of red, transparent plastic mouse igloos and 
tunnels (EMSICON Jung GmbH, Forstinning, Germany) that were cleaned weekly, when the cage was 
changed. Additionally, nesting material (tissue) was provided. Impoverished cages simply contained 
bedding material. All mice were kept in the same room, in a 12h:12h reversed dark-light cycle, lights 
on at 6.00 p.m, water and food pellets were available ad libitum. Body weight was assessed once a 
week when the cages were changed. All experiments were approved by German animal welfare 
authorities. After 7 weeks of housing under the aforementioned conditions, all animals were subjected 
to tests for locomotion, exploration and anxiety, followed by the Learned Helplessness procedure. 
Thus, following earlier recommendations for repetitive behavioural testing, animals were initially 
tested in the experiments ranked as least stressful (147, 226). Considering that the determination of the 
pain threshold by the Hotplate Test could have a direct influence on helpless behaviour, we assessed 
the effect of housing conditions on pain sensitivity in a different group of mice reared under identical 
housing conditions. Test procedures were essentially performed as described earlier (33, 71, 180). 
Between the individual tests was a pause of at least 24 h. Prior to each test, mice were acclimatized to 
the experimental room for at least 30 min. All behavioural tests were conducted during the dark cycle, 
i.e. during the animals' active phase.  
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        single impoverished        group impoverished  
   
           single enriched      group enriched 
Figure 6: Housing conditions. Mice are housed in different conditions implying an enriched environment and 
different social constellations for seven weeks prior to the behavioural assessment of housing effects. 
 
2.2 Genetic Approaches 
Animals carrying diverse mutations of target genes, which are postulated to be involved in 
pathological mechanisms of depression, were monitored with regard to depressive-like behavioural 
and physiological features to verify their compatibility to represent an animal model for depression. 
 
2.2.1 BDNF Heterozygous Animals (BDNF+/-) 
BDNF+/- male mice on a mixed C57BL/6 x SV129 background were supplied by the Jackson 
laboratories (Bar Harbor, Maine, USA) and used for breeding. They were crossed to C57BL/6N 
female mice obtained from Charles River (Sulzfeld, Germany). All experiments were performed with 
offspring of this breeding. For all experiments only female BDNF+/- mice were used, and BDNF+/+ 
female littermates served as controls. The age of the experimental animals was between 3 and 5 
months. For genotyping, 3 mm tail segments were taken for polymerase chain reaction (PCR) at about 
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4 - 6 weeks of age. A conventional tail prep kit (DNeasy tissue Kit, Qiagen GmbH, Hilden, Germany) 
was used to prepare the DNA for PCR, which was conducted according to the reference provided by 
the Jackson Laboratories.  
 
2.2.2 CREB Ser142A Mutant Animals 
CREBS142A mice were generated and bred as described elsewhere (83). For the present study animals 
were backcrossed for more than 10 generations into the C57BL/6N background. 3-6 months old male 
CREBS142A mice were purchased from the German Cancer Research Centre (dkfz) in Heidelberg. 
Genotypes were determined by PCR as described earlier (83).  
 
2.2.3 Glucocorticoid Heterozygous Animals (GR+/-) 
The founders of GR heterozygous mice (GR+/-) were developed by using homologous recombination 
in embryonic stem cells as described elsewhere (216). For all experiments three months old male 
mice, provided by the German Cancer Research Centre (dkfz) in Heidelberg, were used. Mice were 
bred as F1 hybrids from two commonly used inbred strains, C57BL/6 and FVB/N (backcrossed for 
more than 10 generations), to ensure the so-called hybrid vigour.  
 
2.2.4 Glucocorticoid Overexpressing Animals (YGRs) 
Furthermore, so-called YGR mice were investigated, which carry two additional copies of the GR, 
generated by a transgenic approach using a yeast artificial chromosome (177). In order to obtain an F1 
hybrid background in YGR mice, double transgenic male YGR founders on a pure FVB/N background 
were mated with female C57BL/6N wildtype mice. All animals were between 3-6 months of age when 
exposed to the tests.  
 
2.2.5 Interleukin-6 Knock-out Animals (IL-6-/-) 
The IL-6-deficient mice (125) had been back-crossed on a C57BL/6 genetic background for more than 
10 generations. For genotyping, 3-mm tail segments were taken for tissue samples for polymerase 
chain reaction (PCR) at about six weeks of age. A conventional tail prep kit (DNeasy Tissue Kit, 
Quiagen GmbH Hilden, Germany) was used to prepare the DNA for the PCR, which was conducted 
according to the recent publication of Butterweck et al. (26). 
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2.2.6 Endothelial Nitric Oxide Synthase Knock-out Animals (NOS III-/-) 
Male 3-5 months-old homozygous NOS III knock-out mice (n = 10) with the same genetic background 
(for review see (109)) and wildtype controls (n = 10), obtained from the Molecular and Clinical 
Psychobiology, University of Würzburg, were investigated. 
 
2.3 Behavioural Analysis 
2.3.1 Basal Behaviour 
All behavioural tests were conducted during the dark cycle, i.e. in the animals' active phase. Prior to 
each test, mice were acclimatized to the experimental room for at least 15 min. Test procedures were 
essentially performed as described earlier (33, 71). The animals were subjected to several basal tests of 
locomotion, exploration, and anxiety as well as depression-relevant paradigms such as the Porsolt 
Forced Swim Test, Fear Conditioning, and Learned Helplessness. The order of the tests followed 
earlier recommendations ranking the tests from least stressful to more stressful (147, 226). Between 
individual tests was a pause of at least 24 h. In all experiments, the investigator was blind to the 
genotype of the mice during behavioural testing.  
 
2.3.1.1 Motoric Abilities 
The rotarod Test assesses motoric abilities of mice placed onto a rotating rod by evaluation of the 
latency to fall within maximal 300 s when the velocity of the rotation is increasing.  
 
 
Figure 7: Rotarod Test 
Assessment of locomotor abilities on a rotating rod 
2.3.1.2 Openfield 
The Openfield Test examines the locomotor- and explorative features of an animal placed into an 
unknown arena. Activity monitoring was conducted in a square, white Openfield, measuring 50x50 
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cm2 and illuminated from above by 25 Lux. Mice were placed individually into the arena and 
monitored for 15 min by a Video camera (Sony CCD IRIS). The resulting data were analysed using 
the image processing system EthoVision 2.3 (Noldus Information Technology, Wageningen, the 
Netherlands). For each sample, the system recorded position, object area and the status of defined 
events. Parameters assessed for the present study were total distance moved, velocity, and time in 
centre, which was defined as the area 10 cm distant from the walls.   
 
 
Figure 8: Openfield Test 
Videotracked assessment of locomotor and exploratory features of 
mice placed in an unknown Openfield arena 
2.3.1.3 Novel Cage 
The Novel Cage Test is used to investigate exploratory behaviour in a new environment by measuring 
vertical activity. Animals were placed in a new macrolon cage, with a thin layer of bedding material as 
described earlier (180). Rearings were counted for 300 s under dimmed redlight conditions. 
 
 
Figure 9: Novel Cage Test 
Assessment of exploratory features of mice placed in an unknown 
new cage, indicated by number of rearings 
www.pdfmailer.de   PDFMAILER.DE 
 
Kostenfrei und werbegesponsert PDF drucken und direkt per E-Mail 
versenden >Test it free www.pdfmailer.de 
Material and Methods 
___________________________________________________________________________ 
  33 
2.3.1.4 Barrier Test 
The Barrier Test represents an alternative measure for the exploratory drive of mice. This test was 
performed in a plastic macrolon cage type II inside the animals’ housing rooms. The cage was 
equipped with a 1 cm high plastic barrier separating the cage in two equal-sized compartments. The 
mice were placed into the centre of one section following a random order. The latency (max. 300 s) to 
climb over the barrier was interpreted as a measure of exploration.  
 
 
Figure 10: Barrier Test 
Assessment of exploratory features of mice by assessing the latency 
until the mouse crosses a hurdle to get into the other section. 
 
2.3.1.5 Dark-Light Box (DLB) 
In the Dark-Light Box, animals can be investigated in terms of anxiety to explore an aversive bright 
compartment. The Dark-Light Box consisted of two plastic chambers, connected by a small tunnel. 
The dark chamber measured 20x15 cm2 and was covered by a lid. The other chamber, measuring 
30x15 cm2, was white and illuminated from above with an intensity of 600 Lux. Mice were placed into 
the dark compartment and latency to first exit, number of exits, and total time in the light compartment 
were recorded for 300 s. 
 
 
Figure 11: Dark-Light Box Test 
Assessment of exploratory drive and anxiety-like behaviour during 
bright illumination based on an approach-avoidance conflict 
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2.3.1.6 O-Maze 
In the O-Maze mice are analysed regarding anxiety to enter the elevated, exposed sections of a round 
maze, inflicting an approach-avoidance conflict. The maze consisted of a grey plastic annular runway 
(width 6 cm, outer diameter 46 cm, 50 cm above ground level), covered with black cardboard paper to 
prevent mice from slipping off the maze. Two opposing 90° sectors were protected by inner and outer 
walls of grey polyvinyl (height 10 cm). Animals were placed in one of the protected sectors and 
observed for 300 s. The maze was illuminated with 25 Lux. The following parameters were analysed: 
latency to first exit, number of exits to, and total time spent in the open compartments. 
 
 
Figure 12: O-Maze Test 
Assessment of anxiety-like behaviour in mice confronted with an 
aversive situation on the unprotected and elevated sections of the maze 
 
2.3.1.7 Marble-Burying (Defensive Burying) 
In the Marble-Burying Test, an anxiolytic-evaluated test to assess anxiety-like behaviour in rodents 
(160), the mice were placed into a standard macrolon cage type III containing 5 cm of compactly 
compressed sawdust bedding covered with 20 conventional glass marbles (diameter: 1.5 cm) for 30 
minutes in red illumination. Since mice show an aversion when exposed unknown reflecting objects 
and crave to hide them, the number of buried marbles was assessed as an indicator of defensive 
behaviour. 
 
2.3.2 Learning 
2.3.2.1 Fear Conditioning 
Fear Conditioning was done as described previously (82) and represents a type of emotional learning 
that is hippocampus- as well as amygdala-dependent. For both, contextual and cued conditioning, mice 
were individually placed into the conditioning chamber (58x30x27 cm3, TSE, Bad Homburg, 
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Germany) and allowed to habituate for 120 s, before the onset of a discrete conditioned stimulus (2800 
Hz tone; 85 dB) that lasted 30 s. At the end of the tone, animals were subjected to the unconditioned 
stimulus (2 s of continuous footshock of 0.8 mA). 24 h after training, the hippocampus-dependent 
context conditioning was assessed by measuring freezing, defined as a complete lack of movements 
apart from respiration. Context learning was tested in the same plexiglass chamber that was used 
during the training. Freezing behaviour was scored at intervals of 10 s for 300 s. The amygdala-
dependent cued conditioning was analysed in a visually and olfactorically novel context at 48 h after 
training by exposing the animals to the tone for 3 min, during which freezing was scored as described 
above. 
 
 
Figure 13: Fear Conditioning 
Assessment of Fear Conditioning in cued and context conditions after 
presentation of an aversive stimulus in the Fear Conditioning chamber 
 
2.3.2.2 T-Maze 
The T-Maze Test is a spatial short-term working memory paradigm, analysing the animals’ ability to 
recognize and differentiate between a new unknown and a familiar compartment (43, 44, 133). The T-
shaped maze was made of black wood with two 20 cm long arms, which extended with a right-angle 
from a 40 cm long alley. The arms and the alley had a width of 10 cm and were surrounded by 25 cm 
high walls. The test consisted of two trials with an intertrial interval of one hour, during which the 
animals were put back to their home cage. During an 8 min acquisition trial, one of the short arms was 
closed. In a second 180 s retention trial, mice had access to all three arms. Number of visits and time 
spent in either of short arms were assessed. Light intensity was 20 Lux.  
www.pdfmailer.de   PDFMAILER.DE 
 
Kostenfrei und werbegesponsert PDF drucken und direkt per E-Mail 
versenden >Test it free www.pdfmailer.de 
Material and Methods 
___________________________________________________________________________ 
  36 
 
Figure 14: T-Maze 
Assessment of spatial learning in which the animals ability to recognize 
the known arm and differentiate between known and unknown sections 
without a motivational component (food reward) is assessed. 
 
2.3.3 Depression-linked Behaviour 
2.3.3.1 Porsolt Forced Swim Test 
Mice were placed into a glass cylinder (23 cm height, 13 cm diameter), which was filled with water 
(22°C) up to a height of 8 cm, as described earlier (255). A testing period of 6 min was used to 
determine the onset and the percentage of time spent immobile. Immobility was defined as motionless 
floating in the water, only allowing movements necessary for the animal to keep its head above the 
water. In contrast, swimming was defined as time spent with active escape or struggling movements. 
24 h after the first testing, a re-test was performed under the same conditions as before. 
 
 
Figure 15: Porsolt Forced Swim Test 
Assessment of “despair” behaviour by placing mice into a water-filled glass 
cylinder, indicated by latency to float and total time spent floating. 
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2.3.3.2 Sucrose Consumption 
“Anhedonia” represents one of the crucial signs of depression and a suitable behavioural indicator of a 
depressive-like state in rodents (209, 243). The Sucrose Consumption Test assesses whether mice 
demonstrate a loss of interest in consuming pleasurable sweet solutions when they have the possibility 
to choose between a sugar solution and plain tab water. Despite of being a valuable tool for the 
examination of depression, the Sucrose Consumption Test is not stable, reproducible experiment, and 
therefore remains restricted in its application. However, a modification of the test resulted in an 
improvement of the representability of the results. For 5 weeks, 5 days a week, 2 hours per day (10:00-
12:00 am), each normal water bottle was replaced by two bottles containing a sucrose solution at 
different concentrations (0.0 1.0, 2.5 or 5.0 %, w/v). The position of the bottles was randomised. This 
phase is considered as necessary training so that the animals get used to the restricted availability of 
sucrose in the drinking bottles. In the following 16 days, a two-bottle choice test adapted from that 
used by Martinetti (143) was used. Again 5 test sessions were conducted per week. Thus, all animals 
received a series of 16 choice conditions, 2 h per day. During these choice conditions (summarised in 
Table 1) two solutions were concurrently available and the consumption of each one was calculated by 
weighing the bottles after each session using an electronic scale accurate to 0.1 g. 
 
 
Figure 16: Sucrose Preference Test: 
Assessment of “anhedonia” by analysing the quantity of sugar solution 
consumed relative to the consumption of water. 
 
2.3.4 Novel Object Test 
In the Novel Object Test assesses potential neophobic features of animals, which may indicate a 
depressive-like state (209), towards an unknown object placed into an Openfield arena. The same 
arena and test conditions were employed as for the Openfield Test. At the end of the Openfield testing 
period, a new and unknown object (a water-filled 50 ml Falcon tube, placed top down) was introduced 
to the centre of the arena. Object exploration was assessed for 300 s, monitoring the mean distance to 
the object, the latency of first approach, as well as the total number of approaches. 
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2.3.4.1 Learned Helplessness 
In the Learned Helplessness paradigm, as described by Reif et al. (180), the animals were exposed to a 
transparent plexiglas shock chamber (18 x 18 x 30 cm), equipped with a stainless steel grid floor 
(Coulborn precision regulated animal shocker, Coulborn Instruments, Düsseldorf, Germany), through 
which they received 360 footshocks (0.150 mA) on two consecutive days, respectively. The 
footshocks applied were scrambled across the rods and unpredictable, with varying shock- (1-3 s) and 
interval-episodes (1–15 s), amounting to a total session duration of approximately 52 min. 24 h after 
the second the shock procedure, Learned Helplessness was assessed by testing shuttle box 
performance (Graphic State Notation, Coulborn Instruments, Düsseldorf, Germany). The shuttle box 
consisted of two equal-sized compartments (18 x 18 x 30) that were separated by a small gate (6 cm 
wide and 7 cm high). The shuttle box also contained a grid floor, through which current could be 
applied, and a signalling light at the top of both compartments. Spontaneous initial shuttles from one 
compartment to the other were counted during the first two min by redlight beams at the bottom of 
each of the two divisions. Performance was analysed according to the behaviour during 30 shuttle 
escape trials. Each trial started with a light stimulus of 5 s, announcing a subsequent footshock of 
maximum 10 s duration. The intertrial interval was 30 s. The following behavioural reactions were 
defined (numbers of responses): avoidance as adequate reaction to the light stimulus by changing to 
the other compartment immediately, escapes as shuttling to the other section as reaction to the electric 
shock, and failures, when no attempt to escape was made. Escape latency was assessed computerized 
by the determination of the time (seconds) it took the animal to escape after onset of the footshock. 
For determination of the activity during the intervals, shuttles in between the trials were recorded. 
Total time of testing for Helplessness was about 20 min, the exact time period depending on the 
animal’s ability to learn the paradigm. 
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Gate 
Light 
Figure 17: Learned Helplessness 
Assessment of helpless behaviour by analyzing avoidance, escapes, failures, escape latency, ITI activity 
considering failures and escape latency as the most relevant parameters for the definintion of Helplessness 
Shock procedure: 
360 shocks of  0.15 mA 
on 2 consecutive days 
24 h prior to testing 
Test procedure with 30 trials: 
2 min. of free exploration (initial activity) 
5 s light followed by 10 s shock (0.15 mA) 
30 s intertrial interval (ITI activity) 
 
To exclude pain sensitivity as a confounding factor, all mice were tested on the Hotplate (ATLab, 
Vendargues, France) at a temperature of 52°C for 45 seconds. Latency to first reaction, licking hind 
paws or jumping was assessed. 
 
 
Figure 18: Hotplate Test 
Assessment of pain sensitivity by analysing the latency to first 
reaction the Hotplate, i.e. licking hindpaws or jumping 
2.4 Stress Endocrinology 
2.4.1 Corticosterone Determination 
Basal corticosterone levels: To test the circadian secretion of corticosterone mice were sacrificed at 
respective timepoints of their active (dark) and inactive (light) phase.  
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Corticosterone levels after restraint stress: Mice were restrained for a period of 30 min during their 
light phase in plastic tunnel. 40 and 60 min after the termination of the immobilization stress plasma 
corticosterone levels were assessed. 
 
 
Figure 19: Restraint Stress 
The animal is restrained in a plastic tube equipped with holes to ensure 
oxygen delivery for 30 minutes 
 
2.4.2 Dexamethasone Test (Dex-Test) and Dex/CRH-Test 
The mice received an intraperitoneal (i.p.) injection of dexamethasone (3 µg/100g body weight, 
Sigma-Aldrich, Schnelldorf, Germany) 6 hours prior decapitation and determination of corticosterone 
suppression.  
6 hours after application of dexamethasone, the mice were injected i.p. with 5 µg of corticotropin 
releasing hormone (CRH Ferring, Kiel, Germany) and sacrificed 30 min later. All corticosterone levels 
were analysed by a commercial radioimmunoassay kit (ICN Biomedicals, Eschwege) as described 
elsewhere (255).  
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Figure 20: The dexamethasone suppression Test. This test assesses a negative feedback function of the HPA 
axis typical for depressive individuals determining the dysfunction as a characteristic non-suppression following 
the challenge of the system by the synthetic glucocorticoid dexamethasone 
 
 
2.4.3 ACTH Determination 
ACTH serum levels were analysed using commercially available radioimmunoassay kits (ICN 
Biomedicals, Eschwege, Germany).  
 
2.5 Neurotrophins and Monoamines 
The determination of neurotrophins and monoamines in BDNF+/- mice, as well as the time course 
experiment, was done in cooperation with Prof. Dr. Rainer Hellweg and Prof. Dr. Heide Hörtnagl, 
Department of Psychiatry, Charité Berlin. 
 
Modell et al., Neuropsychopharmacology, 1998 
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2.5.1 Brain–Derived Neurotrophic Factor and Nerve Growth Factor 
Each frozen brain tissue was homogenized by ultrasonication in 10-20 vol of lysis buffer containing 
0.1 M Tris-HCl pH 7.0, 0.4 M NaCl, 0.1 % NaN3 and a variety of protease inhibitors (99) and was 
stored at –80°C until analysis. Endogenous NGF levels in the re-thawed homogenates were 
determined by a fluorometric two-site enzyme immunoassay (ELISA), which has been described in 
detail elsewhere (98, 99). The mean recovery of mouse NGF (125 pg/ml) added to the homogenate 
ranged from 60 to 90 %. NGF content was expressed as equivalents of mouse 2.5 S NGF. The 
detection limit of the assay was 0.25 pg/ml. Endogenous levels of BDNF were measured in the re-
thawed homogenates using commercial ELISA kits in principle according to the manufacturer’s 
instructions (Promega Inc., Mannheim, Germany), but were adapted to the fluorometric technique also 
used for NGF determination as described in detail previously (33). The BDNF content was expressed 
as equivalents of recombinant human BDNF. The detection limit of the assay was 1 pg/ml. Each brain 
tissue was consecutively processed for quantification of each neurotrophin, i.e. NGF and BDNF. 
Determinations of recovery, specific, and unspecific neurotrophin binding (the latter against mouse 
IgG1 obtained from MOPC 21) involved quadruplicate fluorescence determinations for each tissue 
sample. The neurotrophin levels were expressed as pg/mg tissue (wet weight). In order to minimize 
the influence of possible variances between experiments, neurotrophin levels from treated animals 
were normalized as a percentage of control, and refer to those from untreated control tissues, always 
being included in the same experiment.  
 
2.5.2 Time Course Experiment 
To assess the time course of BDNF protein regulation after foot shock stress, the mice were sacrificed 
by decapitation at different time points within the period of a robust helpless state. Time points 
included 0, 3, 6, 12, 24 and 48 hours post shock as well as 7 and 14 days, when Helplessness is not 
apparent anymore. 
 
2.5.3 Monoamines and Choline Acetyltransferase 
Dissection of the brains and homogenisation procedures: Mice were sacrificed, the brains were rapidly 
removed, immediately frozen on dry ice, and stored at -80°C until use. Various brain areas, including 
hippocampus, striatum, frontal cortex, and hypothalamus, were dissected on a cold plate (-16°C) 
according to Franklin and Paxinos (74). The tissue samples were weighed and stored at -80°C until 
homogenisation. The hippocampus, striatum, and frontal cortex from the left hemisphere and the 
hypothalamus were used for the measurement of monoamine levels and activity of choline 
www.pdfmailer.de   PDFMAILER.DE 
 
Kostenfrei und werbegesponsert PDF drucken und direkt per E-Mail 
versenden >Test it free www.pdfmailer.de 
Material and Methods 
___________________________________________________________________________ 
  43 
acetyltransferase (ChAT). For the determination of neurotrophin levels the hippocampus, striatum, and 
frontal cortex of the right hemisphere were used. 
Homogenisation procedure: Each frozen tissue sample of the various brain areas was homogenized by 
ultrasonication in 10-20 vol of deionized water at 4°C. Immediately after sonication an aliquot of the 
homogenate (200-300 µl) was added to an equal volume of 0.2 N perchloric acid and centrifuged at 
25000 x g for 10 min at 4°C. The supernatant was used for the measurement of 5-HT, 5-
hydroxyindoleacetic acid (5-HIAA), NE, DA, and homovanillic acid (HVA). The remaining aqueous 
homogenate was used for the measurement of the activity of ChAT.  
Determination of monoamines and metabolites: 5-HT, 5-HIAA, and HVA were analysed as described 
previously (205) using high performance liquid chromatography (HPLC) with electrochemical 
detection. NE and DA were measured by high-performance liquid chromatography with 
electrochemical detection after extraction to alumina according to Felice et al. (70) with minor 
modifications (206). 
Determination of ChAT activity: The activity of ChAT was determined according to Fonnum (72) 
with minor modifications described previously (98). ChAT activity was expressed as microunits (µU) 
per milligram wet weight, i.e., picomoles acetylcholine per minute per milligram wet weight. 
 
 
2.6 Interleukin-6 (IL-6) 
For the determination of shock exposure effects during the Learned Helplessness paradigm on IL-6 
expression, shocked and unshocked animals were quickly sacrified by decapitation and hippocampal 
tissue was dissected and frozen on dry ice. The analysis of IL-6 protein levels was done in cooperation 
with the group of PD Dr. Markus Schwaninger, Department of Neurology, University of Heidelberg. 
 
2.7 Pharmacological Experiments 
2.7.1 Pharmacological Validation 
Especially with regard to animal models it is essential to validate that the output of what is modelled is 
due to the assumed basic principle. Since the examination of depression in animals is restricted by the 
fact that the emotional status cannot be assessed like in human conditions, one has to adduct molecular 
markers on one hand and well-characterized behavioural features on the other hand.  Proper 
description of depressive-like behaviour always requires a validation with an antidepressive therapy 
that is effective in the human disease and capable to convert depressive symptoms.  
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To evaluate the readout of the Learned Helplessness paradigm in mice, the animals were treated 
subchronically, i.e. for five days, with two different doses of imipramine (10 and 30 mg/kg 
bodyweight Sigma, Germany) starting one day after the shock and shuttle box procedure. Shocked 
animals and respective controls were retested in the shuttle box on day 6 after induction of Learned 
Helplessness to verify the effect of the treatment. To exclude the effect of handling and stress caused 
by the injection, an additional cohort of mice were included in the study receiving just saline 
injections.  
Animals that were selected for the study had to fulfil the criteria of having more than 6 failures and an 
escape latency higher than 4.75, which was applicable for a subgroup of approximately 30 %, a 
proportion that reflects fairly well the percentage of depressive patients referring to the total 
population. The analysis and definition of marginal values was conducted on the constantly adjusted 
data basis of helpless animals (for detailed description see appendix). 
 
2.8 Statistical Evaluation 
For statistical evaluation mainly parametric statistical measures were used, since distribution of values 
was normal in most of the cases. One and two-way ANOVAs were calculated with XLstat (Version 
7.5, Addinsoft). In cases in which data were not normal distributed, non-parametric statistics were 
applied. A detailed description of the particular statistical analyses can be found in the Results section.
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3 Results 
3.1 Establishment of the Learned Helplessness Paradigm 
 
The Learned Helplessness, originally developed in dogs, represents one of the most valuable animal 
models of depression with good predictive validity (242). One current approach to determine which 
genes are involved in vulnerability to Helplessness, is the examination of specific candidate genes of 
depression in mouse knock-out models (a technique, that is not applicable in rats), which makes it 
necessary to look for standardized reproducible protocols that incorporate not only changes caused by 
the disrupted gene (84), but also the consideration of background and genotype as well as consistency 
of housing and testing conditions. Since the mouse inbred strain C57BL/6 is one of the most 
frequently used strains, the establishment and characterization of the Learned Helplessness was 
accomplished in this particular strain. To construct a databank comprising suitable data from valid 
experimental procedures, the experimental design included different protocols published in literature, 
which were used and modified and subsequently analysed statistically. The process was conducted in 
male approximately 12 months old, single-housed C57BL/6N mice. 
For a more precise understanding of the procedure it is essential to be aware of the relevant parameters 
of the paradigm, as well as the mechanisms (Table 1). Escape failures as well as escape latency are 
considered as the most relevant parameters for the characterization of a helpless state by defining the 
coping deficit most precisely. 
 
Table 1: Learned Helplessness Parameters 
 
Shuttle Box Protocol:  Recorded parameters: 
Adaptation: 2min  - initial activity (number of shuttles) 
Light: 5s   - avoidance (shock prevention) 
Shock: 10s (0.15 mA)  - failure (Helplessness) 
ITI (intertrial interval): 30s - escapes (shock reaction) 
   - escape latency (Helplessness) 
   - ITI (number shuttles between ITI) 
3.1.1 Protocols 
For the optimal output, different protocols were compared and level of Helplessness as well as the 
amount of animals to become helpless were considered as markers for quality concerning the 
practicability of the model in future experiments. The protocols compared are listed below (Table 2). 
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Table 2: Learned Helplessnes Protocols 
 
            Trial         Protocol                                         Shock                                              Shuttle Box                               Result___________       
 
A      Anisman, 1988                           360x0.150mA 2sec                             30 trials: 2 min adapt.                  activity ↑ 
                   (permanent houselight)                       5sec HL, 10sec shock                 esc.lat.↑ (day1) 
                        30 min ITI (3 days)             esc. lat.↓ (day3) 
 
B       Anisman, 1988                          360x0.150mA 2sec                             30 trials: see above (1day)          activity (con)↑ 
         Caldarone, 2000 *                      vs scrambled (1-3 sec)                                                                           Ø other difference 
 
C       Caldarone, 2000*                      360x0.150mA scrambled (2days)       30trials: see above (1day)           scrambled shock 
          Newton, 2000*                          vs steady shock in shuttle box                                                                 most effective  
          Ukai, 2001*                               vs steady shock 0.300mA (1day)                                                            esc.lat./failures↑ 
                                                           (permanent darkness) 
                                                                                                                          
         *= modified protocol        esc.lat.= escape latency       con= control      HL= houselight       vs= versus 
 
When evaluated in different conditions, the readout, i.e. escape deficits, of the Learned Helplessness 
paradigm turned out to be most effective when preceded with two days of 360 scrambled shocks/day 
at an intensity of 0.150mA in constant darkness (Fig. 21).  
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Figure 21: Evaluation of three potential protocols for the establishment of the Learned Helplessness. 
Scrambled “double shock” (ds) on two consecutive days results in the most prominent escape deficits regarding 
the number of failures and escape latency when compared to a protocol in which the shocks are applied within 
the shuttle box itself (shuttle) or the application of strong shocks (strong) with equal shock duration and 
intervals. Bars represent mean + SEM. 
The duration of Helplessness was assessed by re-testing the shuttle-box procedure at different time 
points after the shock procedure (Fig. 22). Due to the learning progression in the re-test the level of 
Helplessness decreased, but compared to control animals escape failures and latency Helplessness was 
still constantly detectable after 10 days post shock exposition, a period – which, related to the lifetime 
of a rodent -resembles the situation in humans. After 12-14 days, Helplessness starts fading in most of 
the cohorts examined.  
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Figure 22: Time course of coping deficits: Percentage of helpless animals. 360 footshock with an intensity of 
0.150mA on two consecutive days result in significant coping deficits, i.e. increase of failures and escape latency 
in the shuttle box Learned Helplessness paradigm 24 hours later  (p < 0.05), lasting at least 10 days. The time-
period between day 10 and 14 represents a critical labile condition in which a significant improvement becomes 
detectable as indicated by a sign-test (p = 0.0172) with principally merely tendencies of helpless behavioural 
standards.  
 
According to the acquired practice concerning the described protocols one final version was selected 
for further experiments in male animals and for creation of the databank. 
 
3.1.2 Final Protocol for the Learned Helplessness: 
In the Learned Helplessness paradigm the animals were exposed to a transparent plexiglas shock 
chamber (18 X 18 X 30 cm), equipped with a stainless steel grid floor (Coulborn precision regulated 
animal shocker, Coulborn Instruments, Düsseldorf, Germany), through which they received 360 
footshocks (0.150 mA) on two consecutive days. The footshocks applied were scrambled and 
unpredictable with varying shock- (1- 3 s) and interval-episodes (1 – 15 s), amounting to a total 
duration of approximately 52 minutes. 24 hours after the second day of the shock procedure, Learned 
Helplessness was assessed by testing shuttle box performance (Graphic State Notation, Coulborn 
Instruments, Düsseldorf, Germany). The shuttle box consists of two equal-sized compartments (18 X 
18 X 30) that were separated by a small gate (6 cm wide and 7 cm high), also containing a grid floor, 
through which the current was applied, and a light at the top of both sections. Spontaneous initial 
shuttles from one compartment to the other were counted during the first two minutes by redlight 
beams at the bottom of each of the two divisions. Performance was analysed according to the 
behaviour during 30 shuttle escape trials (light stimulus: 5 s, footshock: 10 s, intertrial interval: 30 s), 
defining avoidance as adequate reaction to the light stimulus by changing to the other compartment 
immediately, escapes as shuttling to the other section as reaction to the electric shock and failures, 
when no attempt to escape was made. Escape latency was assessed computerized by the determination 
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of the time (seconds) it took the animal to escape after onset of the footshock. For determination of the 
activity during the intervals, shuttles in between the trials were recorded. Total time of Helplessness 
training was about 20 minutes, depending on the animal’s ability to learn the paradigm. 
 
3.1.3 Validation 
For the pharmacological validation of the Learned Helplessness paradigm, helpless mice were treated 
subchronically with two different doses of imipramine (10 and 30 mg/kg body weight) and saline 
injections respectively and re-tested in the shuttle box. Re-tests were performed within 7 days after 
induction of Helplessness, when characteristic response features according to our time course 
experiment, are still detectable. As expected, control animals treated with saline injections did not 
differ in their coping performance (apart from the regularly observed subtle learning effects, when 
exposed to the shuttle box for the second time not revealing statistically significant differences). Since 
broad effects of imipramine on pain sensitivity or activity were excluded, these findings suggest a 
beneficial effect of imipramine (p = 0.0095) in a dose of 10 mg/kg body weight in this paradigm, 
while imipramine at a dose of 30 mg/kg body approached statistical significance (p = 0.083) (Fig. 23) 
(For detailed procedure see appendix). 
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Figure 23: Treatment effects in the Learned Helplessness. While NaCl treatment does not result in a 
statistically significant reduction of Helplessness, imipramine in a dose of 10 mg/kg body weight significantly 
decreases the number of escape failures after 5 days of treatment (1 = before pharmacological treatment; 2 = 
after pharmacological treatment). 
3.1.4 Neurotrophin Timecourse 
Since BDNF levels are decreased after different types of stressors including restraint stress (229), we 
analysed the regulation of BDNF as well as NGF in a time course experiment after the regular shock 
exposition, which is capable of inducing a Helplessness behavioural phenotype. Neither BDNF nor 
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NGF revealed any specific induction pattern when assessed after 0, 3, 6, 12, 24, 48 hours or 7 and 14 
days, respectively. 
3.1.5 Associated Parameters 
Since the Learned Helplessness paradigm is employed in the examination of depressive-like features it 
is supposed to be associated to depressive-like characteristics in corresponding behavioural tests. For a 
primary establishment of the protocol, this hypothesis was tested in male C57BL/6N mice, revealing a 
significant correlation of all relevant parameters in the Porsolt Forced Swim Test (Fig 24), a 
pharmacologically evaluated behavioural test for assessment of despair behaviour (175). General 
parameters assessed by the tests, which are employed in our test battery, did not interact with 
Helplessness. 
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Figure 24: Associated Parameters. Correlation between depressive-like parameters in the Learned 
Helplessness   and the Total floating time in the Porsolt Forced Swim Test (Escape Failures; p = 0.027, R2 = 
0.485 and Escape Latency; p = 0.036, R2 = 0.440) 
3.1.6 Chronic Stress and Housing Conditions 
As housing represents a fundamental aspect, which is controversially debated to affect the animals’ 
emotionality, this experiment aimed at investigating the implication of social and environmental 
stimulation for the development of a depressive-like syndrome. 
3.1.6.1 Group Housing Affects Exploratory Behaviour but not Locomotion 
In the Openfield Test, the housing conditions did not affect basal locomotor activity of the animals, i.e. 
the total distance moved (Fig 25A) or the locomotor velocity (Table 3). However, a single exposure to 
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the Openfield Test also confronts the animals with an approach-avoidance conflict, in which the 
exploration of the animals, measured by the time spent in the centre of the Openfield arena [10], was 
significantly influenced by social housing conditions [F/ (1,62)=10.962; p < 0.002]. Posthoc tests 
demonstrated that both group housed cohorts (impoverished and enriched) spent more time in the 
centre than the respective single housed groups (Fig 25B). P-values of Fisher’s (LSD) posthoc tests are 
presented in Table 3. There was no statistically significant effect for the interaction between the 
factors structural and social housing (34).  
3.1.6.2 Group Housing and Enrichment Evoke Reduced Anxiety-like Behaviour  
Both housing factors, social [F/ (1,62)=7.797; p < 0.007] and structural conditions [F/ (1,62)=4.86; p < 
0.031], significantly affected the latency to enter the aversive light compartment, while the interaction 
between factors did not show a significant effect (Fig. 25C). Posthoc tests (Table 3) demonstrated 
significantly reduced anxiety-like behaviour, i.e. latency to enter the lit compartment, in group 
enriched animals compared to single enriched (p < 0.008) or compared to group impoverished mice (p 
< 0.031). Single impoverished mice showed a statistical trend towards increased anxiety-like 
behaviour, when compared with group impoverished animals (p = 0.06, Fig. 25C). Moreover, 
ANOVA showed that structural rearing (impoverished vs. enriched) affected the number of exits into 
the aversive compartment [F/ (1,62) = 6.005; p < 0.017]. Posthoc tests also revealed a significant 
difference between single impoverished and group impoverished rearing (p < 0.016, Fig. 25D). The 
time spent in the aversive light compartment was additionally dependent on social conditions            
[F/ (1,62)=8.025; p < 0.006], with group housing resulting in decreased in anxiety levels, while 
structural housing conditions only caused a trend for reduced anxiety under enriched conditions [F/ 
(1,62)=3.613; p < 0.062]. The interaction between the factors social and structural housing did not reach 
statistical significance for any of the three parameters investigated (i.e. latency, number of exits, time 
in lit compartment). All p-values of Fisher’s (LSD) posthoc test are presented in Table 3 (34). 
www.pdfmailer.de   PDFMAILER.DE 
 
Kostenfrei und werbegesponsert PDF drucken und direkt per E-Mail 
versenden >Test it free www.pdfmailer.de 
Results 
_____________________________________________________________________ 
  51 
Openfield Test
Centre time
0
5
10
15
20
25
30
single
impoverished
single
enriched
group
impoverished
group
enriched
[%
]
A Openfield Test
Total distance moved
0
2000
4000
6000
8000
single
impoverished
single
enriched
group
impoverished
group
enriched
[c
m
]
B
Dark-Light Box
Latency to first exit
0
20
40
60
80
100
single
impoverished
single
enriched
group
impoverished
group
enriched
[s
]
C Dark-Light Box
Time spent in lit compartment
0
50
100
150
single
impoverished
single
enriched
group
impoverished
group
enriched
[s
]
D
 
 
Figure 25: Basal Behaviour. While no changes in locomotor activity were observed, housing significantly 
affected the exploratory drive in the Openfield arena as indicated by the time spent in the centre. In the Dark-
Light Box, housing conditions exerted effects on anxiety in terms of the latency to enter the bright compartment, 
as well as concerning the time they spent therein. Bars represent mean + SEM. 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3: Significant inter-group 
differences: Fisher's (LSD) 
posthoc test p-values. Group 
comparisons: p-values indicate inter-
group differences in all parameters 
assessed, according to a Fisher’s 
(LSD) post hoc comparison. n.s. = 
not significant; enr. = enriched; imp. 
= impoverished. 
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↓= decreased helpless performance 
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3.1.6.3 Housing Conditions Affect the Coping Behaviour in the Learned Helplessness 
Paradigm 
Before analysing potential effects of housing on learned Helplessness, we wanted to know, whether 
housing affects the two-way avoidance task, which is the “behavioural read-out” for Helplessness in 
this paradigm. Therefore, groups of non-shocked mice were compared by ANOVA for possible effects 
of the different housing conditions on the parameters escape failures and escape latencies, 
respectively. However, no differences were observed (Fig. 26). These results indicated that housing 
conditions do not produce an effect on avoidance learning per se.  
Non-shocked and shocked groups subjected to the same specific housing conditions significantly 
differed in their shuttle-box performance (failures: single impoverished p < 0.034; single enriched      
p < 0.038; group impoverished p < 0.021; group enriched p < 0.067, escape latency: single 
impoverished p < 0.035; single enriched p < 0.45*10-7; group impoverished p < 0.15*10-5; group 
enriched p < 0.26*10-9, Fig. 2). These results confirmed for all 4 housing conditions, that exposure to 
the uncontrollable shock protocol produced increased Helplessness.  
In the learned Helplessness paradigm, ANOVA of the shocked groups subjected to the different 
housing conditions did not show a main effect for enrichment nor for group housing, but a significant 
interaction of both factors (Fig. 26). This finding was true with for both major parameters of interest, 
escape failures [F/ (1,64)=8.46; p < 0.005, Fig 26A] and escape latencies [F/ (1,64)=5.223; p < 0.026,    
Fig. 26B]. This effect was confirmed by posthoc analyses, which revealed that group housed 
impoverished mice show significantly increased Helplessness with more failures and prolonged 
latencies, compared to single impoverished as well as to group enriched mice (Fig. 26, Table 1). Thus, 
when reared in an impoverished environment, group housed animals showed the poorest coping 
abilities. However, group housing per se as well as impoverished environment per se did not affect the 
extent of helpless behaviour (p-values of Fisher’s (LSD) posthoc tests are presented in Table 1). 
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Figure 26: Learned Helplessness after different housing. In the Learned Helplessness no difference occurs 
between the different rearing conditions in unshocked animals, while significant interactions occur for both, 
escape failures and escape latency, when animals were exposed to the stressful experience of the Learned 
Helplessness paradigm. Bars depict mean + SEM. 
 
3.1.6.4 Hotplate: Housing Conditions do not Affect Pain Sensitivity 
As analysed by a two-way ANOVA, pain sensitivity was not changed in the Hotplate Test conducted 
with animals from each housing condition. 
 
3.2 Genetic Approach 
The contribution of mutations in BDNF, CREB, and GR was examined regarding behavioural and 
stress-relevant parameters. Furthermore, mutations of IL-6 as well as eNOS, two additional genes of 
interest for depressive-like features, were implicated in behavioural testing and the Learned 
Helplessness paradigm. Mutations of the BDNF and CREB gene, respectively, did not reveal any 
effect referring to earlier results (223) in any of the parameters assessed while IL-6, eNOS, and 
especially the over- and underexpression of the glucocorticoid receptor resulted in alterations that are 
illustrated below. 
 
3.2.1 BDNF+/- Animals do not Represent an Animal Model of Depression               
According to the Neurotrophin Hypothesis of Depression, the reduction of BDNF would predict 
depressive-like behavioural alterations.  In our hands such changes did not become evident, 
confirming the results of a study of MacQueen et al., in which the positive result in the Learned 
Helplessness paradigm was an artefact caused by altered pain sensitivity in these mice (137).            
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3.2.1.1 Basal Behaviour 
BDNF+/- mice with approximately 50 % reduced levels of BDNF mRNA and protein are behaviourally 
indistinguishable from their control littermates when analysed in a battery of tests for locomotor, 
exploratory, and anxiety-related behaviours (Fig. 27) (33, 137).  
 
General and Anxiety-related Behaviour were unchanged in BDNF Heterozygous Mice  
The Openfield Test evaluates the general locomotor and exploratory behaviour of mice exposed to a 
large open arena under dimmed light conditions. In this test, the total distance moved and the velocity 
of moving were similar in BDNF+/- mice and controls (Fig. 27A,B). However, BDNF-heterozygous 
animals spent significantly more time in the centre of the Openfield (Fig. 27C) (p = 0.036). In the 
Novel Cage Test, a paradigm investigating exploratory behaviour by measuring vertical activity, 
BDNF+/- mice showed regular numbers of rearings (Fig. 27D). The elevated O-Maze, as well as the 
Dark-Light Box Test, analyses anxiety-related behaviours by inflicting an approach-avoidance conflict 
on the animals, in which the level of anxiety correlates with the avoidance of the aversive 
compartments of the arena. In the Dark-Light Box Test, BDNF+/- mice demonstrate a regular latency 
to enter the open arms, a normal number of exits to these aversive compartments, and they spent 
similar time therein (Fig. 27 E,F). In elevated O-Maze, BDNF+/- mice and wildtypes also did not differ 
with regard to latency, total exits, and time spent in the aversive compartment. BDNF-heterozygous 
animals showed regular motor abilities when tested on a rotarod (data not shown). Furthermore, both 
genotypes learned to improve their motoric abilities when repetitively tested on consecutive days. At 
the age of 3 months, BDNF+/- mice exhibited a significantly higher body weight when compared to 
their wildtype littermates (24.35 ± g vs. 21.5 ± g; p = 0.034) as recently described by Lyons et al. 
(136). 
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Fig. 27: Basal Behaviour. In the Openfield, BDNF+/- mice show similar locomotor speed and distance moved 
as their control littermates (A,B). However, they spend significantly less time in the centre of the field  (p = 
0.036; C). In the Novel Cage Test, BDNF +/- mice exhibit a normal number of rearings (D). In the Dark-Light 
Box Test, BDNF +/- mice demonstrate a similar amount of exits to the lit compartment and time spent therein 
(E, F). Columns represent means ± SEM. 
 
3.2.1.2 Depressive-Linked Behaviour 
In contrast to the predictions of the Neurotrophin Hypothesis of Depression, BDNF+/- mice do not 
differ from wildtype controls in their despair behaviour as observed in the Forced Swim Test or 
regarding their hedonic capacity as measured by sucrose consumption (33, 137). In the Learned 
Helplessness paradigm, a delayed escape latency has been observed (32). However, the authors 
attributed this deficit to a reduced sensitivity to the electric foot shocks. Their conclusion is in 
agreement with ours: BDNF-heterozygous mice are not more likely to display anxiety-related or 
depressive-like behaviours than wildtypes and, consequently, do not represent a genetic depression 
model. 
 
 
Fear Conditioning was not Altered in BDNF Heterozygous Mice  
Fear Conditioning is an associative (Pavlovian) learning paradigm that can be tested in two different 
forms. The context version is dependent on both hippocampus and amygdala, while the cue version is 
reported to be exclusively amygdala dependent (183). In both versions, the amount of freezing 
(immobility) represents a correlate of associative memory. BDNF+/- mice and their littermates 
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demonstrated similar freezing scores in both versions of the test. In agreement with the locomotor data 
obtained in the Openfield, both genotypes revealed no difference in horizontal and vertical locomotor 
activity in the pre-training phase of the test (data not shown).  
 
BDNF Heterozygous Mice Behaved Inconspicuously in the Porsolt Forced Swim Test 
The Forced Swim Test is an established paradigm to measure the tendency "to give up" on attempts to 
escape from an unpleasant environment, with fewer attempts to escape interpreted as evidence of 
behavioural despair. This test possesses high predictive validity and good face validity as a screen for 
depression-like behaviour (45, 174). BDNF+/- mice and wildtype animals did not exhibit differences in 
total duration of floating. In the test on day 1, BDNF+/- mice displayed a longer latency to start floating 
(p = 0.027), but exhibited the same total floating time. On day 2, the two groups of mice revealed no 
differences in any of the parameters studied (Fig. 28).  
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Figure 28: Porsolt Test in BDNF+/- mice. Mice of both genotypes exhibit a significant reduction of the latency 
to start floating when compared with day 1, but there is no intergroup difference. Again both genotypes also 
reveal a similar total floating time. Columns represent means + SEM. 
 
 
3.2.1.3 Stress Endocrinology 
The HPA axis is not affected by the reduction of BNDF as shown by analyses of serum corticosterone 
and ACTH levels. BDNF+/- mice had normal values under baseline conditions and after 30 min of 
restraint stress (Fig. 29) (33). 
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Figure 29: Corticosterone and ACTH levels in BDNF+/- mice. Mutant mice show normal corticosterone (A) 
and ACTH levels (B) under baseline conditions at nadir as well as after 30 min of restraint stress. Columns 
represent means + SEM.  
 
3.2.1.4 Neurotrophins and Monoamines 
BDNF+/- mice demonstrated a reduction of BDNF protein expression to about 60 % in all brain areas 
as analysed by ELISA, i.e. hippocampus, frontal cortex, striatum, and hypothalamus (Fig. 30A). In 
contrast, BDNF+/- mice showed normal NGF levels in these brain regions (Fig. 30B).  
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 Figure 30: Neurotrophins in BDNF+/- mice. BDNF protein levels as measured by ELISA, are significantly 
reduced in the hippocampus (HC 64.0 %; p < 0.01), frontal cortex (FC 64.8 %; p < 0.001), striatum (ST 57.5 %; 
p < 0.001), and hypothalamus (HT 56.6 %; p < 0.001) of BDNF+/- mice as compared to their wildtype littermates 
(A). In contrast, NGF protein levels do not differ in any of the four brain regions investigated (B). Columns 
represent means + SEM. 
 
 
Analyses of monoaminergic neurotransmitter systems (5-HT, NE, and DA) revealed regular tissue 
levels of all three biogenic amines and their degradation products 5-HIAA and HVA (Table 4). 
However, the activity of ChAT, the key enzyme for acetylcholine synthesis, was significantly reduced 
in the hippocampus of BDNF+/- mice to 81 % of wildtype levels (Table 2).  
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Table 1: Tissue contents of monoamines and cholin-acetyltransferase in BDNF+/- mice  
 
 
  BDNF+/- 
( n = 9) 
wildtype 
( n = 8) 
Hippocampus 
   5-HT 
   5-HIAA 
   5-HIAA/5-HT 
   NA 
   DA 
   ChAT 
    
683.0 ± 15.5 
644.8 ± 42.4 
0.896 ± 0,050 
404.8 ± 23.1 
74.6 ± 17.2 
136.59 ± 5.56 * 
735.8 ± 50.1 
710.1 ± 27.5 
0.911 ± 0.060 
401.9 ± 26.7 
81.3 ± 30.7 
167.23 ± 10.77 
 
 
 
 
Frontal cortex 
   5-HT 
   5-HIAA 
   5-HIAA/5-HT 
   NA 
   DA 
   ChAT 
n.d. 
n.d. 
 n.d. 
440.1 ± 22.4 
14.6 ± 1.3 
167.37 ± 10.07 
 n.d. 
 n.d. 
 n.d. 
419.8 ± 39.7 
15.7 ± 1.1 
160.78 ± 5.83 
Striatum 
   5-HT 
   5-HIAA 
   5-HIAA/5-HT 
   NA 
   DA 
   HVA 
   ChAT 
    
880.3 ± 72.8 
712.8 ± 49.4 
0.757 ± 0.040 
129.2 ± 21.0 
14708.1 ± 770.0 
1328.9 ± 70.2 
629.04 ± 30.26 
 
889.7 ± 42.8 
729.5 ± 34.2 
0.764 ± 0.040 
133.3 ± 27.3 
14774.5 ± 732.0 
1325.4 ± 46.6 
570.53 ± 22.59 
 
 
 
Hypothalamus 
 
 
 
   5-HT 
   5-HIAA 
   5-HIAA/5-HT 
   NA 
   DA 
   ChAT   
    
573.2 ± 38.3 
701.6 ± 81.7 
1.054 ± 0.080 
1459.3 ± 50.3 
299.6 ± 50.3 
127.72 ± 11.57 
  
647.9 ± 56.2 
835.3 ± 72.5 
1.237 ± 0.130 
1439.5 ± 100.9 
410.2 ± 65.1 
138.93 ± 13.91 
 
  
Table 2: Tissue content of monoamines, their degradation products, and choline acetyltransferase in different 
brain regions of BDNF+/- mice (5-HT: serotonin; 5-HIAA: 5-hydroxyindolacetic acid; NA: norepinephrine; DA: 
dopamine; HVA: homovanillic acid, ChAT: choline acetyltransferase). The values of monoamines and 
metabolites are expressed as pg/mg wet weight. ChAT (µU/mg wet weight) was significantly reduced in the 
hippocampus of BDNF+/- mice to 81.6 % of wildtype controls (n = 8 in both groups; p = 0.02). n.d.=not done 
 
3.2.2 CREBS142A Animals do not represent an Animal Model of Depression 
Despite the characteristical phase shift in locomotor activity as described by Gau et al. (83), 
CREBS142A mutant mice failed to demonstrate further indications of a depressive behaviour or changes 
in corticosterone release.  
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3.2.2.1 Basal Behaviour 
CREBS142A mice demonstrated normal horizontal and vertical locomotor activity in both, the Openfield 
and the Novel Cage Test. To assess their activity at different circadian time points, locomotion was 
analysed in activity chambers during subjective day and night, respectively. At both time points, 
CREBS142A mice moved equivalent distances as their control littermates.  
CREBS142A mice did not exhibit alterations of anxiety-related behaviours, as monitored in the elevated 
O-Maze by the latency to visit the aversive open compartment of the maze and the time spent therein. 
Similar findings were obtained for the anxiety-related parameters of the Dark-Light Box Test. Again, 
CREBS142A mice showed similar latencies to enter the aversive compartment as the littermate controls, 
and also spent comparable time periods therein. In addition, CREBS142A mice demonstrated unaltered 
behaviour in the Openfield with respect to the parameters, which correlate with anxiety, namely mean 
distance to the walls and time spent in the centre of the arena (data not shown). 
 
3.2.2.2 Depressive-Linked Behaviour 
When given a free choice between water and a 1 % sucrose solution, CREBS142A mice did not display 
any difference in sensitivity to the rewarding properties of the sweet solution, as seen by a normal 
amount of total liquid intake (Fig. 31A) and a regular sucrose preference (Fig. 31B). Thus, CREBS142A 
mice did not display anhedonic behaviour compared to littermate controls. In the Forced Swim Test, 
CREBS142A mice did not differ from wildtype mice in despair behaviour, as monitored by the latencies 
to start floating, as well as by the immobility times in different phases of the test (Fig. 31C). Both 
genotypes showed decreased latencies to start floating and an increased total floating time, when the 
test was repeated 24 h after the first trial (Fig. 31D), an indication for unaltered coping strategies of 
CREBS142A mice. Furthermore, CREBS142A mice revealed regular emotional learning both in contextual 
and in cued Fear Conditioning as indicated by unaltered freezing (Fig. 31E,F).  
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Figure 31: Depressive-like behaviour in CREBS142A mice. A,B) In the Sucrose Preference Test CREBS142A 
mice show similar total liquid intake and equivalent preference for sucrose as the wildtype controls. C,D) In the 
Porsolt Test, CREBS142A mice reveal unaltered latencies to start floating and similar total floating on day 1 and 
day 2. E,F) CREBS142A mice exhibit regular emotional learning in context and cued Fear Conditioning. During 
the training period, mutant mice do not show differences in locomotor behaviour. Columns represent means + 
SEM. 
 
3.2.2.3 Stress Endocrinology 
CREBS142A mice showed similar baseline corticosterone levels as control littermates (Fig. 31A). After 
30 min of immobilization stress, a significant increase of the corticosterone level was observed in both 
genotypes, but again no difference was found between the CREBS142A and their littermates (Fig. 31B). 
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Figure 32: HPA system analyses in CREBS142A mice. (A) CREBS142A mice have similar corticosterone serum 
levels as their control littermates, both under baseline conditions at the beginning of their inactive phase (nadir), 
and (B) after 30 minutes of restraint stress. Columns represent means + SEM. 
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3.2.3 GR+/- Animals Display a Depressive-Like Phenotype with Characteristic 
Stressphysiology in the DEX/CRH Test and Reduction of Neurotrophins 
Heterozygous mice with a 50 % reduction of GR expression can be used to elucidate the role of this 
receptor in mood disorders. While their HPA system regulation is not affected under baseline 
conditions, stress causes higher corticosterone plasma peak levels and a prolonged elevation. At the 
behavioural level, they do not differ from wildtype controls in a battery of tests assessing anxiety- and 
despair-related behaviours. Again, when subjected to stress in the Learned Helplessness model, GR 
heterozygous mice show increased helpless behaviours: fewer escapes, longer escape latencies, and 
more escape failures than wildtypes. Furthermore, GR heterozygous mice show a reduction of BDNF 
protein in the hippocampus. Thus, these mice may represent a line with a genetic predisposition to 
depression-like behaviours (Fig. 33).  
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Figure 33: Role of the glucocorticoid receptor. A heterozygous reduction of GR induces depressive-like 
changes in the Learned Helplessness paradigm. Reduction of the receptor causes an increase of glucocorticoids 
after stressful challenge and leads to a decrease of BDNF protein. Antidepressive treatment, on the other hand, 
can antagonize these effects.    
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3.2.3.1 Basal Behaviour 
GR+/- mice display normal behaviour under basal conditions  
To analyse, whether the reduced GR expression also influences the animals' behaviour, a series of 
behavioural tests was performed. GR+/- mice exhibited normal behaviour under basal conditions and 
were indistinguishable from their wildtype littermates in the Openfield Test (Fig. 34A) and the Novel 
Cage Test (Fig 34B). These two tests evaluate various aspects of locomotor and explorative behaviour. 
GR+/- mice also showed unaltered anxiety-related behaviour in two tests based on an approach-
avoidance conflict, i.e. the elevated O-Maze (Fig. 34C) and the Dark-Light Box paradigm (data not 
shown). In both tests, GR heterozygous and wildtype mice exhibited similar scores in visiting the 
aversive, anxiety-related compartments of the maze, respectively. In addition, no differences between 
the two genotypes were observed in Fear Conditioning experiments that tested both context- and cue-
dependent fear-associated learning (data not shown). GR+/- mice also demonstrated normal scores in 
the Porsolt Forced Swim Test. In this assay, the latency to start floating and the total time spent 
immobile are regarded as correlate of “despair-like” behaviour (Fig. 34D).  
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Figure 34: Basal behaviour in GR+/- mice.  GR+/- mice show normal basal behaviour in terms of locomotion, 
exploration, anxiety, and despair (A) GR+/- mice exhibit regular locomotor activity in the Openfield as 
demonstrated by similar scores in the total distance moved and velocity measurements. (B) In the Novel Cage 
Test, GR+/- mice reveal a similar vertical activity as their control littermates, as measured by the number of 
rearings. (C) GR+/- mice display normal anxiety-related behaviour in the elevated O-Maze, with regular latencies 
of first exits to the aversive open arms of the maze and similar time periods they spend thereon. (D) GR+/- mice 
demonstrate unaltered behaviour in the Forced Swim Test. Both, latency to start floating and total floating time 
are similar in both genotypes.  
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3.2.3.2 Depressive-Linked Behaviour 
The Learned Helplessness paradigm evaluates the coping capabilities of mice in an aversive test 
situation after two days of intense stress evoked by exposure to a series of unpredictable and 
uncontrollable foot shocks. When tested for helpless behaviour, GR+/- mice displayed significantly 
increased escape latencies (p < 0.05; Fig. 35A) and a higher number of escape failures (p < 0.05; Fig. 
34B). When mice were scored individually (Fig. 35C), the most helpless individuals were exclusively 
GR+/- (GR+/- r = 0.984, wildtype r = 0.929, α = 0.05). These results reflect true coping deficits as they 
were not caused by altered pain sensitivity in a Hotplate Test (data not shown) or general changes in 
activity (Fig. 35). 
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Figure 35: Learned Helplessness in GR+/- mice. GR+/- mice display increased Helplessness in a Shuttle Box 
Test after exposure to inescapable footshocks on the two days preceding the test. (A) GR+/- mice exhibit 
significantly increased escape latencies compared to their wildtype littermates (p < 0.05). (B) GR+/- mice also 
show a higher number of escape failures (p < 0.05). (C) Latencies and numbers of failures are highly correlated 
when plotted for individual mutant and wildtype mice, demonstrating that the subjects with the worst coping (in 
the right upper area of the graph) are all GR+/- mice. 
 
 
3.2.3.3 Stress Endocrinology 
GR+/- mice have normal basal but increased stress-induced corticosterone levels 
To investigate the effects of reduced GR expression on the regulation of the HPA system, 
corticosterone levels of GR+/- mice and wildtype littermate controls were analysed by a 
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radioimmunoassay. Under basal, unstressed conditions, no differences were observed between GR+/- 
and control mice, neither during the dark phase nor during the light phase of the circadian rhythm (Fig. 
36a). Both genotypes showed about three times higher levels of corticosterone in the dark than in the 
light phase (Fig. 36A). Since the HPA system is more active under stressful than under basal 
conditions, we also analysed corticosterone levels following 30 min of restraint stress. Immobilization 
caused a strong increase of corticosterone levels in both genotypes, but levels were higher in GR+/- 
mice when measured at 40 and 60 min (p < 0.05) after restraint stress (Fig. 36B). These data indicate a 
disturbed feedback control of the HPA system in GR+/- mice under stress.  
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Figure 36: Corticosterone levels in GR+/- mice. Under basal and stressful conditions, (A) Plasma 
corticosterone levels are unchanged in GR+/- mice as compared to wildtype mice, both during the animals’ active 
(dark) and inactive (light) phase. (B) After stress exposure, however, corticosterone levels are higher in GR+/- 
mice at 40 and 60 min (p < 0.05) following immobilization. 
 
3.2.3.3.1 Dex-Test and Dex/CRH Test 
GR+/- mice exhibit a depression-like Dex/CRH Test 
Since coping deficits in the Learned Helplessness paradigm have been postulated to reflect depression-
like behaviour, we subjected the animals to two clinically established neuroendocrinological tests for a 
depressive state, the dexamethasone suppression Test and the combined Dex/CRH Test. 6 h after 
injection of dexamethasone, GR+/- mice exhibited significantly higher corticosterone levels than 
wildtype controls (p < 0.01; Fig 37A). In the combined Dex/CRH Test, GR+/- mice showed also 
significantly higher corticosterone levels in response to the CRH challenge than the control littermates 
(p < 0.001; Fig. 37B). Similar changes are typical in patients with severe depressive episodes. 
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Figure 37: Dex/CRH Test in GR+/- mice. GR+/- mice are non-suppressors in the DEX/CRH Test. (B) After 
administration of dexamethasone, wildtype mice show decreased corticosterone levels, while GR+/- mice exhibit 
non-suppression (p < 0.01). (B) In the combined Dex/CRH Test, corticosterone levels are significantly elevated 
in GR+/- mice compared to the levels of wildtype mice (p < 0.001).  
 
3.2.3.4 Neurotrophins 
GR+/- and YGR mice show altered levels of hippocampal BDNF expression 
Since downregulation of BDNF has been postulated to play a critical role in the pathogenesis of 
depressive disorders, we analysed the levels of BDNF protein in the hippocampus by ELISA. GR+/- 
mice exhibited a significant downregulation of BDNF to 56.9 % of controls.  
 
(See Fig. 41 for comparison of neurotrophins in GR heterozygous and YGR mice) 
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3.2.4 YGR Mutant Animals Demonstrate an Anti-Depressive Phenotype 
In order to investigate whether an overexpression of the glucocorticoid receptor would exert opposite 
effects at both, behavioural and stressendocrinological level, the experiments that were done in GR 
heterozygous animals were transferred to YGR mice, revealing exactly what was suggested by the 
hypothesis. 
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Figure 38: Role of the glucocorticoid receptor. Overexpression of GR induces depression-resistant changes in 
the Learned Helplessness paradigm. Reduction of the receptor causes a reduced increase and faster decrease of 
glucocorticoids after stressful challenge and leads to an elevation of BDNF protein.     
 
3.2.4.1 Basal Behaviour 
As observed in the GR heterozygous animals, basal behaviour in the GR overexpressing animals was 
unchanged.  
 
3.2.4.2 Depressive-Linked Behaviour 
 
Finally we intended to investigate, whether increased levels of GR would also lead to altered 
behaviour. Similar to GR+/- mice, YGR mice did not show a conspicuous phenotype in the test battery 
for baseline behaviour (Openfield, Novel Cage, O-Maze, Dark-Light Box, Fear Conditioning, Porsolt 
www.pdfmailer.de   PDFMAILER.DE 
 
Kostenfrei und werbegesponsert PDF drucken und direkt per E-Mail 
versenden >Test it free www.pdfmailer.de 
Results 
_____________________________________________________________________ 
  67 
Test; data not shown). Again, significant differences were restricted to the Learned Helplessness 
paradigm. In this test, YGR mice displayed significantly lower escape latencies (p < 0.05; Fig. 39A) 
and - correlating to that - lower numbers of escape failures (+/YGR r = 0.898, wildtype r = 0.997, α = 
0.05) compared to their littermate controls (p < 0.05; Fig. 39B). Again, altered pain sensitivity could 
be excluded to account for these differences, since both groups showed similar results in the Hotplate 
Test (data not shown). Thus, while GR+/- mice were more prone to develop depression-like coping 
deficits, YGR mice were more resistant to develop Helplessness. 
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Figure 39: Learned Helplessness in YGR mice. YGR mice are more resistant in the Learned Helplessness 
paradigm. (A) YGR mice exhibit significantly decreased escape latencies compared to their wildtype littermates 
(p < 0.05). (B) YGR mice also show a reduced number of escape failures (p < 0.05). (C) Latencies and numbers 
of failures are highly correlated when plotted for individual mutant and wildtype mice, demonstrating worse 
coping (in the right upper area of the graph) in wildtype mice, whereas YGR mice cluster at the left lower area of 
the graph.  
 
3.2.4.3 Stress Endocrinology 
After the observation that the loss of one copy of the GR leads to a “depression-like syndrome” we 
tried to confirm the specificity of these findings by analysing mice that overexpress GR. We therefore 
asked whether these mice have accordingly a lower sensitivity to stress-induced behavioural and 
endocrinological alterations. Similar to GR+/- mice, YGR mice had unaltered corticosterone levels 
under basal conditions (Fig. 40A). Following 30 min of restraint stress, YGR mice exhibited 
significantly decreased peak levels of corticosterone at 40 min after stress exposure (p < 0.0048), 
while at 60 min no difference was observed anymore (Fig. 40A).  
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3.2.4.3.1 Dex-Test and Dex/CRH Test 
In the dexamethasone suppression Test, corticosterone levels in YGR mice were significantly more 
suppressed than in wildtype controls (p < 0.01; Fig. 40B). In the combined Dex/CRH Test, 
corticosterone levels were lower in YGR mice than in control littermates, but this difference did not 
reach statistical significance (p = 0.07; Fig. 40C). In summary, YGR mice demonstrated exactly the 
opposite changes in HPA-system (dys)regulation than GR+/- mice. 
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Figure 40: HPA system in YGR mice. YGR mice have a stress-resistant HPA-system and are over-suppressors 
in the DEX Test. (A) After stress exposure, corticosterone levels are significantly lower in YGR mice at 40 min 
following immobilization than in wildtype controls (p < 0.05). (B) After administration of dexamethasone, YGR 
mice show a significant over-suppression of corticosterone levels compared to wildtype mice (p < 0.01). (C) In 
the combined Dex/CRH Test, corticosterone levels are lower in YGR mice compared to the levels of wildtype 
mice (p = 0.07). 
 
 
3.2.4.4 Neurotrophins 
YGR mice revealed a significant upregulation of 51.7 % of BDNF (Fig. 41). In contrast, the 
expression levels of NGF protein, another key member of the neurotrophin family, were unaltered in 
both GR mutated strains, indicating the specificity of the results obtained for BDNF (Fig. 41).  
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Figure 41: Neurotrophin levels in GR+/- and YGR mice. BDNF protein levels in the hippocampus are 
significantly diminished in GR+/- mice (p < 0.05), and significantly increased in YGR mice (p < 0.05). In 
contrast, the expression levels of NGF are unaltered in both mutant strains (wt = wildtype). 
 
 
3.2.5 IL-6 Deficient Animals Demonstrate a Stress Resistance 
In order to investigate the effects of a decreased expression of Interleukin-6, which, according to 
current hypotheses, is postulated to be involved in the pathophysiology of depression (6), IL-6 knock-
out animals were investigated in terms of basal and depressive-linked behavioural performance, 
demonstrating a resistance to stressful challenge. The finding, that IL-6 is involved in the development 
of a helpless phenotype was furthermore substantiated by an experiment, in which the content of IL-6 
protein in the hippocampus of helpless wildtype animals was analysed, revealing an induction of IL-6 
in these animals. 
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Figure 42: Role of Interleukin-6. The knock-out of IL-6 causes a decrease in depressive-like behaviour in the 
Learned Helplessness paradigm. Furthermore, when mice are subjected to the Learned Helplessness procedure, 
an induction of IL-6 was assessed.  
 
3.2.5.1 Basal Behaviour 
When investigated in our behavioural test battery, including the examination of locomotion, anxiety, 
exploration, and learning, IL-6 deficient mice did not show a conspicuous phenotype (data not shown). 
 
3.2.5.2 Depressive-Linked Behaviour 
IL-6 mutant mice displayed regular “despair” behaviour, when they were examined in the Forced 
Swim Test, but significantly differed in terms of depression-like behaviour when subjected to a 
matched law procedure of sucrose consumption, as well as in the Learned Helplessness paradigm, 
where they exhibited a resistance to develop a depressive-like phenotype, demonstrating less coping 
deficits in terms of failures (p = 0.0048) and escape latency (p = 0.049) (Fig. 43). 
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Figure 43: Role of Interleukin-6. IL-6 mice are more resistant in the Learned Helplessness paradigm. (a) IL-6 
mice exhibit significantly decreased escape latencies compared to their wildtype littermates (p < 0.05). (b) IL-6 
mice also show a reduced number of escape failures (p < 0.05). (c) Latencies and numbers of failures are highly 
correlated when plotted for individual mutant and wildtype mice, demonstrating worse coping (in the right upper 
area of the graph) in wildtype mice, whereas mutant mice cluster at the left lower area of the graph.  
 
3.2.6 NOS III (-/-) Mutant Animals  
NOS III knock-out animals were investigated for differences in depressive-like behavioural 
characteristics, since it was postulated that altered neurogenesis in these mice may be associated to a 
depressive-like phenotype. 
 
3.2.6.1 Basal Behaviour 
NOS III mutant mice, when examined in our behavioural test battery, did not exhibit an altered 
phenotype regarding locomotion, exploration anxiety or present any obvious abnormalities (Data not 
shown). 
 
3.2.6.2 Depressive-Linked Behaviour 
Despite the hypothesis, that NOS III mice would demonstrate a phenotype with regard to depressive-
like behaviour when subjected to the Learned Helplessness paradigm, NOS III deficient mice 
demonstrate a resistance to develop Helplessness regarding escape latency (p = 0.01) in the shuttle box 
procedure. This is not due to an altered pain sensitivity, which was ensured by examination of pain 
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threshold on the Hotplate, not revealing any differences. A fewer number of escape failures as well as 
an improved avoidance performance (p = 0.0015) were observed, which cannot be explained by 
general differences in locomotoric or activity features as observed in the Openfield Test. The Porsolt 
Forced Swim Test however, no differences in either direction occurred between the mutants and their 
wildtype littermates. 
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Figure 44: Learned Helplessness in NOS III-/- mice: NOS III knock-out animals demonstrated an improved 
avoidance and less escape deficits in the Learned Helplessness paradigm when compared to their wildtype 
littermates. 
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4 Discussion 
4.1 General Discussion 
This thesis had the set goal of shedding light on the phenomenon of Learned Helplessness by 
examining the relevant parameters in mice, (i.e. coping deficits in a shuttle box paradigm) and 
elucidating environmental (i.e. housing and stress) as well as genetic factors. To assess the impact of 
genetic factors, this thesis implies the investigation of transgenic mice, which have been hypothesized 
to represent animal models for depression according to characteristic alterations in their HPA system, 
neurotrophic factors or potentially associated aspects. 
At this time animal models represent the unique option to expand the information about the 
mechanisms involved in the pathogenesis of defined diseases. Depression constitutes a major 
challenge because its characterization is difficult due to the multifactorial derivation of disease-
specific traits. The consideration of the associations of diverse factors therefore represents a key 
concern of behavioural animal models of depression. Modelling a depressive-like state, such as the 
Learned Helplessness, consequently requires exact knowledge regarding relevant modulators to ensure 
representative results. This thesis aimed at investigating the role of target genes, suggested to be 
involved in the pathogenesis of depression, which makes it very important to elucidate potential 
distorting factors, such as the housing of the experimental animals, which is controversially debated to 
affect the animals’ emotionality. The exclusion of such environmental factors, which evaluates the 
specificity of the behavioural findings in mutant animals, represented one of the assignments in this 
thesis. To guarantee a specific readout, which permits concrete statements regarding the quality of our 
model, we compared the effects of different social as well as structural factors with regard to general 
and Helplessness-specific effects on behaviour. Furthermore, the model was validated by a 
pharmacological regimen.  Especially in studies of depression and emotionality it is essential to 
establish standardized protocols, involving the animal’s environment, to be able to precisely assess 
potential sources of stress and exclude artefacts. The high-quality design and modification of animal 
models, such as Learned Helplessness, subsequently bears the bonus not only to detect genetic aspects 
by investigating mice with mutations of particular target genes, but also to exploit elementary basics of 
depressive-like phenotypes. 
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4.2 The Learned Helplessness as a Model of Depression 
Originally the Learned Helplessness model of depression was described by Seligman et al. in dogs 
(139), which was afterwards extended to many other species, including mice, rats, and even humans. It 
is characterized by performance deficits in subsequent learning tasks after exposure to acute 
inescapable stress, which are absent in individuals, who experienced the same stress but were able to 
control it (76, 110, 149, 192). Following a series of inescapable and unpredictable shocks, rats and 
mice show a variety of behavioural deficits, including a profound disruption of escape performance 
(194, 195) as well as neurochemical signs of depression-like changes in norepinephrine (NE), 
dopamine (DA), and serotonin (5-HT), neurotransmitters, which have been implicated in the human 
disease. Characteristic features, which arise in the animal as a consequence of the procedure, reflect 
the symptoms of a depressive state in men rather well (139). Furthermore these symptoms can be 
reverted by chronic administration of monoamine oxidase (MAO) inhibitors, tricyclic antidepressants 
(TCAs), selective serotonin reuptake inhibitors, and electroconvulsive therapy (ECS), but not by 
chronic treatment with neuroleptics, stimulants sedatives, and anxiolytics (196). Therefore the Learned 
Helplessness is suggested to be a suitable model to mimic depressive-like symptoms in animals. The 
severity of depressive disorders and its high prevalence in the modern society increases the need of 
valid reliable animal models for depression, such as the Learned Helplessness paradigm, particularly 
in mice, which reach importance due to the possibilities opened by genetic engeneering for the 
investigation of pathological mechanism. Thus, the reproducibility across laboratories remains to be 
one of the major problems, which makes it difficult to simply establish a model according to the 
description in the literature. Moreover, the understanding as well as interpretation of the effects 
observed in this paradigm requires further examination, ideally approaching from various disciplines. 
Only a fraction of rodents exposed to inescapable shock develop the Learned Helplessness syndrome, 
estimated to reach 10-80 % (58). Even though some of this variability can be explained by the stress 
parameters used to induce Helplessness, the difficulty and type of escape response, or the criterion 
used to define Learned Helplessness, a proportion of the variability is likely due to genetic variation. 
For instance, some inbred mouse strains exhibit severe escape deficits while other strains are not 
affected (194). Besides that, environmental factors have to be considered. Additionally,  rat lines have 
been selectively bred for susceptibility to develop Learned Helplessness resulting in helpless lines 
with more than 95 % of helpless animals, with some rats even demonstrating this behaviour without 
being trained, and very resistant non-helpless lines (228, 229), in which only about 5 % become 
helpless (126).   
One goal of this thesis included the characterization of the Learned Helplessness in mice (35), which 
required a modification of current protocols in literature (27, 194, 221). Besides the establishment of a 
new protocol for the assessment of depressive-like phenotypes in mutant mouse strains, it was 
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investigated in how far obligatory external factors, like housing conditions, affect this model to 
exclude the possibility of artefacts according to peripheral issues. Our data show that group housing 
has a profound impact in the development of Helplessness after uncontrollable exposure to electrical 
shocks, but that the exact direction of these changes depends on the level of structural enrichment of 
the environment in which the mice are reared. These results are in line with the few studies available 
at present (94, 114), and suggest that the manipulation of housing conditions may be a suitable model 
to study the impact of chronic social stress on helpless behaviour. In addition, these observations may 
be of interest for establishing standard housing conditions that ensure the animals welfare. 
Thus, in the Learned Helplessness paradigm, group housed mice reared in impoverished cages 
displayed a higher number of coping deficits, i.e. Helplessness, indicated by an increased number of 
escape failures and larger latencies to escape than mice in other housing conditions. However, an 
enriched environment seems to have a protective effect on the development of helpless behaviour. No 
differences occurred between the individually housed groups indicating that enrichment improves the 
coping in a stressful situation only if it is combined with a respective social environment, where 
positive and negative interactions between the individuals may require a more pronounced behavioural 
repertoire than in the solitary animals.  
Differences in Helplessness could arise from an effect of housing conditions in different components 
of the testing procedure. First, an increase on the number of failures and/ or increased latencies to 
escape could result from motor deficits produced by specific housing configurations. However, as 
assessed in the Openfield (total distance) and Dark-Light Box (number of exits), the locomotion was 
not different among groups (34). Second, housing conditions could affect pain thresholds, 
subsequently changing the real impact of the uncontrollable shock exposure preceding Helplessness 
testing. This explanation does not seem to account for the Helplessness results either, since the pain 
thresholds, as measured in the Hotplate, were also unaffected by housing conditions. Third, anxiety- 
and mood disorders like depression show partial overlapping in both humans and rodents (239). 
Therefore, it could well be that housing conditions could alter Helplessness by changing anxiety-
related parameters. However, although some differences among groups were found in anxiety-related 
measures, the pattern of these results was not coincident with those of the shuttle performance, and in 
fact no significant correlation between both sets of data was found. Finally, differences in shuttle 
performance were only observable after uncontrolled shock exposure, as non-shocked animals 
displayed similar avoidance regardless of their housing conditions. This observation suggests that 
these housing conditions did not affect two-way avoidance per se; i.e. affecting learning and memory 
processes (34). 
Therefore, the results of the present study reveal a specific effect of housing conditions on the 
development of helpless behaviour. Thus, group housing can be a source of stress in territorial animals 
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such as mice (80) that may result in enhanced behavioural despair (114). Consequently, in our study, 
group housed animals reared in a impoverished environment showed the highest scores in two indices 
of Helplessness, the number of failures and the latency to escape in a two-way avoidance task. Vice 
versa, enrichment can have a protective effect in the development of these features, as reflected by the 
improved performance in the group housed animals reared in an enriched context. This behavioural 
observation is unprecedented but seems to be in accordance with previous studies that have shown that 
an enriched environment improves some physiological parameters, which accompany depression-like 
states in both rodents and humans (49, 69, 77, 219). Moreover, supporting this protective effect of 
environmental enrichment, it should be noted that the performance of mice individually housed was 
not sensitive to environmental enrichment, which again is in line with previous results showing an 
enhanced efficacy of imipramine treatment only in group housed mice (114). 
In summary, the results of the present study reveal that the manipulation of housing conditions can be 
a suitable procedure to study behavioural despair in mice. We believe that this procedure presents 
some advantages over other available alternatives. First, it allows a bi-directional manipulation of this 
behavioural phenomenon, which is manipulated by social (i.e. group housing) as well as structural (i.e. 
enrichment) factors. Moreover, these manipulations are more naturalistic than those currently used in 
this field (80) and have been partially pharmacologically validated (114). In addition, as observed in 
our non-shocked animals, the manipulation of housing conditions does not produce helpless behaviour 
per se, but rather results in a predisposition that is only expressed after a precipitant factor (i.e. 
uncontrollable shock exposure), then mimicking the diathesis-stress model currently accepted for 
affective disorders such as major depression (90). On the other hand, our findings also have 
implications when considering animal welfare and the attempts to standardize the rearing of rodents. 
Thus, individual housing, which is usually criticized to be stressful (12), may be an adequate type of 
housing depending on the species and strains as well as on the experimental needs.  
 
The awareness of such fundamental effects of social as well as structural environment represents a 
crucial factor considering the quality of the results in the species one is working with. The 
standardization of our protocols by including external factors therefore appears to fulfil the 
requirement of a valid model of depression, with regard to the investigation of additional aspects, such 
as genetic effects. 
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4.3 Role of Neurotrophic Circuits 
Neurotrophins are postulated to be involved in pathogenetic as well as therapeutic pathways by a 
variety of authors (61, 158, 215, 224), describing the antidepressive properties of BDNF as well as 
stress-induced decreases of BDNF in rodent models. This appears to be in line with the decline of 
BDNF levels found in postmortem studies of depressive patients without antidepressive treatment. 
According to these findings two mutations of genes involved in the “Neurotrophin Hypothesis of 
Depression”, BDNF, and CREB, were analysed related to the results published in the literature and 
discussed in the following paragraphs. 
 
4.3.1 Brain-Derived Neurotrophic Factor 
The presented experiment assessed potential neurochemical, neuroendocrinological, and behavioural 
changes in adult mice with a heterozygous mutation of the BDNF gene. We showed that these mice 
have a circa 60 % reduction of BDNF protein levels in several forebrain regions. Our aim was to test 
one of the predictions of the "Neurotrophin Hypothesis of Depression", i.e. that the reduction of 
BDNF levels would induce depression-like features in these mice. However, BDNF+/- animals 
exhibited regular levels of monoamines and their metabolites, a normal regulation of the HPA-system 
and - apart from minor differences - unchanged emotional behaviours.  
Our behavioural data are in agreement with the results of a study by MacQueen and colleagues on 
BDNF-heterozygous mice (137). In this study, similar behavioural analyses to ours did not reveal any 
abnormalities apart from impaired pain sensitivity (137). Both, the latter study and ours, 
unambiguously show unaltered locomotor, anxiety-related, and depression-related behaviours. Similar 
as described by Lyons and colleagues (136), a significant difference occurred in the Openfield Test, 
where BDNF+/- mice spent significantly more time in the centre than control animals. In view of the 
normal anxiety-related behaviour of BDNF+/- mice in the elevated O-Maze and in the dark-light-box 
paradigm (Fig. 3E-F), this finding most likely reflects an increased exploration of BDNF deficient 
mice (255). Increased exploration, however, reflects "non-depressive" or "depression-resistant" 
behaviour, because depressed animals have a tendency to exhibit neophobic behaviours (239). In the 
Forced Swim Test, BDNF-heterozygous mice had a shorter latency to start floating on the first day of 
testing. However, BDNF+/- mice revealed an unchanged latency and total floating time on day 2 of the 
test, when depression-like behaviour, according to the reported reverse of this behaviour by 
antidepressant treatment is most evident (45, 46). MacQueen and colleagues did not detect any 
changes in the Forced Swim Test of their BDNF-heterozygous mice, also strongly arguing against a 
depression-like behavioural phenotype in this test (137). The fact that the most measures of emotional 
behaviour are unchanged in BDNF+/- mice is perplexing, considering the proposed role of BDNF in 
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the pathophysiology of depression and other stress-related disorders (3, 61, 199). A possible 
explanation may be that a 60 % reduction of BDNF is not sufficient to induce strong behavioural 
effects. However, BDNF-heterozygous mice have been shown to display other behavioural 
abnormalities, i.e. increased aggressiveness, learning deficits, and hyperphagia, the latter being in 
accordance with the significantly increased body weights of BDNF+/- mice also observed in our study 
(60, 120, 131). Mice carrying a mutation since early embryogenesis may develop compensatory 
mechanisms to overcome the effects of gene targeting during development. However, NGF expression 
was normal in all brain areas with reduced BDNF levels. Nevertheless, mice with a complete 
forebrain-specific conditional BDNF knock-out displayed increased anxiety-related behaviours. Other 
behavioural tests more related to depression-like behaviours have not been performed as yet with this 
strain.  
We also analysed the tissue levels of 5-HT, NE, and DA in several brain regions of BDNF+/- mice, 
because the monoaminergic neurotransmitter systems play an important role in the pathogenesis and 
therapy of depression. BDNF+/- mice exhibit normal amounts of all monoamines and degradation 
products investigated, which may explain their unaltered emotional behavioural phenotype. In line 
with these findings, BDNF+/- mice exhibit a normal regulation of the HPA-system, both under baseline 
conditions and after restraint stress. Our neurochemical analyses revealed a significant reduction of 
choline acetyl transferase (ChAT) activity to about 80 % selectively in the hippocampus of BDNF+/- 
mice. This loss of activity agrees with the previous finding that in the medial septum of BDNF-/- mice 
the number of cholinergic neurons is reduced at postnatal days 6 and 15 as compared to BDNF+/- and 
wildtype littermates (234). Although the number of cholinergic septohippocampal cells is not reduced 
in BDNF+/- mice in the early postnatal period, the decrease in enzyme activity in the adult animal may 
reflect a disturbance in the maintenance of function and survival of these neurons in response to the 
reduced BDNF levels. It has been suggested that synaptic plasticity in the hippocampus is influenced 
by neurotrophins via reciprocal regulation of acetylcholine, BDNF, and NGF, representing a 
"molecular framework" (122). This may be explained at least in part by the fact that BDNF regulates 
postnatal maturation and neurite outgrowth of cholinergic forebrain neurons and their projections to 
the hippocampus (234). Furthermore, a protective effect of BDNF was demonstrated for ChAT mRNA 
levels following peripheral injury of motor neurons, indicating the existence of regulatory pathways 
for cholinergic gene expression responsive to neurotrophic factors (233). Basal forebrain cholinergic 
neurons projecting their axons throughout the hippocampal formation and the neocortex are important 
for learning and memory (68, 234). Thus, deficiencies in cholinergic projections to the hippocampus 
may be in part responsible for the learning deficits observed in mice with impaired BDNF-TrkB 
signalling. BDNF deficient mice, as well as mice with a conditional TrkB knock-out in the forebrain 
exhibited severe impairments in hippocampus-dependent spatial learning (131, 150). In contrast to 
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those deficits in explicit or declarative learning and memory, BDNF-TrkB compromised animals 
revealed normal results in hippocampus-dependent associative learning paradigms, such as Fear 
Conditioning in the present study and passive avoidance in the study of Minichiello (150). Similar as 
BDNF-heterozygous mice, TrkB conditional knock-out mice also demonstrate regular emotional 
behaviours (255).  
The fact that mice with mutations impairing the BDNF-TrkB pathway do not show any features of 
depression challenges the hypothesis that this signalling pathway may play a major role in the 
pathogenesis of depression. However, despite the conflicting results on the role of this pathway in the 
pathogenesis of depression, this signalling cascade clearly seems to be involved in the mechanisms of 
antidepressive therapy. Thus, chronic antidepressive treatment evokes an increase in BDNF expression 
(158, 248). Mice with reduced BDNF expression as well as mice with impaired TrkB function do not 
show the normal reduction of behavioural despair seen in wildtype mice following antidepressant 
treatment, indicating that BDNF-mediated TrkB activation is necessary for at least some behavioural 
effects of antidepressants (187). These findings in transgenic mice, together with the direct 
antidepressive effects of BDNF in mouse models of depression (197, 199), as well as the increased 
BDNF levels in patients under antidepressive medication (32), suggest a cumulative evidence for a 
central role of this neurotrophin and its receptor in the molecular mechanisms of antidepressive 
therapy. There are several possible biological mechanisms that could mediate the antidepressant 
effects of BDNF. On a molecular level, the MAP kinase cascade is activated by BDNF-TrkB 
signalling and induces the plasticity-related transcription factor c-fos. On a cellular level, BDNF is 
involved in synaptic remodelling and functioning (141, 145, 173). Such cellular adaptations may also 
improve monoaminergic signalling in the forebrain, which is a major participant in the therapy of 
depression according to the monoaminergic hypothesis. While our results, as well as those of others, 
suggest that mice which are compromised in BDNF-TrkB signalling do not provide a genetic mouse 
model for depression, they may represent a valuable instrument to study molecular and cellular effects 
of antidepressive therapy. 
 
4.3.2 CREB 
Mice with a mutation of the CREB Ser142 phosphorylation residue were regarded as a candidate 
strain for depression-like behavioural or neuroendocrinological symptoms for several reasons. First, 
they have a desynchronization of their circadian rhythm (83), a key feature of subgroups of patients 
suffering from depression, e.g. Seasonal Affective Disorder (SAD) patients (24, 155, 208). Second, 
CREB is downregulated and/or underactivated in patients with depression (57, 249). Third, CREB 
induction and activation is induced by antidepressive therapy in mice and men (for review see (155)). 
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However, in the present study, CREBS142A mice did not show behavioural or neuroendocrinological 
features of depression when investigated in a test battery for locomotion, anxiety, despair, anhedonia, 
and emotional learning or stress-induced HPA-system abnormalities. The lack of a depression-like 
phenotype of CREBS142A mice is in line with the behavioural data in other strains of mice with a 
genetically modified expression of CREB, i.e. mice overexpressing dominant-negative mutant CREB 
in striatal regions, which blocks CREB function, show decreased immobilization in the Forced Swim 
Test, while an opposite effect is observed in mice virally overexpressing CREB in that region (172). In 
accordance with this, Eisch et al. found brain-region specific effects of BDNF and its receptor TrkB 
exerting depressive-like behavioural effects when injected in the ventral tegmental area – nucleus 
accumbens (67). CREBaD mutant mice, which lack the a and D CREB isoforms, leading to a more 
than 90 % reduction of CRE-binding activity in the brain, demonstrate less despair behaviour in the 
Forced Swim Test and in the tail suspension Test than wildtype controls (41). Mice with decreased 
CREB activity in the forebrain due to expression of a dominant-negative CREB-mutant polypeptide 
show reduced depression-like behaviours in the learned-Helplessness paradigm (156). However, 
despite their lack of depression-like behaviours, CREBaD mutant mice and also mice with a brain-
specific lack of all CREB isoforms exhibit increased levels of anxiety when tested in the elevated T-
Maze and the Dark-Light Box Test (89, 225). In summary, despite the obvious role of CREB in the 
molecular mechanisms of antidepressant therapy, CREB expression and/or function does not seem to 
be involved in the pathogenesis of depression-like symptoms in mice.  
Our hypothesis is supported by the fact that our study did not provide evidence for a role of CREB 
Ser142 in the pathogenesis of depressive syndromes, neither in mice nor in men. However, depression 
is a multifactorial and also a multigenetic disease. Therefore it can be assumed, that different genetic 
factors as well as various psychosocial and environmental variables contribute to this disorder. Thus, it 
is also conceivable that manipulation of one single genetic function, like CREB Ser14,2 may be 
necessary but not sufficient to cause a complex syndrome of behavioural alterations. Improved 
strategies for genetic modelling of depression-like syndromes in animals may therefore require a 
simultaneous targeted dysregulation of several genes involved in the pathogenesis of depression. This 
approach can be complemented in human models by the identification of behavioural traits, which are 
thought to be encoded by a limited set of genes. These so-called "endophenotypes" (46, 87), may 
reveal novel insights into the molecular mechanisms underlying circadian rhythmicity as well as 
specific subgroups of depression, such as SAD. In this respect we have identified a molecular switch 
in the CREB gene, CREB Ser142, which seems to be responsible for a specific symptom, i.e. the 
(dys)regulation of circadian rhythms, in mice and men.  
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4.4 Role of the HPA System 
Changes in the hypothalamus-pituitary-adrenocortical (HPA) system are typical for depression. Since 
the effects of glucocorticoids are mediated by intracellular receptors including, most notably, the 
glucocorticoid receptor, various studies have investigated the number and/or function of GR in 
depressed patients. Because an overall examination of CNS-related mechanisms in humans is 
restricted due to the unavailability of human brain tissue, it is necessary to search for corresponding 
animal models, in which pathophysiological changes can be investigated. 
4.4.1 Glucocorticoid Receptor 
The present study analysed the effects of reduced and increased expression of GR on behaviour and 
the HPA system in mice. On both levels, alterations only became evident after a stressful challenge, 
while none of the strains showed a phenotype under basal conditions in a test battery for locomotor, 
exploratory, anxiety-related, and emotional behaviour. In this context it is of interest that a selective 
loss of GR function in hepatocytes did not affect gluconeogenesis under basal conditions, but caused a 
gluconeogenesis deficit under challenge conditions by fasting the animals (163). Similarly, GR+/- mice 
exhibited a depression-like phenotype, i.e. increased Helplessness after challenge by uncontrollable 
footshocks. GR overexpressing mice, conversely, revealed a resistance to develop helpless behaviour. 
While GR+/- mice demonstrated a disinhibited HPA axis after stress exposure and a depression-like 
Dex/CRH Test (as the consequence of an altered feedback regulation due to a reduced GR gene 
dosage at the level of the PVN and the anterior pituitary), YGR mice had a stress- and challenge-
resistant HPA system.  
The Learned Helplessness model represents a rodent depression model with good face- and construct-
validity (46, 197, 230). It is based on the concept that depressed individuals show a loss of coping 
strategies in aversive environmental situations (198). This paradigm has been successfully used to 
demonstrate depressive behaviour in genetically altered mice (157). In the present study, GR+/- mice 
demonstrated significantly prolonged escape latencies and increased failures in the active avoidance 
task of the Learned Helplessness paradigm after two sessions of footshock exposure. The impaired 
coping behaviour strongly indicates the development of depression-like behaviour in GR+/- mice.  This 
altered behavioural reactivity to stress is accompanied by depression-like alterations of the HPA 
system. Similar to the behavioural level, changes of the HPA axis are not present under basal 
conditions in GR+/- mice, but a significant disinhibition occurs after stress. Furthermore, GR+/- mice 
exhibit a pathological Dex/CRH Test, currently the most relevant biological marker in patients for 
both, florid depression and the risk to develop a depressive episode. This test combines the 
suppressive effect of dexamethasone with the stimulatory potency of CRH (102). In 70-80 % of 
severely depressive patients, the CRH-elicited ACTH and cortisol response is blunted, and 
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dexamethasone pretreatment does not elicit a suppressive effect and paradoxically induces enhanced 
cortisol levels following a CRH challenge (102). In healthy individuals, in contrast, the Dex/CRH Test 
creates the situation of a pharmacological (partial and transient) adrenalectomy, in which 
hypothalamic CRH expression is increased due to a decrease in plasma cortisol (155). Similar as 
depressed patients, GR+/- mice display a characteristic non-suppression following dexamethasone 
treatment and the paradoxical increase of corticosterone levels after combined Dex/CHR application. 
Very recently, a depression-like phenotype similar as for GR+/- mice was described in mice with a 
forebrain-specific GR knock-out (21). These animals also exhibit impaired negative feedback 
regulation of the HPA axis, as well as increased depression-like behaviour (21). These findings 
indicate that crucial brain regions responsible for the phenotype of GR+/- mice may be located in the 
forebrain. Mice with a forebrain-specific complete GR-knock-out, induced by the calcium-calmodulin-
dependent protein kinase II (CamKII) promoter, exhibit a depression-like phenotype at 3 weeks of age 
already under basal (unstressed) conditions (21).  
Our results show that GR under- and overexpression from early development on does not lead to an 
overt phenotype under baseline conditions with low levels of stress. This could be due to a mere gene 
dosage effect. On the other hand, the lack of a specific phenotype might also be caused by early 
ontogenetic compensatory or adaptational processes, possibly reflecting the condition of patients with 
a high genetic (familiar) risk for depression, who are initially inconspicuous but develop depressive 
episodes following stressful life events. The lack of a phenotype under baseline conditions in the GR 
mutant strains examined here may also be due to the distinct genetic background of the animals. In 
accordance with the recommendations of the Banbury conference (38) all mice used in our 
experiments were F1 hybrids (from C57BL/6 and FVB/N parent mice). This results in a so-called 
hybrid vigour, which can reduce the impact of genetic alterations compared to a mixed or inbred 
genetic background. On the other hand, the detection of phenotypic alterations or pathologies in mice 
on a hybrid background (245) - in our GR mutant mice altered stress sensitivity - implies that the 
consequences of the underlying mutations are robust and reliable. These considerations regarding the 
behavioural findings can also be employed to physiological systems like the HPA axis. Despite their 
altered GR expression, GR mutant mice show normal baseline corticosterone levels during circadian 
rhythm. Following immobilization stress, however, significant changes in the response of the HPA 
system are present in GR+/- as well as in YGR mice. Since depression is a multigenetic disease, the 
dysregulation of a single system may not be sufficient to induce depression-like alterations in mice 
under basal conditions, in particular not in a robust F1 hybrid background. Therefore, provoking or 
destabilizing factors, such as stress or early childhood environmental factors may be necessary in 
addition to the existing genetic predisposition to effectively elicit a behavioural and also 
neuroendocrinological phenotype (36). This concept may explain why the depression-like phenotype 
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of GR+/- mice manifests only after a stress challenge. The latter fact, however, can be regarded as 
strength of this model, because also depression-vulnerable humans often develop a depressive episode 
due to external or internal stress factors.  An indirect genetic approach to prove the specificity of the 
depression-like alterations of GR+/- mice seemed to be the behavioural and neuroendocrinological 
examination of mice overexpressing GR. In these mice one would expect the opposite phenotype of 
GR+/- mice. Indeed, YGR mice carrying four copies of the GR gene demonstrate a stress-resistance on 
both the behavioural and the hormonal level. These animals exhibit less Helplessness, lower 
corticosterone levels after immobilization, and an over-suppression of corticosterone following 
dexamethasone treatment. This is in agreement with the predictions of our hypothesis.  Recently it was 
reported that mice overexpressing GR specifically in the forebrain display increased emotional lability 
in the Porsolt Forced Swim Test indicated by increased baseline immobility (235). Furthermore, these 
animals exhibited increased anxiety-like behaviour in the Elevated Plus-Maze and in the Dark-Light 
Box (235). This was not observed in our YGR mice that express GR under control of its own 
regulatory sequences. These conflicting results could be explained by the late onset and forebrain 
restricted mutation induced by the calcium-calmodulin-dependent protein kinase II promotor 
(CamKII) used in the former study (235). As already discussed above, in our mice developmental 
adaptive processes as well as a robust F1 hybrid background may account for the lack of a phenotype 
under basal conditions. Given that depression is a multifactorial disease (36), we assume that our GR 
mutant mice represent models for combined effects of both genetic and environmental manipulations.  
The results in GR+/- mice resemble the human situation in depressive disorders, in which individuals at 
risk are predisposed to develop depressive episodes after stress. In this respect, GR+/- mice differ from 
mice with a forebrain-specific complete GR knock-out (21), which already demonstrate depression-
like behavioural and neurochemical alterations under baseline conditions. However, the findings in 
both strains indicate that compromised GR function constitutes a crucial molecular risk factor in the 
pathophysiology of depression. Therefore we suggest that the mouse lines with altered GR expression 
are suitable tools for further physiological, biochemical, and pharmacological investigations of GR 
function with regard to depressive disorders. These analyses are also of clinical relevance, since in 
preliminary studies GR antagonists have been of value in the treatment of severe depressive episodes 
(15).  
Recently, the so-called Neurotrophin Hypothesis of Depression postulated that a downregulation of 
BDNF is essential for the pathogenesis of depression in humans and rodents, and can be reversed by 
antidepressant therapy (46, 61, 127, 155, 247). In concordance with this hypothesis, GR+/- mice – 
which have a predisposition to stress-induced depression-like behaviour – show a significant 
downregulation of BDNF in the hippocampus, while YGR mice exhibit a significant BDNF 
upregulation. Indeed, this is the first experimental evidence that reduced GR function concurrently 
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evokes a BDNF dysregulation and a predisposition to depressive behaviour. In future experiments 
with these strains we will investigate further mechanisms of neural plasticity thought to be involved in 
the molecular and cellular pathogenesis of depression, e.g. monoaminergic systems, arginine 
vasopressin and neurogenesis. In addition to the potential involvement of neurotrophins, respective 
experiments could also reveal a link between these systems, GR function, and depression-like 
behaviour.  
 
4.5 Role of Interleukin-6 
Depression is accompanied by an immune response. It is not clear whether activation of the immune 
system and in particular an increased production of IL-6 is a cause or consequences of depressive 
disorders. In addition to its well-known role in the immune system (e.g. induction of fever), IL-6 is 
constitutively expressed in various areas of the brain where it can exert neuromodulatory effects. IL-6 
deficiency has been shown to increase emotional reactivity to a novel environment. In this study, we 
subjected IL-6-/- mice to a battery of tests for anxiety and depression-related behaviours. Our findings 
confirm that they are more anxious than wildtype controls and display a less depressive-like behaviour 
in the Learned Helplessness paradigm. Additionally, IL-6-/- mice are more sensitive to the rewarding 
properties of sucrose. Moreover, in normal C57BL/6 mice, IL-6 levels are elevated in the 
hippocampus after the Learned Helplessness procedure. Thus, IL-6-deficient mice are more anxious 
but less depressive than control mice and our results suggest that IL-6 activation might be more a 
cause than a consequence of depression. 
In summary, the investigation of IL-6 knock-out animals revealed a decrease in Helplessness in the 
same paradigm, suggesting depression-resistance, which was supported indirectly by the detection of 
IL-6 induction in helpless wildtype animals. This is in line with the finding in eNOS knock-out 
animals, which demonstrated better coping performance in the Learned Helplessness paradigm which 
may contribute to the judgment of IL-6 action due to a recent hypothesis of Rönnbeck et al. (184), 
who state a contribution of IL-6 as well as NO in the modulation of glutamatergic neurotransmission 
by impairing astroglial glutamate transport. As glutamate signalling is crucial for information intake 
and processing within the brain, and due to the pivotal role for glutamate in brain metabolism, 
dynamic alterations in glutamate transmission could be of pathophysiological importance for mental 
fatigue, which may be of utmost importance for breaking the vicious cycle, which comes with the risk 
for secondary anxiety and depression (184). Although mental fatigue is not exactly the same as 
depression there are overlaps (e.g. the enhanced production of proinflammatory cytokines (4) and 
“sickness behaviour” (107, 116)) and both disorders present behavioural manifestations such as a 
reduction in motivation that would appear similar in animal models, where the affective state is either 
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irrelevant or difficult to assess. Even “sickness behaviour” contains a component of fatigue (116). 
Mental fatigue appears as a decreased ability to absorb and process information over time, and 
becomes pronounced when cognitive tasks have to be performed for longer time periods without 
breaks (cognitive loading). Often the symptoms are absent or mild in a relaxed stress-free environment 
(184), which refers to our findings in which depressive-like symptoms occur after stress exposition but 
not under basal conditions. 
In states of anxiety and stress, increased levels of glucocorticoids have been demonstrated. 
Interestingly, long term increases of glucocorticoids have been shown to result in the production of 
proinflammatory cytokines such as TNF-α and IL-1β (56), which, from a hypothetical point of view, 
seems to be in line with the behavioural results in glucocorticoid-deficient and overexpressing mice. 
Combining these findings with what is described in literature reveals an appropriate idea of how 
factors that may be investigated by means of the Learned Helplessness or other suitable animal models 
might be correlated and help to explain interrelations. 
 
 
4.6 Role of NOS III 
The role of adult neurogenesis in the pathogenesis of depression represents a core question for the 
understanding of pathological mechanisms of this disease (119). As suggested by Santarelli et al., an 
increase in adult neurogenesis might be a phenomenon of antidepressive treatment or contribute to the 
mechanism of antidepressive therapies (188). Since, according to these findings, the robust reduction 
in adult neurogenesis in NOS III deficient mice was hypothesized to lead to a depressive-like 
phenotype, we subjected these animals to the Learned Helplessness paradigm. Surprisingly, the 
opposite phenotype with a good performance in the task, was found, while no behavioural changes 
occurred in the Forced Swim Test. In line with this is the finding that NOS III-/- demonstrate good 
learning capabilities in the Morris Watermaze, indicating improved spatial learning (75). Anxiety-like 
behaviour was not affected apart from subtle alterations on the Elevated Plus-Maze (75), in our 
experiments, neither in those of others (51, 52). According to these observations, in which artefacts 
concerning the Learned Helplessness were excluded, since general effects of this mutation on pain 
sensitivity and locomotoric features were not evident, it may be concluded that adult neurogenesis 
does not represent a decisive factor for the genesis of a depressive-like phenotype. This idea was 
previously supported by Vollmayr et al. (231), however, despite current improvements in the 
conductibility of animal models one has to keep in mind the problem of transferability of results of 
animal models to the human situation (46). Possibly the reduction of adult neurogenesis, as it is found 
in NOS III knock-outs, was not sufficient or compensatory mechanisms were involved. Since cell 
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survival was unchanged, maybe this represents the decisive mechanism with regard to a depressive 
state (180). The improvement in the Learned Helplessness, however, continues to be difficult to 
understand. Since neither neurogenesis nor depression are likely to be explainable by simple rules, but 
are regulated by fine-tuning of several regulatory systems, which remain to be illuminated, a 
continuous exchange between disciplines is required to clarify the behavioural impact of neurogenesis. 
 
4.7 General Conclusions 
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For evaluation of the Learned Helplessness paradigm in mice different aspects were investigated, 
considering the induction of a helpless state by stress as the primary criterion, which can be reverted 
by antidepressive therapy. While no alteration of BDNF levels were detectable after footshock stress, 
and a heterozygous mutation of BDNF did not reveal true depressive-like characteristics, thus 
challenging the Neurotrophin Hypothesis, when exposed to Learned Helplessness stress, GR over- and 
underexpression affected BDNF levels in opposite directions, thereby confirming the postulation of 
the Stress Hypothesis of Depression. This indicates, that BDNF itself has to be questioned regarding 
its role in the pathogenesis of depression, but potentially represents a cofactor in the stress-induced 
course of this disease, with great relevance in the treatment of a depressive state.  
GR+/- and YGR mice demonstrated converse coping in the Learned Helplessness, which refers to the 
respective up- and downregulation of BDNF protein as suggested by the Neurotrophin Hypothesis. 
Once more this emphasizes the assumption, that BDNF is significant as a secondary coaspect under 
particular conditions, i.e. increased vulnerability by a disturbed HPA system. When exposed to 
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(restraint) stress, GR+/- and YGR mice differed again, suggesting a depression-like phenotype in GR 
heterozygotes and a depression resistance in GR overexpressing mice. These results were furthermore 
underlined by characteristic findings in the Dex/CRH Test, which, in summary, substantiates the 
validity of these two mutant lines as models for depression and depression-resistance, respectively. 
The investigation of IL-6 knock-out animals revealed a decrease in Helplessness in the same 
paradigm, suggesting, similar as in YGR mice, depression-resistance, which was supported indirectly 
by the finding of an IL-6 induction in helpless wildtype animals, which may be related to the opposite 
findings in GR mutant mice. 
Furthermore, it was found, that NOS III knock-out animals, with a robust reduction in adult 
neurogenesis demonstrated better coping performance in the Learned Helplessness paradigm. 
Probably the reduction of adult neurogenesis, as it is found in NOS III deficient mice, was not 
sufficient or compensatory mechanisms were involved. However, in view of the fact that neither 
neurogenesis nor depression are likely to be explained by simple mechanisms, but are modulated by an 
interplay of several regulatory systems, which remain to be illuminated, a permanent exchange 
between disciplines is required to elucidate the behavioural impact of neurogenesis. 
In summary, the individual behavioural, pharmacological, and genetic contribution to the results of 
this thesis validate the Learned Helplessness model as a valuable instrument for the research on 
depression. The adjustment and modification of this paradigm, which is currently mainly used in rats, 
to mice bears the advantage of simultaneous examination of environmental as well as genetic factors 
by investigating the effects of manipulated target genes in transgenic mice. General problems of such 
procedures may therefore be solved, since an approach from different perspectives becomes possible 
when working with mice. Current ideas might be investigated and verified by the reflection of 
findings, which are suggested to overlap with the identified phenomena, thus completing hypotheses, 
which are examined by animal models of depression. 
The fact that the Learned Helplessness model, as it was established in this thesis, is plastic to 
environmental influences, i.e. housing stress, which is in line with what is discussed in the literature, 
and thereby supports its position in reflecting diseases, which are also dependent on environmental 
conditions. Furthermore, this model proved to be representative not only by being reactive to 
antidepressive treatment, but also when it was employed for the detection of depressive-like effects at 
behavioural level in genetic animal models of depression, like GR deficient mice. The suitability of 
this model for the investigation of the pathogenesis and pathophysiology of depression is moreover 
supported by the finding that only a proportion of animals develop a helpless state which mimics the 
human situation, representing a realistic illustration of the disease, which should be implied in future 
scientific issues. 
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4.8 Perspectives 
The high prevalence of depression in humans and only partially effective treatment possibilities 
suggests that valid animal models could play a central role a further understanding of this disorder. 
Thus, the Learned Helplessness in mice represents a promising tool, which can be expanded. Among 
the issues which should be expanded it remains how far the induction of a helpless state may modulate 
the mechanisms of the HPA-system. If this is the case these findings do correspond to the observed 
vulnerabilities caused by environmental conditions. Moreover, the pharmacological validation of the 
GR+/- and YGR mice needs to be carried out to evaluate  these models suitability for studying 
neuroplasticity in depression. Another interesting aspect would be the identification of particular brain 
regions involved by expression studies and chip analyses as well as the examination of neurogenesis-
related processes.  
Another essential question would be, arising from own studies isif IL-6 is changed in GR- 
heterozygous and overexpressing animals. Since the association to the other findings presented in this 
thesis is still unclear, additional aspects have to be included in future hypotheses. One factor to focus 
on may be the heat shock factor 1 (HSF1), which to some extend appears to cross-talk with the current 
candidate systems examined in this thesis by regulating the transcription capacity of the glucocorticoid 
receptor as well as Interleukin-6.  
Another subject, related to HSF 1, which must be considered in upcoming physiological and 
behavioural research on consequences of genetic and environmental causes for depression, is the 
examination of female mice, which are frequently excluded due to their hormonal cycles. Thus it 
seems a crucial issue to establish reliable methods for the assessment and/or synchronization of the 
animals’ oestrus cycles. This would allow defined experiments, incorporating natural occurring gender 
variations as possible causative factors, too. Since women in the human population are more affected 
by this disease, it appears as an imperative object to look for differences that may cause this 
predisposition at genetic and/or environmental level. 
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7 Appendix 
Abbreviations 
a.m.   ante meridiem 
ACTH   “adrenocorticotrophic hormone” 
ANOVA  “analysis of variance” 
BDNF   “brain-derived neurotrophic factor” 
BDNF+/-  heterozygous BDNF knock-out mice 
cAMP   “cyclic adenosine monophosphate” 
CET   Central European Time 
ChAt   “choline acetyltransferase” 
cm   centimetre   
CNS   central nervous system 
con   control 
CRE   “cAMP response element” 
CREB   “cAMP response element binding protein” 
CRH   “corticotrophin releasing hormone” 
Dex   Dexamethasone 
DNS   “desoxyribonucleic acid” 
ds   double shock 
ECT   electroconvulsive therapy 
enr.   enriched 
e.g.   exempli gratia 
esc. lat.  Escape latency 
et al.   et alteri 
Fig.   Figure 
g   gram 
h   hour 
GR   glucocorticoid receptor 
GR+/-   heterozygous glucocorticoid receptor knock-out mice  
HPA   “hypothalamus-pituitary-adrenal” 
i.e.   id est 
IL   interleukin 
IMI   imipramine 
imp.   impoverished 
kg   kilogram 
K.O.   “knock-out” 
LH   Learned Helplessness 
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LTP   “long-term potentiation” 
mA   milliampere 
MAO   Monoaminoxidase 
mm   millimetre 
mg   milligram 
ml   millilitre 
MR   mineralocorticoid receptor 
mRNA   “messenger ribonucleic acid” 
n   number of experimental subjects 
ng   nanogram 
NA   noradrenaline 
NaCl   natriumchloride 
ng   nanogram 
NGF   nerve growth factor 
NOS   nitric oxide synthase 
n.s.   not significant 
p   probability 
PBS   “phosphate-buffered saline” 
PCR   “polymerase chain reaction” 
PFA   paraformaldehyde 
pH   potential hydrogenii 
PKA   protein kinase A 
p.m.   post meridiem 
RIA   “radioimmunoassay” 
RNA   “ribonucleic acid” 
s   second 
S.E.M.   “standard error of the mean” 
Ser142   “serine 142” 
Tab.   Table 
TrkB   “tyrosine kinase receptor B” 
vol   volume 
vs.   versus 
wt   wildtype 
YGR   glucocorticoid receptor overexpressing mice 
 
 
 
 
 
www.pdfmailer.de   PDFMAILER.DE 
 
Kostenfrei und werbegesponsert PDF drucken und direkt per E-Mail 
versenden >Test it free www.pdfmailer.de 
Appendix 
__________________________________________________________________________ 
  113 
 
Chronological Table 
 
10000 a.d.:  Ritual culture of the scull 
   Trepanations in living persons, i.e. opening of the scull, are reported,  
   but proof of medical indication is missing 
3000 a.d.:  No psychiatric proofs, but indications that sickness in general, was  
   caused by obsession (Mesopotamia) 
500 a.d.:     Inauguration of psychiatric curing history primary occurs in the      
   greek antique and mental cases are described in the literature. 
   Reversal of credence in obsession by supernatural beings to the   
   assumption that psychiatric diseases represent organic illnesses 
460-370 a.d.:  Hippokrates creates the theory of the “humuralpathology”, in which  
   an imbalance between the body juices (blood, bile, and slime) is  
   illustrated 
80-130 a.d.:  Description of melancholy and mania by Aretaios from Kapadokia 
9th century:  Foundation of a psychiatric compartment in Bagdad 
1493-1541:  Paracelsus distinguishes psychiatric illnesses as natural diseases 
1621:   “Anatomy o the melancholy” by Robert Burton is published in   
   Oxford 
1790-1830:  “Romantic Psychiatry”: “psychic” vs. “somatic” theories draw an  
   opposite pathogenesis concerning cause and consequence of   
   psychiatric disorders 
1803/1808:  The term “psychiatry” is manifested by Christian Reil    
   (“Rhapsodias”) and the common treatment of patients is criticized 
1845:   Foundation of the “German Society for Psychiatry and juristic   
   Psychology” 
1859:   Discussion of the “Social Darwinism” 
1878:   First psychiatric University Hospital in Heidelberg is founded 
1895:   Sigmund Freud and Josef Breuer create the psychoanalysis 
1903:   Barbitural (Barbiturat) is synthesized 
1913:   Karl Jaspers publishes one of the most important books in   
   psychiatry: “General Psychiatry” 
1929:   Hans Berger publishes about the EEG 
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1933:   The National Socialists enact the “law of avoidance of inherited  
   diseases in the next generation” 
1938:   Electroconvulsive therapy is applied first by Celetti and Bini 
1939-1941:  Systematic elimination of psychiatric patients in Germany (“T4-action”) 
1946:   Meprobomat (Tranquilizer) 
1949:   Lithium (Antimanic) 
1950:   “Clinic Psychopathology” is published by Kurt Schneider 
1952:   Chlorpromazin (Neuroleptic); Reserpin (Antipsychotic) 
   DSM (US-american “Diagnostic and Statistical Manual of   
   Mental  Disorders”) 
1957/1959:  Imipramine (Tricyclic Antidepressant) is discovered by Kuhn 
1958:   Haloperidol (Neuroleptic) discovered by Janssen 
1959:   “Antipsychiatry” 
   “The divided Self” by Laing describes schizophrenia as   
   consequence of a negative social environment, not as disease 
1960:   Chlordiazepoxide (Benzodiazepine) 
1963:   Diazepam (Benzodiazepine) 
1967:   Lithium as Moodstabilizer 
1968:   DSM-II 
1972:   Clozapine (atypical Neuroleptic) 
1980:   DSM-III 
1991:   ICD-10 
1994:   DSM-IV 
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Learned Helplessness Protocol:  
Validity and Reliability of Depressive-Like States in Mice 
 
The Learned Helplessness paradigm is a depression model in which animals are exposed to 
unpredictable and uncontrollable stress, e.g. electroshocks, and subsequently develop coping deficits 
for aversive but escapable situations (9). It represents a model with good face, construct, and 
predictive validity in rats. Despite an increased need to investigate emotional, in particular depression-
like behaviors in transgenic mice, so far only a few studies have been published using the Learned 
Helplessness paradigm. One reason may be the fact that – in contrast to rats (18) - there is not a 
generally accepted Learned Helplessness protocol available for mice. This prompted us to develop a 
reliable helplessness procedure in C57BL/6N mice, to exclude possible artifacts, and to establish a 
protocol, which yields a consistent fraction of helpless mice following the shock exposure. 
Furthermore, we validated this protocol pharmacologically using the tricyclic antidepressant 
imipramine. Here we present a mouse model with good face and predictive validity that can be used 
for transgenic, behavioral, and pharmacological studies. 
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1. Type of research 
(1) The protocol described here allows murine studies of molecular, neurochemical, stress-
physiological, and behavioral consequences of the Learned Helplessness paradigm, a 
behavioral model of depression. 
(2) A detailed characterization of this model, defining a time course of coping deficits 
(helplessness) and employing clearly structured definitions of helpless behavior, also 
evaluated by pharmacological treatment, supplies good validity and reliability of this 
procedure. 
(3) As a result, this protocol can be used for transgenic and pharmacological approaches to study 
depression in mice. 
 
2. Time required 
The course of the Learned Helplessness paradigm starts with an inescapable shock procedure 
on two consecutive days, each of these shock sessions lasting approximately 52 minutes. 
Learned Helplessness is assessed 24 hours after the second shock procedure and lasts up to 24 
minutes, depending on the animals’ performance in the shuttle box. More then 80 % of 
helpless animals remain helpless for at least 1 week (Fig. 1). 
 
 
3. Materials 
 3.1. Special equipment 
The shock procedure was applied in a transparent plexiglas shock chamber (18x18x30 cm3), 
equipped with a stainless steel grid floor (Coulborn precision regulated animal shocker, 
Coulborn Instruments, Düsseldorf, Germany).  
The two-way avoidance test was conducted in a two-compartment shuttle box  (Coulborn 
Instruments, Düsseldorf, Germany), equipped with red-light beams at the bottom of each of 
the two compartments to monitor spontaneous shuttling as well as behavioral responses to a 
light (conditioned) or an aversive footshock (unconditioned) stimulus, respectively. The 
shuttle box consisted of equal-sized compartments (18x18x30 cm3) that were separated by a 
small gate (6 cm wide and 7 cm high). Both compartments of the shuttle box contained a grid 
floor, through which the current was applied, and a signaling light at the top of each 
compartment. Protocol charts for both, the shock procedure and shuttle box testing, 
respectively, were designed using Graphic State software (Coulborn Instruments, Düsseldorf, 
Germany). 
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 3.2. Hotplate  
 To exclude altered pain sensitivity as a confounding factor, all mice were tested on the 
 hotplate (ATLab, Vendargues, France). 
 
3.3.  Pharmacological treatment  
 The model was pharmacologically validated with the tricyclic antidepressant imipramine in 
two different doses (10 and 30 mg/kg body weight). We assessed the capacity of imipramine 
to revert helpless behavior in the shuttle box. NaCl served as vehicle control. 
 
4. Detailed Procedure 
4.1.  Animals 
10 weeks old male C57BL/6N mice were purchased from Charles River, Sulzfeld, Germany, 
and acclimatized to single housing in macrolon cages (type II) at constant conditions with a 12 
h dark-light cycle and an average room temperature of 22°C for two weeks prior to the 
experiments, with food and water ad libitum. All experiments were approved by German 
animal welfare authorities (Regierungspräsidium Karlsruhe). 
 
4.2.  Inescapable shock procedure 
(1) Mice were exposed to inescapable shocks during their active (dark) phase. Animals had to be 
transported in their homecages to the experimental room, and were then placed into the shock 
chamber.  
(2) The shock procedure comprised 360 scrambled footshocks (0.150 mA) on two consecutive 
days. The footshocks were unpredictable with varying duration (1-3 s) and interval-episodes 
(1–15 s), amounting to a total session duration of approximately 52 min. During the shock 
exposure lights were turned off. 
(3) Control animals underwent the same handling and contextual procedures without receiving the 
footshocks. By thorough cleaning with 70 % ethanol, we took care that control animals, which 
did not receive electroshocks, were exposed to the shock chambers without being distressed 
by the smell of shocked mice. 
 
4.3.  Assessment of Learned Helplessness 
24 h after the second the shock procedure, Learned Helplessness was assessed by testing 
shuttle box performance (Graphic State Notation, Coulborn Instruments, Düsseldorf,  
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Germany). Each trial started with a light stimulus of 5 s, announcing a subsequent footshock 
of maximum 10 s duration (intensity: 0.150 mA). The intertrial interval was 30 s. The 
following behavioral reactions were defined: avoidance as adequate reaction to the light 
stimulus by changing to the other compartment immediately, escape as shuttling to the other 
compartment as reaction to the electric shock, and failure when no attempt to escape was 
made. Furthermore, the parameter escape latency was recorded as the time needed to shuttle 
into the other compartment after onset of the footshock. For determination of the general 
activity, the shuttles before the first footshock (initial activity), as well as the activity in-
between the trials (intertrial interval activity or ITI) were recorded. Total time of testing for 
helplessness lasted about 20-24 min, the exact time period depending on the animal’s ability to 
learn the paradigm and to respond properly. Before each trial the apparatus was thoroughly 
cleaned with 70 % ethanol.  
 
4.4. Pain sensitivity 
To exclude potential artifacts by altered pain sensitivities, which could influence the effect of 
the electroshocks, a subgroup of mice was tested on the hotplate prior to the learned helpless 
procedure at a temperature of 52°C. The latency to first reaction (jumping or licking the hind 
paws) was monitored. 
 
4.5. Defining helplessness  
Following the evaluation of the behavioral parameters, the shocked animals were classified as 
“helpless” or “resistant”, depending on their performance in the shuttle box test. Failures and 
escape latencies were taken as indicators for helplessness, and a k-means (k = 2) clustering 
algorithm was applied to a data pool including 212 mice subjected to the described protocol 
(see 5.3). The number of failures and the escape latencies were used as performance scores of 
the individual animals, because these are the most commonly reported indices of helplessness 
(2, 11, 12, 15, 16, 18). These behavioral indices were normalized (i.e. transformed to Z scores) 
to prevent differences in the range of each variable, which could produce a bias, and then 
inadvertently be used to implement a clustering process. This classification was further refined 
by means of a two-step discriminant-canonical analysis, which also provided classification 
equations for identification of helpless/non-helpless mice following this protocol. 
 
4.6. Pharmacological validation 
 94 additional C57BL/6N mice were trained and tested in our protocol. Prior to any 
pharmacological treatment, these mice were classified as “helpless” or “non-helpless” using 
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the classification equations previously obtained (see sections 4.5 and 5.1) which takes into 
account the number of failures and the latency to escape.  
The duration of helplessness for approximately 10 days dictated a subchronical antidepressive 
treatment interval of 5-6 days (Fig. 1). Thus, the animals underwent 5 days of vehicle (NaCl), 
10 or 30 mg/kg b.w. imipramine regimen. On day 6, animals were re-tested in the escape task. 
The classification equations were used again to classify each subject, but now the values of the 
re-test session were used in for the calculation. The changes in this categorical classification 
(i.e. mice moving from “helpless” to “non-helpless” group) after imipramine treatment were 
considered as an index of sensitivity of the provided operational definition of helplessness. 
This analysis was complemented by the assessment of variations in the squared mahalanobis 
distance (for detailed explanation see 5.3) to the centroid of the non-helpless group 
before/after the pharmacological treatment to have a continuous rather than categorial index of 
imipramine effects. 
Figure 1: Time course of the Learned Helplessness procedure 
360 footshocks with an intensity of 0.150 mA at two consecutive days (day-2, day-1) result in about 30 
% of all shocked animals in significant coping deficits 24 hours later (day 0), i.e. increased failures and 
escape latencies in the shuttle box (p  <  0.05). From 100 % helpless mice at day 0, 83 % of the mice are 
still helpless at day 7, with rapid improvement thereafter. The time-period between day 9 and 13 
represents a critically labile condition in which a significant improvement becomes detectable as 
indicated by a sign-test (p = 0.0172). 
 
 
5. Results 
5.1. Definition of helplessness 
Cluster analysis (Fig. 2) is a group of exploratory data analysis tools, which aim at sorting 
different objects into groups in a way that the degree of association between two objects is 
maximal if they belong to the same group and minimal otherwise. Thus, cluster analysis can 
be used to discover structures in data without providing an explanation or interpretation. 
shocks  shocks LH  LH                     LH         LH                LH 
100%          spontaneous course                                83% 67.5%    33.3%                       22.2% 
day  - 2  day  - 1   day0 day1   day2   day3  day4  day5   day6  day7 day8  day9 day10 day11  day12  day13  day14 
antidepressant treatment 
Treatment: 
Helplessness :
Time: 
p = 0.0172 
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Among the different clustering algorithms available we used the k-means procedure, because it 
allows the a priori specification of the number of clusters suspected to be in the sample. In 
general, the k-means method will produce exactly k different groups of greatest possible 
distinction. In our case this number was restricted to two clusters, aimed at separating helpless 
and non-helpless mice. In our sample, 65 subjects (approximately 30 % of the sample) were 
categorized as our “helpless” cluster, and 149 subjects were in the “non-helpless” cluster, 
respectively. The Euclidean distance between both clusters was 2.007933 (squared Euclidean 
distance = 4.031235) and two independent ANOVAs revealed that the obtained clusters 
significantly differed in the number of failures [F(1, 212) = 668.716, p < 0.000001] and latencies 
to escape [F(1, 212) = 643.243, p < 0.000001 (for descriptive statistics see Table 1A).  
To further confirm that these empirically defined clusters were mainly reflecting differences in 
the variables of interest (failures and escape latencies) and to obtain a classification equation 
for new cases, we performed a two-step discriminant-canonical analysis (Fig. 2). Discriminant 
function analysis is used to determine which variables discriminate between two or more 
naturally occurring groups, and when applied to two groups its computation and interpretation 
is almost identical to a multiple linear regression. We used our clusters as naturally occurring 
groups and different dependent variables of our escape procedure (failures, escape latency, 
intertrial interval activity, and initial activity) as possible discriminant factors. The number of 
escapes and avoidances were not included in this procedure, because these indices are not 
mutually independent and they are redundant towards others already included (i.e. the number 
of escapes is an algebraic combination of failures and avoidances). Results indicated that only 
the number of failures and, to a lesser extent, the escape latencies defined both groups ([F(2,214) 
= 7.634, p < 0.001] and [F(2,214) = 4.728 p < 0.01], respectively). The factors “intertrial 
activity” and “initial activity” failed to enter in the model. Therefore, this model is exclusively 
based on the number of failures and the latency to escape, because these indices accounted for 
100 % of the variance (Eigenvalue: 3.200). Thus, the activity parameters can be ruled out as a 
confounding factor in this paradigm. Although it differed according to the group, this model 
presented an average concordance of 97 % (see Table 1B for detailed results). 
 
 
 
 
www.pdfmailer.de   PDFMAILER.DE 
 
Kostenfrei und werbegesponsert PDF drucken und direkt per E-Mail 
versenden >Test it free www.pdfmailer.de 
Appendix 
__________________________________________________________________________ 
  121 
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Table 1: A) k-means clustering revealed two distinct clusters among a total number of 214 animals, 
which reveals a distribution of 30.37 % and 69.26 %, respectively. Means ± SEM of the 2 parameters of 
relevance, failures, and escape latency.  
 Cluster 1 
”Helpless” 
Cluster 2 
”Non-Helpless” 
Number of subject 
(% of total sample) 
65 
(30.37 %) 
149 
(69.26 %) 
 
Failures 
 
19.80 + 0.79 
 
2.55 + 0.24 
 
Latency to escape(s) 
 
7.51 + 0.21 
 
2.49 + 0.09 
 
PREDICTED 
 Helpless 
(p = 0.30374) 
Non-helpless 
(p = 0.69626) 
Percent correct 
 
Non-Helpless 
 
0 
 
 
149 
 
100 % 
 
Helpless 
 
 
59 
 
6 
 
90.77 % 
 
O 
B 
S 
E 
R 
V 
E 
D 
 
Total 
 
 
59 
 
155 
 
97.2 % 
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B) 2-step discriminant-canonical analysis confirmed the categorization according to k-means 
clustering with a probability of 90.77 % in helpless animals, and was in a 100 % accordance with the 
classification of non-helpless animals, respectively. 
 
 
 Figure 2: Statistical characterization of helplessness.  
 Statistical analysis was applied to a datapool comprising relevant parameters of the paradigm, e.g. 
escape latency or escape failures. k-means clustering indicates a classification of helpless and non-
helpless individuals. For confirmation of appropriateness of the classification a canonical analysis was 
performed, including intertrial interval activity in the parameters evaluated, in order to determine its 
relevance for the categorization of helplessness. Canonical  analysis verified a proper classification 
and subsequent defined criteria for helplessness with a probability of 97 %.  
 
In a second step, canonical coefficients (data not shown) and classification equations (adjusted 
to the sample size) were obtained. While these results are presented in Table 2, we would like 
to highlight that these equations can be used to calculate the classification of any subject tested 
in the avoidance task described in section 4.3 the probability of being classified as “helpless” 
or “non-helpless”. To estimate the possible incidence of “spontaneous helplessness” as a  
Datapool 
(Escape latency,  
 escape failures,  
ITI activity) 
K - means clustering 
(Escape latency OR  
failures) 
helpless (~30%)  
non - helpless (~70%) 
Canonical analysis 
(Escape latency AND  
failures AND ITI) 
helpless (~30%)  
non - helpless (~70%) 
Escape latency and  
failures: relevant 
ITI:  no relevance 
97 % 
agreement 
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confounding factor, 93 control (non-shocked) mice were tested in this procedure. As expected, 
all these subjects were classified as “non-helpless” according to the given equations. Figures 
3A and 3B show the frequency histograms of the distribution of number of failures and escape 
latencies for these three groups. 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2: Classification equations obtained after a two-step discriminant-canonical analysis. Cells display the 
constant and the weights corresponding to the two parameters relevant for each subject’s classification as 
“helpless” or “non-helpless”, respectively. These values are combined in a linear equation: NLH = -8.19995 + (-
2.26963 * failures) + (8.60186 * escape latency) or LH = -20.5300 + (-1.6956 * failures) + (9.7177 * escape 
latency). These equations can be used to perform a priori classifications of any subject tested with the protocol. 
The case would be classified as belonging to the group for which it has the highest classification score, which 
reflects a smaller squared Mahalanobis distance towards the centroid of the corresponding group. Also and 
because we assume a multivariate normal distribution around each centroid, these distances (i.e. the scores of 
these equations) can be used to calculate the posterior probabilities (i.e. probability of belonging to the group to 
which each subject has been ascribed). 
 
  
Constant 
 
 
Failures 
 
 
Escape Latency 
 
Non-Helpless 
 
-8.19995 
 
 
-2.26963 
 
8.60186 
 
Helpless 
 
 
-20.5300 
 
-1.6956 
 
9.7177 
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 Figure 3: Distribution of critical parameters for helplessness  
A) Escape latencies and B) number of failures observed in our Learned Helplessness paradigm. Mice (n 
= 307) were tested in a shuttle box for escape deficits as described in section 4.3 after uncontrollable 
shock exposure (n = 214) or sham-treatment without footshocks (n = 93). The distribution curves 
demonstrate that shock-exposed mice, which are classified as “non-helpless” by k-means clustering (n = 
155, see text for details), and “control” (i.e. non-shocked) animals display the lowest values in both 
variables. The overlapping distribution of these values in both groups also suggests that all these mice 
fit into a unique population. Conversely, mice classified as “helpless” (n = 59) show a different (i.e. 
non-overlapping) distribution and display high values in both parameters, confirming the interpretation 
that these mice belong to a different population with different behavioral features. 
 
 5.1. Time course of helplessness 
The average duration of robust Learned Helplessness was 10 days after the second footshock 
exposure (Fig. 1). This period was followed by a ”critical phase”, in which significant 
improvements of the coping deficits were observed. The given time window of 10 days 
corresponds closely to the time course of Learned Helplessness in rats (17). This time course 
restricted the pharmacological validation of this model and will also limit future 
pharmacological experiments to a subchronic treatment interval of 5-6 days. 
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5.3. Pharmacological validation of the model  
The duration of helplessness for approximately 10 days dictated a subchronical antidepressive 
treatment interval of 5-6 days. Thus, the animals underwent 5 days of vehicle (NaCl), 10 or 30 
mg/kg b.w. imipramine regimen. 94 male C57BL/6N mice were trained and tested according 
to the methods described in sections 4.2 and 4.3. These mice were classified as “helpless” or 
“non-helpless” according to the classification equations presented in Table 2A. The next day, 
vehicle or imipramine treatments were administered as described in 4.5 followed by re-testing 
in the avoidance task on day 6. The change (after - before treatment difference) in the squared 
mahalanobis distances to the centroid of the “non-helpless” group was used as main indicator 
of effects of imipramine treatment (Fig. 4). This is a measure of the distance between two 
points in the multidimensional space defined by the predictor factors similar to the Euclidean 
distance, which does not presuppose that the predictors are orthogonal. By taking the centroid 
of a group as one of these points, and each individual score as the other, the probability of 
belonging to that group can be estimated, and considering the difference after - before, the 
impact of the imipramine treatment in the two criteria involved in the helpless definition can 
be quantified simultaneously. Thus, a two-way ANOVA revealed a significant effect of both 
factors, group (helpless vs. non-helpless) and treatment (vehicle (NaCl), 10 or 30 mg/kg b.w. 
imipramine)) [F(1,88) =  35.49, p < 0.0001] and [F(2,88) =  5.25, p < 0.01], respectively. As the 
interaction between both factors failed to reach statistical significance, appropriate Bonferroni 
corrections were performed in the subsequent mean comparisons. These comparisons revealed 
a significant (p < 0.05) dose-dependent reduction of the squared mahalanobis distances to the 
centroid of the “non-helpless” group in helpless animals treated with imipramine. 
Interestingly, the same pharmacological treatment did not show any significant effect in the 
same variable in non-helpless mice, thus discarding an indiscriminate improving effect of 
imipramine in learning/memory processes. Therefore, as it is selectively reverted by 
antidepressant treatment, these results seem to confirm that poor avoidance performance after 
uncontrollable shock exposure is indicative of helplessness. We also compared the 
individual’s classification provided by the equations presented in Table 2 before and after 
pharmacological treatment. Pharmacological treatment only affected the classification of 
“helpless” mice, thereby confirming the results of Fig. 4. Thus, in the cohort of “helpless” 
mice treated pharmacologically, imipramine produced not only a significant average 
improvement of latencies and failures, but also in more than half of the animals a reversal 
from “helpless” to “non-helpless”. As expected, these changes were also related to the 
imipramine dose, a higher dose being more effective (percentage of subjects becoming “non-
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helpless”: 57.1, 50.0 and 0.0 % of subjects after 30, 10 and 0 mg/kg of imipramine, 
respectively, see also Table 3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3: Effects of pharmacological treatment with imipramine (10 or 30 mg/kg b.w. vs. saline) on 
the classification as helpless or non-helpless. Cells display mean + SEM of failures (F) and latency to 
escape (L) before and after treatment. Numbers in brackets contain the number of helpless animals 
before/after treatment in each group. 
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Figure 4  
Figure 4: Pharmacological validation 
Effects of imipramine on murine helplessness: bars depict mean + SEM of the difference before-after 
pharmacological treatment in the squared Mahalanobis distances from the “non-helpless” cluster  
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 Failures: 24.4 + 0.82 
Latency: 8.74 + 0.45 
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Latency: 8.63 + 0.41 
(8) 
 
Failures: 23.6 + 2.8 
 Latency: 9.03 + 0.42 
(7) 
 
 
AFTER 
 
 
 
Failures: 21.7 + 3.54 
 Latency: 7.68 + 1.03  
(8) 
 
  Failures: 13,6 + 4.48 
Latency: 5.4 + 1.2 
(4) 
 
 Failures: 16.4 + 5.47 
 Latency: 5.97 + 1.70 
(3) 
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centroid (see methods section for details). Mean comparisons revealed that imipramine does not modify 
this distance in “non-helpless” animals but it significantly (p < 0.05) reduces it in “helpless” mice. 
Repeated injection of vehicle solution (0.9 % saline) does not modify this parameter in any group. 
Taken together, these results suggest that imipramine produces a selective and specific reduction of 
helplessness. 
 
Alternatively, it has to be considered that the pharmacological treatment produced a variable 
improvement of depression-like symptomatology within each group. Thus, as an example of 
another possible application of the herein proposed operational definition of helplessness, the 
classification equations in Table 2 can be used to provide a qualitative index of the response to 
antidepressant (i.e. ”responsive” vs. “resistant”) or vehicle (i.e. “spontaneous remission”) 
treatment. 
 
5.4. Assessment of potential artifacts 
Statistical evaluation of the activity in-between the shuttle-escape trials showed that 
helplessness represents a true shock effect, which is not related to general changes in activity 
that could falsify the results by assessing spontaneous shuttling. Furthermore, alterations in 
pain sensitivity were excluded to correlate with the level of helplessness (p = 0.998 and R2 = 
0.0000000108), which could be responsible for escape deficits because of a lack of sensitivity 
to the unconditioned aversive stimulus. 
 
6. Discussion 
 6.1. Setup of the protocol 
In order to establish a valid and reliable model of depression as it has been described in rats 
(18), we designed a Learned Helplessness procedure, in which two series of unpredictable and 
uncontrollable footshocks applied over 2 days under dark conditions evoke helpless 
performance in a shuttle box. This is in line with most rodent depression models that use stress 
as a tool to induce depression-like symptoms. 
 
 6.2. Time course 
Supporting the face validity of our paradigm, time course experiments revealed a helpless 
period of about 10 days, which seems comparable to the duration of a depressive episode in 
humans if set in relation to the lifespan of a mouse. This time window should also be 
considered, when the Learned Helplessness paradigm is embedded in a behavioral test battery, 
which includes stressful handling or testing, because this may prolong the period of 
helplessness. 
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 6.3. Categorization: Definition of Learned Helplessness 
According to our criteria for the definition of Learned Helplessness, approximately 30 % of 
the stressed mice become helpless after shock exposure, which is high in comparison to the 
general prevalence of depression in humans. On the other hand, this rather large fraction 
allows the investigation of several relevant biological factors, because the procedure yields 
enough animals for several cohorts, e.g. with different antidepressant treatment. Furthermore, 
a robust fraction of 30 % is not prone to floor or ceiling effects. 
 
 6.4. Pharmacological validation of the model 
The pharmacological validation of our model confirms its specificity by demonstrating  a 
statistically significant improvement of helplessness following antidepressive treatment, while 
NaCl was not effective. Consequently, helplessness, as defined by our experiments, seems to 
represent a specific depression-like syndrome, since it can be antagonized by pharmacological 
treatment (57.1 % after 30 mg/kg imipramine) with a similar efficiency as in humans, which 
have an approximate remission rate of 60 % (1). 
 
 6.5. Potential artifacts and troubleshooting 
To confirm a depressive-like phenotype, several artifacts due to general changes in behavior 
have to be considered, i.e. general changes in activity, which may alter the performance in the 
shuttle box, or pain sensitivity, which may alter the impact of footshock stress. In our set-up, 
using C57BL/6N mice, artifacts due to alterations in locomotion (i.e. ITI activity) or pain (i.e. 
hotplate) could be excluded, again supporting the validity of this model. Similarly, anxiety-
like effects, which could also modify the performance, could be excluded. It is crucial that 
these potential confounding aspects are investigated and always included in the experimental 
design, especially when phenotyping mutants, in which general changes in baseline behavior 
could account for “false positive effects” in the Learned Helplessness paradigm and other 
behavioral depression models. 
 
6.5.1. The animals are hyperactive 
If a large proportion of animals shows hyperlocomotion, which could minimize the read-out of 
the Learned Helplessness, it is suggested to decrease stress levels by i) reducing noise 
pollution in the housing facilities, ii) supplying nesting material [17,18], and iii) separating the 
genders, in order to reduce olfactoric stimulation. It goes without saying that adequate and 
standardized handling (i.e. with gloves) is fundamental. Prior to the Learned Helplessness 
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procedure, an openfield can be performed to identify and differentiate between hyperactive 
and normal animals. Since hyperactivity may be a confounding factor in models of anxiety 
and depression, it is suggested to solve this problem by a covariance analysis, thereby 
excluding the effects attributed by the hyperlocomotion. Nonetheless, severe hyperactivity 
will cause a floor effect, which cannot be compensated, and will therefore limit the suitability 
of the Learned Helplessness paradigm, and any other model that implicates locomotion. 
 
6.5.2. Too few or too many animals are helpless 
If, after inescapable shock treatment, too few or too many animals turn out to be helpless, this 
may indicate that the paradigm is not sufficiently stressful or includes too much stress, 
respectively. It is essential that the protocol allows a broad spectrum of behavioral responses, 
therefore floor and ceiling effects have to be avoided, possibly by changing current intensity 
(see (8)) or the length of the unconditioned stimulus. Additionally, a faecal bolus can lead to 
short-circuiting of the shock generator, resulting in only minimal current delivery or even an 
absence of the electric stimulus to the mouse. Permanent monitoring is therefore crucial to 
exclude those animals from the experiment. In general, housing conditions in terms of 
predispositions for stress-susceptibility (i.e. group or single, enriched or impoverished), should 
to be considered for a successful experimental design. 
 
6.6. Conclusions and preview 
 To investigate depressive-like behaviors in mice, we designed a Learned Helplessness 
protocol with good face, construct, and predictive validity. A reliable and valid protocol in 
mice is particularly important with respect to the investigation of transgenic animals, 
representing potential genetic models of affective disorders. Apart from the analysis of mutant 
mice this model can be generally used as a test for emotional behavior, to investigate 
neurobiological mechanisms in mice that exhibit helplessness or good coping performance in 
the shuttle box, respectively. Last but not least, this paradigm may turn out to represent a 
valuable tool for the assessment of new antidepressant strategies. 
 
7.    Quick procedure 
(a) Expose the mice to 360 scrambled footshocks (intensity: 0.150mA) on two consecutive 
days. 
(b) 24 hours later perform a two-way avoidance paradigm (30 shuttle escape trials) in a 
shuttle box. 
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(c) Analyze the data by considering “failures” and “escape latency” as the most relevant 
parameters for the identification of helpless animals. 
 
8.    Alternative protocols  
 Training procedures reported previously, based on the paradigm by Shanks and Anisman 
(1988) and Caldarone (2000) may represent alternative protocols (2, 14). In these protocols, 
Learned Helplessness is induced by administering 120 inescapable 4 s footshocks (0.30 mA) 
with a random interval (range 3-50 s) over a 1 h session. Training is given in two sessions that 
are spaced approximately 24 hours apart. Mice are placed on either side of the shock chamber, 
so that the shock is administered either to one or two mice simultaneously. Mice of the same 
gender are always shocked together. A control group does not receive shock but is exposed to 
the apparatus for an equal period of time. Shuttle escape testing is conducted approximately 
24 h after the second LH training session. The side of the chamber, on which each mouse is 
placed at the start of the test session, is alternated. Mice are given 30 shuttle escape trials with 
30 s intervals between the start of each trial. A gate between the two chambers opens when the 
shock turned on and the trial terminated when the mouse crosses through the gate into the 
adjacent compartment. Shock termination is delayed by 1 second after crossing. If an escape 
response is not made, the trial is terminated 24 s after shock onset. 
 MacQueen et al. (2001) make use of another modification, in which the animals receive 360 
shocks, at an intensity of 0.150 mA, lasting 2 seconds with inter-shock intervals of 9 s. Testing 
in a 30 shuttle escape trial paradigm is conducted immediately after application of the 
footshocks (6). The chambers, in which testing takes place, are equipped with a hurdle that 
opens 4 s after onset of the shock. Shock is terminated as soon as the mouse crossed to the 
other chamber. The gate is closed immediately and reopens until 4 s after initiation of the next 
escape trial. 
Alternatively to our proposed canonical analysis, the subjects could be classified by using the 
95 % confidence intervals. This classifies animals, which have scores higher than the mean ± 
2 standard deviations of the non-helpless population, as defined by k-means clustering, as 
helpless. In our case, animals with an escape latency ≥ 4.75s and failures ≥ 6 qualified as 
helpless. This method, though, has the caveat of splitting the classification into two 
independent variables. Thus, an animal, which qualifies as helpless by having a high escape 
latency may still display a low number of failures, and consequently has to be excluded from 
the study. 
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